Search by Journal
- HOME
- > Search by Journal
- > Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Volume , Issue suppl.1 / 2011
English Article 
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
Enjoy Pharmacists' Lifestyles Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2011. |
|---|
|
|
Mainly on expectation - to a medical future image and pharmacist particularly initiative medical care - Hiroo Imura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2011. |
|---|
|
|
Hospital management based on work-life balance Yoshiki Seino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2011. |
|---|
|
|
Expectation to a pharmaceutical administrative problem and pharmacist Yoshinobu Hirayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2011. |
|---|
|
|
We think about infection practice again Kentaro Iwata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2011. |
|---|
|
|
Individualization treatment of the cancer molecules target medicine Hiroshi Minami sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2011. |
|---|
|
|
Promotion of the medical supplies proper use by the application to development, a true clinic of the simple gene diagnosis The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2011. |
|---|
|
|
Analysis study of drug interactions, the side effect case aiming at medical supplies proper use Masato Honma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2011. |
|---|
|
|
Utility ... of cystatin C in the initial administration plan of applied - vancomycin hydrochloride to a drug administration design using new renal function marker cystatin C 田中亮裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2011. |
|---|
|
|
Investigation - pharmacometrics of the proper dosage method of the antiMRSA medicine and clinical pharmacokinetic study - about the side effect analysis Yasuhiro Tsuji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2011. |
|---|
|
|
Because we do not go blind for glaucoma Akira Negi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2011. |
|---|
|
|
About Kobe low involvement cancer medical center Kazuro Sugimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2011. |
|---|
|
|
New world ... which medical cloud battle front - smartphone and the fusion of the cloud draw Nakayama Olympics man Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2011. |
|---|
|
|
Regional medicine innovation to send it to from six years system pharmacy education and "medicine area" release - drugstore Ken Hazama solstice Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2011. |
|---|
|
|
It is the suggestion and practice medicine area release design Shinki Sugimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2011. |
|---|
|
|
... that the expectation to a pharmacist increased in a thing about foreign chemotherapy - loanword in the small and medium size hospital Satoko Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2011. |
|---|
|
|
Action for the pharmaceutical management of all patients and the safe outpatient department chemotherapy enforcement 日置三紀 1, Yuka Kobayashi 1, 土手賢史 1, Ayumu Nozaki 1, Hiroki Iwane 1, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2011. |
|---|
|
|
Participation in planning of the pharmacist to treatment strategy decision in the foreign cancer chemotherapy Group bridge Yuki, Yamakawa Kazunori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2011. |
|---|
|
|
The role that a pharmacist should achieve in the team approach in medical care in the foreign chemotherapy room Yoriko Wada, Koichi Matsuo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2011. |
|---|
|
|
Foreign chemotherapy patients support mainly on the side effect of pharmacist leadership management Okada sum intellect, 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2011. |
|---|
|
|
Facilitation of the role of the nurse in the foreign chemotherapy and duties by the cooperation with the pharmacist 平井代恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2011. |
|---|
|
|
Expectation to a role and the pharmacist of the nurse in the team approach in medical care by the foreign chemotherapy Mika Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2011. |
|---|
|
|
Policy of the pharmacist authorized examination specialized in a cancer Yusuke Tanigawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2011. |
|---|
|
|
Specific example (breast cancer) of the pharmaceutical intervention 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2011. |
|---|
|
|
Specific example (colorectal cancer) of the pharmaceutical intervention Masami Kawahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2011. |
|---|
|
|
Specific example (lung cancer) of the pharmaceutical intervention Pond end Hiroaki, Hiroyuki Watanabe, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 24-24, 2011. |
|---|
|
|
Specific example (hematologic cancer) of the pharmaceutical intervention 牛膓沙織 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 24-24, 2011. |
|---|
|
|
With the pharmacoepidemiology Kiyoshi Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2011. |
|---|
|
|
Medical supplies administration and pharmacoepidemiology in the future Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2011. |
|---|
|
|
Need - of the drug epidemiologist in need and pharmacy education - drug industry of the drug epidemiologist Akira Koga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2011. |
|---|
|
|
The need of the pharmacoepidemiology education that we saw from the healthcare setting Mikio Masada, Toshiaki Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2011. |
|---|
|
|
Pharmacoepidemiology education in a pharmacy school and the medicine-based graduate school Mayumi Mochizuki, Masayuki Hashiguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2011. |
|---|
|
|
Methodology - to cancer pharmacotherapy and drug economics - clinic Toshiya Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2011. |
|---|
|
|
Drug economics in the mild medical care Ise Yuya, Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2011. |
|---|
|
|
A molecular target drug and drug economics Takeshi Shiraiwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2011. |
|---|
|
|
After cancer chemotherapy and drug economics - marketing action - of the drug economics study in clinical trials Takashi Fukuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2011. |
|---|
|
|
It is ... from collection of, an evaluation of logistical support - medical information in the Pharmacist Association regional medicine cooperation room to utilization Hisashi Iijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 31-31, 2011. |
|---|
|
|
Many types of job cooperation by cancer practice cooperation pass :s-net in Shizuoka-shi Masakazu Takagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2011. |
|---|
|
|
Action in the foreign chemotherapy room in this hospital Tomoko Nonogaki 1, Toshie Matsumoto 2, Masahiro Kawaguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2011. |
|---|
|
|
From the situation of smooth many types of job cooperation - university hospital in the at-home cancer therapy proposal - of practice and the information sharing of this hospital Shun Ito is elegant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2011. |
|---|
|
|
From the situation of the nurse to be concerned with at the end of life in being at home Satsuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2011. |
|---|
|
|
Utility of a role and the many types of job cooperation of the drugstore pharmacist in the at-home psychological care Yoshiaki Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2011. |
|---|
|
|
Report - from infection control activity investigation - arts and sciences fifth subcommittee in the Japanese Society of Hospital Pharmacists Masaki Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 35-35, 2011. |
|---|
|
|
Action - Hokkaido District - of the infection control activity Just field Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2011. |
|---|
|
|
Action - Tokai district - of the infection control activity Ken Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2011. |
|---|
|
|
Action to infection control activity in Kyushu, Yamaguchi District Takashi Kitahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2011. |
|---|
|
|
Low-volume hospital - out of action - to infection control activity 継田雅美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2011. |
|---|
|
|
The resistant bacteria which we want to know Tachi field Kazuhiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2011. |
|---|
|
|
Viewpoint :one point lesson of the chest X-ray Katsunori Yanagihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2011. |
|---|
|
|
Knowledge of the microorganism test that we know it, and there is not the loss Takashi Kasahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 39-39, 2011. |
|---|
|
|
An antimicrobial agent and therapy for the gram-negative bacteria Kazuaki Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2011. |
|---|
|
|
A therapeutic drug and TDM of infection with MRSA Masahiro Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2011. |
|---|
|
|
Interventional method for antimicrobial agent proper use Yoshiko Takahashi 1, Yoshio Takesue 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2011. |
|---|
|
|
Discharge adjustment of the home care patient acceptance drugstore 白石丈也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2011. |
|---|
|
|
Discharge adjustment of patients with a tube : It is necessary to realize the [want to go back] of the patient 伊東俊雅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2011. |
|---|
|
|
Should face decision aiding in the at-home psychological care for high treatment at home of technological assistance - medical care dependence how; or ... Mitsunori Nishikawa, Kazumitsu Nakajima, Naoya Okumura, Kubokawa Naomi, 洪英在, Toshihiro Matsuura, Yuriko Yokoe, The Mitsuru Ozaki world, Jun Takeda, 芝崎正崇, Kazuyoshi Senda, Hisayuki Miura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 43-43, 2011. |
|---|
|
|
About the role of the drugstore pharmacist in the regional medicine cooperation Noriko Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2011. |
|---|
|
|
What can the pharmacist speak in regional alliances? Hideki Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2011. |
|---|
|
|
About Japanese clinical ER doc society questionnaire findings and an emergency authorized pharmacist system Junko Minemura 1, Furrow well Hiroko 2, Takeshi Kuwahara 3, Kenji Nishizawa 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2011. |
|---|
|
|
Role of the pharmacist in the ER type emergency care Middle bath Shinji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2011. |
|---|
|
|
Role of the pharmacist in ICU/CCU Kato Takahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2011. |
|---|
|
|
From the situation of role and many types of job cooperation - physician of the pharmacist in a first aid, the intensive care - The Jokou ocean Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2011. |
|---|
|
|
The role of emergency services and relations of medical supplies Shin Matsunaga male Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2011. |
|---|
|
|
From the situation of many types of job cooperation - nurse in a first aid, the intensive care - Emiko Asaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2011. |
|---|
|
|
From the situation of role and many types of job cooperation - clinical engineer of the pharmacist in a first aid, the intensive care - Hidetoshi Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2011. |
|---|
|
|
From the situation of the radiographer 坂下惠治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2011. |
|---|
|
|
Role of the social worker in the emergency care 水溜丹都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2011. |
|---|
|
|
Basic knowledge of eating, dysphagia necessary for medication Eiichi Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2011. |
|---|
|
|
Treatment at home, regional alliances and the simple suspension method Koji Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2011. |
|---|
|
|
Cancer therapy and the simple suspension method Kaori Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2011. |
|---|
|
|
Knowledge (characteristic of the preparation to understand from an additive) of the additive necessary for a pharmacist Tsutomu Konno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2011. |
|---|
|
|
Latent energy of pharmacist: Correct dissemination of simple suspension method 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2011. |
|---|
|
|
It is ... from the experience of idea and practice - diabetes theater of the diabetes empowerment Ken Okazaki Taro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2011. |
|---|
|
|
With the medical treatment instruction that they want to receive again and again Sawako Tajima 1, Minoru Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2011. |
|---|
|
|
Practice of the conference by the many types of job that made much of the psychological approach to patients with diabetes Yoriko Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2011. |
|---|
|
|
Likelihood of the diabetes medical treatment support in the health insurance pharmacy Hiroshi Okada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2011. |
|---|
|
|
We think about "empowerment", and let's take it in Toshinari Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2011. |
|---|
|
|
Medical information system to support clinical pharmacy Fumito Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2011. |
|---|
|
|
It is ... in a pharmacist and medical information engineers in charge of a medical information system - drug information room from the situation of the pharmacist Young Susumu Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2011. |
|---|
|
|
Pharmacist who assumes ICT a weapon in the future Masaki Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2011. |
|---|
|
|
A pharmacist and information system (from the situation of a medical information system section, other sections) 佐々木啓充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2011. |
|---|
|
|
Medical information engineer - pharmacist tying medical care and an information system will know the medical information; is ... Kazuyuki Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2011. |
|---|
|
Introduction Takao Orii1, Shigeru Ohmori2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2011. |
|---|
|
|
Medical Logistics -"Triage" of Essential Medicines in Emergency- Eiko Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2011. |
|---|
|
|
Emergency Pharmacy Response: Christchurch Earthquake, 2011 Jane Dawson Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 61-61, 2011. |
|---|
|
|
Medication Therapy Management in Victims of Wenchuan Earthquake Zhang Qin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2011. |
|---|
|
|
Australian Defence Force (ADF) Response to the Queensland Natural Disasters Dec 10 - Feb 11 Wendy Walker Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2011. |
|---|
|
|
The Activity Report of National Center for Global Health and Medicine Atsushi Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2011. |
|---|
|
|
Role of Pharmacists in the Frontline of Pharmacotherapy Tomohiro Terada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2011. |
|---|
|
|
Aims of the China-Japan Pharmacist International Forum Zhao Zhigang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2011. |
|---|
|
|
Pharmacy Practice Research in Collaboration with Pharmacists and Universities Shigeo Yamamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2011. |
|---|
|
|
The making of learning environment that was conscious of - listener who designed participation type learning Makiko Iwasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2011. |
|---|
|
|
We stimulate learning in clinical settings Upper mound Tomoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2011. |
|---|
|
|
To sustain A "point" charming you by role playing in "line" Yoko Ino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2011. |
|---|
|
|
We support B motivation charming you by role playing 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2011. |
|---|
|
|
To promote team approach in medical care Makoto Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2011. |
|---|
|
|
From the thing "viewpoint of patients safety officer and the nurse" to expect of a pharmacist Katsue Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2011. |
|---|
|
|
Action - duties improvement and information sharing - of the pharmacy in the team approach in medical care Masami Nishihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2011. |
|---|
|
|
Activity of the pharmacist in the treatment at home Reiko Utsunomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2011. |
|---|
|
|
About ward activity in this hospital Morihito Sako, Yoshiaki Kurata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2011. |
|---|
|
|
In order to promote team medical smoothly : What is needed is to understand each other 渡邉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2011. |
|---|
|
|
It is ... from experience by role - Great East Japan Earthquake of disaster medical care and the pharmacist Akihiko Furuta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2011. |
|---|
|
|
A change and the future of the role of the pharmacist in the most recent great earthquake disaster Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2011. |
|---|
|
|
The team approach in medical care that we experienced by disaster hospital practice Tatsuya Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2011. |
|---|
|
|
Disaster support activity and the result that we achieved as Okayama University medical care support team 名倉弘哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2011. |
|---|
|
|
The present problems that the hospital side in medicine - medicine cooperation has Reiko Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2011. |
|---|
|
|
The present problems that the opening of an office drugstore side in medicine - medicine cooperation has Emiko Akiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2011. |
|---|
|
|
About the information sharing between pharmacists engaged in cancer using the mailing list Kentaro Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 76-76, 2011. |
|---|
|
|
About education, the training system which a new face pharmacist finds Kenji Koike Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2011. |
|---|
|
|
About education, the training system which a new face pharmacist finds (from the situation of the resident) Hata Kojiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2011. |
|---|
|
|
Education - action and problem ... of the cancer medical care in the general hospital Shuichi Nawata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2011. |
|---|
|
|
Mission ... of the pharmacist for the palliation in mission vision - cancer chemotherapy Iibaru University Minoru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2011. |
|---|
|
|
Leadership, communication, trace of EBM - Japan team on koro Gee program ten years and future ... Yumiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2011. |
|---|
|
|
Team alignment ... which is pursued in team building - psychological care team Tomoko Izawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 80-80, 2011. |
|---|
|
|
It is ... for qualitative improvement of the ... antinausea therapy to make to use the evidence for Kenichi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2011. |
|---|
|
|
A viewpoint and the nature that are found by leader next-generation on koro Gee Chikako Shimizu 1, Tomoko Izawa 2, Hiroshi Ueda 3, 佐治重衡 4, Naoto Ueno 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2011. |
|---|
|
|
- to regard a record as quality management from approach - clinic settings of the medical quality improvement by the clinical path Hidehisa Soejima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2011. |
|---|
|
|
Effective operational ... pass and team approach in medical care ... of the pass Funada Chiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2011. |
|---|
|
|
The team approach in medical care that pass and NST: spread through more and more Eiji Yamanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2011. |
|---|
|
|
Action ... medicine medicine cooperation and clinical path ... to regional alliances pass Yoshiko Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2011. |
|---|
|
|
The hematapostema is different in "here" abstruseness in the physicians! Mitsuhisa Azuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2011. |
|---|
|
|
Nursing care - practice and education ... of patients with hematapostema Emi Fujii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2011. |
|---|
|
|
As for the basics of the approach of thing - pharmacy that felt from care of patients with cancer, same; is ... Ayumi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2011. |
|---|
|
|
Description of new face strenuous efforts in the hematopoietic cells transplantation center Naoki Mukoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2011. |
|---|
|
|
Need ... of presence, the horizontal connection of role - comrade of the pharmacist in the blood medical ward Uchida まやこ 1, Pond end Hiroaki 1, Takayuki Ishimaru 2, Hiroyuki Watanabe 1, Mishima one up 1, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2011. |
|---|
|
|
It is action ... of the multicenter cooperation the many types of job in ... Aichi for adequacy and improvement of the colorectal cancer chemotherapy 室圭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2011. |
|---|
|
|
Examination of the nursing intervention by the multicenter conjugation in the manual preparation 溝口真巨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2011. |
|---|
|
|
Administration management in the colorectal cancer chemotherapy regimen Yumiko Sone Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2011. |
|---|
|
|
Nausea, vomiting measures in the colorectal cancer chemotherapy Hiroaki Sakurada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2011. |
|---|
|
|
Bowel control in the colorectal cancer chemotherapy Isao Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2011. |
|---|
|
|
Suggestion of cutis symptom measures with the antiEGFR antibody preparation in the colorectal cancer chemotherapy Katsuhiro Kondo 1, Koji Kozaki 2, Junpei Utsunomiya 3, 中村卓巨 4, Tree Masaji 5, Junko Kuroda 1, 木村和哲 1, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2011. |
|---|
|
|
Hand foot syndrome in the colorectal cancer chemotherapy Masayuki Ejiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2011. |
|---|
|
|
Vascular pain-like symptom in the colorectal cancer chemotherapy Atsushi Tomita sum 1, Satoshi Hibi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2011. |
|---|
|
|
Stoma management during colorectal cancer chemotherapy Masayo Sofue 1, Ayako Honda 2, Satsuki Kuroki 3, Aiko Koide 4, Keiko Hirose 5, Megumi Oishi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2011. |
|---|
|
|
Making of the medicine medicine cooperation tool supporting colorectal cancer chemotherapy Shigeki Nakane 1, Chie Yamaguchi 1, Toshiko Furukawa 2, Miyuki Suzuki 2, Kae Matsuoka 2, Etsuko Mishima 3, Mayumi Takeuchi 3, Michiko Tatematsu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2011. |
|---|
|
|
About DPC and team approach in medical care and bringing medicine management Masaki Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2011. |
|---|
|
|
Role of the pharmacist in perioperative care 西澤延宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2011. |
|---|
|
|
Significance of the bringing medicine control center Miyake hemp sentence, Naoharu Miyamoto, Country original Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-95, 2011. |
|---|
|
|
Bringing medicine management ... not to use self-institution prescription type bringing medicine - bringing medicine for Kazuyoshi Nakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2011. |
|---|
|
|
Problems of the preoperative cancellation medicine management as the team approach in medical care that an operating room pharmacist receives and future development 畝本賜男, Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2011. |
|---|
|
|
About a bringing medicine control center of this hospital Kenichi Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2011. |
|---|
|
|
Method of the questionary survey Junko Okuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2011. |
|---|
|
|
Statistical basics to evaluate clinical studies data definitely Sato Yasunori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2011. |
|---|
|
|
Point of the document retrieval to push forward clinical studies Juichi Otani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2011. |
|---|
|
|
Summary of the case research Masato Honma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2011. |
|---|
|
|
Be tied to a study and summarize a question of the normal business routine in an article Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2011. |
|---|
|
|
Action for the life study as the scientific organization of the Pharmaceutical Society of Japan Norio Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2011. |
|---|
|
|
Life study and specialized pharmacist Mayumi Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2011. |
|---|
|
|
Action introduction - of branch office activity of the Pharmaceutical Society of Japan and local activity and the life study - China Shikoku Branch (and the University of Tokushima) Yoshihisa Takaishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2011. |
|---|
|
|
Introduction - of Pharmaceutical Society of Japan Branch and a local action introduction: branch office activity of the Pharmaceutical Society of Japan and local activity and the action of pharmacist life study - Tokai branch office Tadashi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2011. |
|---|
|
|
Six years system pharmacy education and pharmacist lifetime education 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2011. |
|---|
|
|
Tohoku district of lifelong study of efforts : That it has sought the pharmacy pharmacist in the Great East Japan Earthquake 高橋寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2011. |
|---|
|
|
How does the basic education help problem solving of the patients? Hiroshi Onishi High School Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2011. |
|---|
|
|
Where does the basic education of the pharmacy school go to? Tomohisa Yasuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2011. |
|---|
|
|
Role of the experimental medicine in the department cooperation type PBL tutorial Ryuta Kataoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2011. |
|---|
|
|
Linkage of experimental medicine and the clinical medicine in the medical education model core curriculum Masami Tagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2011. |
|---|
|
|
About the purpose of this symposium Yoshihisa Kitamura 1, Takashi Egawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2011. |
|---|
|
|
About the joint education curriculum (medical system integrated education) of the medical system department in Kyushu University Takao Shimazoe 1, Yoshida bare sentence 2, Hisako Nakao 3, Ichiro Takahashi 4, Satoshi Morimoto 5, Toshio Kubota 1, Daisuke Kobayashi 1, Utako Iwakiri 1, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2011. |
|---|
|
|
Action ... of the cause practice on-site training of the construction - Dr. instruction of the regional alliances advance program to practice ability for clinical application 名倉弘哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2011. |
|---|
|
|
Action of the advance clinical practice after the business training in the cooperation university hospital Hiroyuki Kamei 1, 半谷眞七子 1, Tsutomu Yoshida 1, Yoichi Hasegawa 1, Yukihiro Noda 1, Ken Mori 1, 牧原俊康 2, Masaya Masuda 2, Takahiro Hayashi 2, Hiroaki Yano 2, Iwata relation straight 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2011. |
|---|
|
|
The enforcement of the workshop of the cooperation education with the paramedical subject and the patients participation and educational discussion Naoko Ideguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2011. |
|---|
|
|
Action of Nagasaki pharmacy, the nursing commissure consortium that looked after medicine, and aimed at the realization of the many types of job team at-home support by the cooperation the term of the organizer Mikiro Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2011. |
|---|
|
|
Action ... of "the hydrangea net" which aimed at the quality improvement of value - regional medicine of the medical cooperation using ICT 松本武浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2011. |
|---|
|
|
The advice of the specialist in role ... meal of dentistry in the at-home practice Yasuko Kotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2011. |
|---|
|
|
What a pharmacist should do in a home medical care support team Teshima infinity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2011. |
|---|
|
|
A home care support drugstore meeting for the study and activity of the nurse in the ethical pharmacy The Kawashima straight beauty Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2011. |
|---|
|
|
Home health care support by the manufacturing Takakazu Ishimatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2011. |
|---|
|
|
From the situation of - physician investigating the way of the team approach in medical care in the HIV infection practice - Asako Kamihira Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2011. |
|---|
|
|
From the situation of - nurse investigating the role of the pharmacist in the HIV infection practice and the way of the team approach in medical care - Petty official Arika Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2011. |
|---|
|
|
From the situation of - pharmacist investigating the way of the team approach in medical care in the HIV infection practice - 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2011. |
|---|
|
|
Problems and the conquest method of the small team Forest Shangyi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2011. |
|---|
|
|
Activity of the pharmacist in the HIV infection team of the Siwash Hospital Well hilum Keiko, Hiroshi Kimura, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2011. |
|---|
|
|
From the viewpoint of management - management plan of the team approach in medical care era - Karimata Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2011. |
|---|
|
|
Technique of the hospital management to send from the drug section Tetsuro Yumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2011. |
|---|
|
|
From the situation of practice - talented person management of the management in the medical care - Yuko Fukazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2011. |
|---|
|
|
Role of the pharmacist in the CKD treatment Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2011. |
|---|
|
|
From the situation of the role physician of the pharmacist in the team approach in medical care of the chronic kidney disease 今井圓裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2011. |
|---|
|
|
We manage pharmacotherapy of glomerulonephritis, the vasculitis Satoshi Kosaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2011. |
|---|
|
|
Acquisition of CKD measures - renal function information carried out in health insurance pharmacy and patients-adaptive - Yuzuru Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2011. |
|---|
|
|
It becomes the total navigator of the pharmacotherapy in dialysis medical care Old Taku Kubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2011. |
|---|
|
|
Skill of the pharmacist necessary for chronic kidney disease (CKD) measures Takeshi Miyake sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2011. |
|---|
|
|
Team approach in medical care in the infection practice 大路剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2011. |
|---|
|
|
Interactive communications of the microorganism test Tsuyoshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2011. |
|---|
|
|
Upbringing of the pharmacist who can watch an antimicrobial agent 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2011. |
|---|
|
|
A pharmacist being team approach in medical care Mutsumi Yoshioka exhibition Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2011. |
|---|
|
|
Chromosome 5 and 7 Abnormalities in Oncology Personnel Handling Anti-Cancer Drugs Melissa A.McDiarmid Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2011. |
|---|
|
|
Anti-cancer agent exposure and risk management 甲田茂樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2011. |
|---|
|
|
Suggestion of the check list utilization for safe anticancer drug preparations Jin Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2011. |
|---|
|
|
Pollution survey of the anticancer drug preparation environment of the laboratory of cancer Ariake Hospital Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2011. |
|---|
|
|
Examination about the effect of aprepitant on vomiting during vinorelbine / cisplatin combination therapy Nakamura light 1, Satoshi Yamada sand Kei 1, Hideyuki Motohashi 1, Celebration Chikako 1, Ikuko Yano 1, Makoto Sonobe 2, Hiroshi Date solstice 2, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011. |
|---|
|
|
Antinausea effect of aprepitant on carboplatin-based chemotherapy in lung cancer treatment 光家勉 1, Kunio Tomita 1, 樹下成徳 1, Akira Yamanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011. |
|---|
|
|
About drug choice for nausea, vomiting in the cancer chemotherapy antiemetics choice investigation (interim report) - by the patients at the - EC therapy Sekiya wisdom, Ryoko Maruyama, Tokie Kondo, Fumiko Tsujiuchi, Kanako Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011. |
|---|
|
|
Evaluation of the depression effect using VAS(Visual analogue scale) for nausea, vomiting with the cancer chemotherapy 篠原義剛 1, 2, Yoshifumi Nakayama 2, Takayuki Torigoe 2, 皆川紀剛 2, Koji Yamaguchi 2, Kojiro Takahashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011. |
|---|
|
|
An antinausea effect and economic effect by the change of nausea, vomiting measures in the cancer chemotherapy 兼行由佳 1, Kazunari Taniguchi 1, Fuminori Matsubara 1, Wasaburo Kataoka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2011. |
|---|
|
|
Examination about the risk factor of nausea, vomiting in the CHOP(R-CHOP) therapy 南目祐希 1, Tomoko Saito 1, Akira Endo 2, Great residence Shinji 2, Taira Aoyama one 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011. |
|---|
|
|
Comparison of a hydrochloric acid Inge Seto Ron lock and the granisetron hydrochloride injection in the EC, FEC therapy 櫻下弘志, Yasuyuki Saeki, Hiroshi Yoshikawa, Tetsuya Murase, Furrow well Hiroko, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011. |
|---|
|
|
Questionary survey about the antiemetics supplementation for cancer chemotherapy-induced nausea and vomiting Small Ido Keiichi 1, 2, Shuichi Oda 1, 3, Makiko Hamada 1, 4, Shoichi Miyata 1, 5, Hiroki Miyata 1, 6, Takako Kuroyanagi 1, 7, Hisashi Shimizu example 1, Tadao Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011. |
|---|
|
|
It is ... about association of an analysis - serum albumin level and the adverse event occurrence of predictor for the adverse event development of patients receiving cisplatin Akira Maeda light 1, Masahide Matsuzaki 1, 宇良敬 2, Tomoya Nagase 1, Shinji Takahashi 1, Michiko Tatematsu 1, Seiya Mizuno 1, Keiichi Kato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011. |
|---|
|
|
Action ... in clinical studies - cure society cancer specialty pharmacist training first year about the antiemetics for patients with breast cancer that a pharmacist stands and nominates 1, Naoya, Hashimoto, Kazuyo Nakamura 2, Nabeta Izumi 2, Akiko Mochizuki 2, 中條倫成 2, Kuromi Mayu 2, Hiroaki Utsuki 2, Midori Kimura 2, 高橋鉄治 2, Tsuneizumi Michiko 3, Kazuhiko Nakagami 3, 河原崎貴伯 2, Takashi Suzuki charges 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2011. |
|---|
|
|
Effect to result in for the making of the cancer pain opioids induction clinical path by the pharmacist leadership and mild pharmacotherapy Noriko Kaneta, Hirohira Fukami, Kayoko Iwamoto, Tsuyoshi Yamashita Shiro, Koichi Hirose, Masatsugu Fujita, Junko Terada, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011. |
|---|
|
|
Relation of prescription actual situation and psychological care Committee of the side effect preventive medicine combination at opioid induction Hiroki Tokutake 1, 2, Kawada Masakiyo 1, Takashi Maruoka good luck 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011. |
|---|
|
|
From utility - therapeutic stage when a pharmacist intervenes in patients with cancer continuously to the terminal phase; and - Misae Takase 1, 2, Hiromi Hara 1, Way field Momoyo 1, 2, Emi Ishikura 1, Yuki Fujii 1, Three possible Hiroshi 1, Masahiro Kikuta 1, Mutsumi Hayashi 1, 武島稔 1, Toshiro Nishimura 1, Kazuhiko Shibata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011. |
|---|
|
|
Examination of intravenous administration prescription of the octreotide injection and filter passage characteristics Reina Nishigaki 1, Hata Kojiro 1, Sanshiro Aizawa 1, Mari Saito 1, Totsuka ゆ K 2, Toru Akagi 1, 牧野好倫 1, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011. |
|---|
|
|
1 case that was able to relieve morphine-resistant pain Narita good luck tree 1, Hiroshi Nakajima 1, Yutaka Kato Jiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2011. |
|---|
|
|
The use situation of the fentanyl citrate percutaneous absorption type preparation of the once a day pasting for cancer pain Chiyoko Yamada, Miwa Yonezawa, Shigeharu Kiyama, Takeshi Nishimori, 柏原宏暢, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2011. |
|---|
|
|
The handling actual situation of patients awareness and the home Residual medicine for the prescription of the nonsteroidal antiphlogistic balm patch 松岡紗代1, 三木晶子2, 佐藤宏樹2, 堀里子2, 3, 澤田康文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011. |
|---|
|
|
A hospital, the pressure sore problem in the nursing facility and development of the prevention of bedsore preparation Naoko Iimura 1, Yuki Endo 1, Akiko Sakamoto 1, 継田雅美 2, Yuriko Inada 2, Takashi Toyoshima thickness 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011. |
|---|
|
|
Study on fact-finding of the medical treatment in the area medical circle 岩月進 1, Takahiro Kito 2, Mitsuhiro Okazaki 2, Tei Nomoto 3, Kaori Kurata 4, Akira Dobashi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011. |
|---|
|
|
Clinical proof experiment report of the health consultation in the drugstore using the extensive remote health consultation system Mitsuhiro Okazaki 1, Yoshicho Masako 2, Teruaki Goto 2, Shingo Tamura 3, Iwamaru Hiroaki 3, Tomoko Shimoda 4, 良村貞子 4, Katsuhiko Ogasawara 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011. |
|---|
|
|
Examination about the drugstore function for self-health care in the regional medicine Yasuhiro Fukahori 1, 2, Yoshicho Masako 1, Teruaki Goto 1, Mitsuhiro Okazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2011. |
|---|
|
|
Recognition degree investigation of the drug information about aspiration pneumonitis, dysphagia in the caretaker Keisuke Yoshida 1, Kazuhito Nakamura 2, Kimihiko Urano 1, Kameyama seven ear 1, Takashi Katano University 1, Jun Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011. |
|---|
|
|
Examination of the utility of the inhalational check sheet in the Saga inclusion breathing rehabilitation cooperation 湯川潤輝 1, Akiko Emoto 1, Masaru Tanaka British 2, Kazuhiro Hirano 1, Shinichiro Hayashi 2, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011. |
|---|
|
|
Using the practice regional collaboration tool of medicine cooperation [My medical record: catheter treatment of coronary artery disease] in the cardiovascular area 柴田啓智1, 一野仁実1, 堀川幸子1, 黒木多美子3, 坂本知浩2, 中尾浩一2, 田上治美1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011. |
|---|
|
|
Of the medicine medicine cooperation of the patients becoming the treatment at home after a discharge wrestle, and participate in conjugation instruction at a - discharge; and - Takanobu Ichino 1, Yuji Noda 2, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2011. |
|---|
|
|
Action of pharmacotherapy managing (CDTM) in the Katsura, Kyoto Hospital blood internal medicine 土手賢史 1, Chiharu Murakami 1, Ayumu Nozaki 1, Yuka Kobayashi 1, Takeshi Hattori 4, Shoichi Doi 3, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011. |
|---|
|
|
Examination of quality and the economic effect by the ward permanent residence of the pharmacist Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011. |
|---|
|
|
Search of the likelihood in the ward duties expansion of the pharmacist Shoji Matsumoto 1, Yayoi Yoshida 1, Tadashi Mikami 2, Yasuyuki Kondo 1, 三木生也 1, Naoki Furukawa 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011. |
|---|
|
|
Fact-finding of the drug-related duties in the ward Naoki Furukawa 1, Yayoi Yoshida 1, Tadashi Mikami 2, Yasuyuki Kondo 1, 三木生也 1, Shoji Matsumoto 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011. |
|---|
|
|
Duties reform of the Ogikubo Hospital drug department Minako Tsukada, One river Etsuko, Makiko Osawa, Two stone Naoko, Yumi Watanabe, Former Eriko, Yumi Kawabata, Matsushima greens, Reiko Yokota, The Yamamoto tomorrow beauty, 井上亜悠, Koshida texture incense, Atsuko Ueda, 前田真輝, Nagano one group, Junko Ota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2011. |
|---|
|
|
Report of the examination for blood drug levels order enforcement for the bringing medicine by the pharmacist 古川静保, Katsuya Nakano, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2011. |
|---|
|
|
Induction examination of the duties support system using medical supplies bar code Takahiro Suzuki 1, 3, Fumito Tsuchiya 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011. |
|---|
|
|
Dispensing error prevention system - using dispensing error measures - PDA in the municipal Sapporo hospital Kaoru Otani, Toshiaki Teratani, Naoko Ozaki, Yoko Makino, Momoko Shishido, Junichi Yamada, 佐藤友啓, Tsuyoshi Takahashi, 結城祥充, Goto Ninna, Hiroshi Kuronuma, Shinji Iwai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011. |
|---|
|
|
Construction and inspection of the high-precision tablet inspection system (brand name: inspection range) which and is high efficiency 阿部武由1, 小西正晃1, 竹内敏己2, 安藤力3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011. |
|---|
|
|
Incident measures and the effect to affect medical supplies Upper kudzu Yoshihiro 1, Akihiko Nimura 1, Tomomi Ito 1, Kenzo Shibata 1, Keiko Nozaki 1, Minako Kawakita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011. |
|---|
|
|
The present conditions and example analysis of the risk aversion (pre-Abo id) by the pharmacist Takahiro Goto, Aiko Koyanagi, Kozue Kurihara, 揚張真利子, Iwamizu proton, Kusaka Toyoshi, Yusuke Taki, Hirokazu Yamashiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2011. |
|---|
|
|
An effect investigation to pre-Abo id by the drug control instruction duties expansion and the analysis Riyo Tamura, Tomoaki Kawano, Rie Ozeki, Shinji Takayama, Kenichiro Kawana, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011. |
|---|
|
|
From the attitude survey results of two times about the safe handling of result - medical supplies of the continuous medical supplies safety management education to a nurse - Keiko Kitajima 1, 後藤志央 1, Shrine Akihiro Ichiro 1, Maruyama Akina 1, Tatsuya Sasaki 1, 末安由拓 1, Kaifu Masayo 1, Akihiro Kai 1, Ishikawa immensity 1, Prince Taniguchi chapter 1, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011. |
|---|
|
|
Actions from the adequacy of the prescription in the Mr. care institution to medical security Tomoki Nozoe 1, Wataru Yasunaga 1, Nakakubo Akiko 1, Toshiro Sonoda 2, Katsuro Orita 2, 牧角丞冶 2, Katsuhiro Ose 3, Mari Shimada cord 3, Ryo Imakiire 3, 牧角寛郎 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011. |
|---|
|
|
Examination of the effect that a color difference gives to the appearance similarity ratio of the PTP sheet of medical supplies Tamaki Hirofumi 1, Hiroki Sato 1, Moat foster child 1, 2, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011. |
|---|
|
|
Factor analysis to give a weight error in the half lock division of the tablet Naoto Ikeda 1, Yasutaka Nakamura 1, 大島幹弘 1, 3, Kazuhito Kosuge 2, Hiroshi Yamada 2, Matsuyama solstice 1-resistant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2011. |
|---|
|
|
Benzodiazepine-based hypnosis, sedative during pregnancy, examination about the anxiolytic use Sakai wish 1, Megumi Tanaka non-1, Daiya Sakurada 1, Trimming off Expo 1, 2, Kazumi Goto 2, Tomonori Nakamura 3, Yasushi Yamamoto Jiro 3, Eriko Kobayashi 3, Noboru Sato example 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011. |
|---|
|
|
Activity of Cytochrome P450 of the liver of the pup decreases when we take in high fat diet during pregnancy 岡庭健洋, 今堀由賀里, 猿田かな子, 石井敬, 戸田雄大, 五十嵐信智, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011. |
|---|
|
|
The duties contents of the lap product mother and the child center permanent residence pharmacist and the evaluation Sect Ayako, Chiaki Okamoto, Nobuko Omoto, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011. |
|---|
|
|
Search of the laxative suitable for constipation induced by hydrochloric acid Seve Lamar Ayaka Sota, Misato Nagashima, Takeki Narita, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011. |
|---|
|
|
Utility evaluation study of the multivitamin supplement for renal disease Tomoko Taira 1, Takashi Ishimatsu 2, Akihiko Sonoda 2, Hideo Hirayama 2, Takeki Narita 1, Daisuke Kadowaki 1, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2011. |
|---|
|
|
Relation of the pharmacist to use of overactivity bladder therapeutic drug Hiroshi Tani child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011. |
|---|
|
|
It is predicted the consumption after the induction of the normal saline solution pre-filled syringe preparation for the securing of route based on the antimicrobial agent consumption Shiho in the ball, Yagi Tatsuya, 山田尚広, Takashi Osawa, Takafumi Naito, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011. |
|---|
|
|
Pediatric medication compliance change interim analysis with the growth 嘉屋道裕, Nabeta Izumi, Keiko Hirano, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011. |
|---|
|
|
Glaucoma in our drugstore, examination about the use of eye drops situation of patients with cataract Aya Ono 1, Junichi Okada 1, Rie Imura 1, Noriko Inoue 1, Your Satoshi Matsuzaki 1, Tomoya Miyauchi 1, Ayumu Yamaguchi 1, Hitomi Ochiai 1, Minoru Hamamoto good luck 1, Yoshie Nishizawa 1, Miki Nagao 1, 楫野知佐乃 1, Seiko Inada 1, Takemori Kimikatsu 1, Ryutaro Fujimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011. |
|---|
|
|
Attitude survey about the intervention of the care staff to drugstore - patients interval Hidekazu Tanaka 1, Masahiko Hirayama 2, Young Susumu Hayashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2011. |
|---|
|
|
Participate in activity - medical safe whole country conjugation behavior of the pharmacist in the medical safe promotion sectional meeting; and - Mitsuhiro Kaneta, Yuji Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011. |
|---|
|
|
The manual observance of the measurement syringe of the oral liquid drug and the cognitive situation Eiji Hotta 1, Nakane disputant 1, Tsutomu Tanaka 1, River Takashi 1 who likes it, Harumi Suzuki 2, Miho Sakurai 3, Michiko Hatanaka 2, Koichi Arita 4, Kojiro Takashima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011. |
|---|
|
|
Taste bitter prediction of the marketing ambroxol tablets which added temperature Haji River dance, Yuka Sugino, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011. |
|---|
|
|
A preparing compound and emission characteristics of the wu-ling-san Yukiko Katagiri, 宮嵜靖則, Satoshi Uchino sincerity, Yoshiyuki Kagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011. |
|---|
|
|
One case that we made a levothyroxine suppository and used for patients with hypothyroidism that we were not able to take 鈴木渉太 1, 2, 3, Yutaka Okada 2, 伊藤有祐 3, 三木生也 1, Yasuyuki Kondo 1, 笠原優瑠 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2011. |
|---|
|
|
The effect that intervention for the proper use of the albumin preparation gives to albumin preparation consumption Ise Yuya 1, Hisashi bearing fruit near the root tree 2, Kenji Tajika 3, Kiyoyuki Ogata 4, Shiro Katayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011. |
|---|
|
|
Recommendation according to the organ system for systemic medical treatment management in the intensive care region Kenichi Nakazono, 高野尊行, Osamu Usui, Manabu Sato, Yasushi Kawatsu kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011. |
|---|
|
|
Initial correspondence aiming at safe security including the common use medicine in patients in emergent admission Satsuma Yukari, Middle bath Shinji, 奥貞佳奈子, 高瀬友貴, Naoko Harada, Ayako Konishi, Kanamori Kengo, Eiki Torii, Kazuko Nishioka, 奥貞智, Kitada Noriaki, 田中詳二, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011. |
|---|
|
|
TDM of the vancomycin hydrochloride at persistent hemofiltration dialysis enforcement Takeshi Morimoto trunk, Katsuji Shimizu, Mieko Suzuki, 山本倫数, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011. |
|---|
|
|
The comparison between ICU and blood level of valproic acid in the patients of the neurosurgical ward and effect of hypoalbuminemia Kazumasa Yasui, Nakamura lawn intellect, Water wisteria Hiroaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2011. |
|---|
|
|
One patient whom drug-resistant coronary spastic angina developed in during conservative treatment of the acute aortic dissection Naoto Hirata 1, Nobuyuki Totsuka 2, Yuka Yamazaki 1, 3, Nakazawa one net 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2011. |
|---|
|
|
Medication guide for patients in the medical supplies risk management Takako Igarashi, Takahiro Inoue, Tatsuo Kishi, Norihiko Yoda, Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011. |
|---|
|
|
Fact-finding of tablet crush, the de-capsule compounding of medicines using receipt data Kaori Ouchi, Shinya Goto, Ryuichi Takamatsu, Ayumi Kawamata, Kyoichi Hayashida, Yasunari Mano, Iori Hirosawa, The Tajima Eastern Orthodox Church, Yoshinori Kato, Harumi Yamada, Kotaki one, Toshiya Ikeda, Mariko Asahi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011. |
|---|
|
|
Is the attached document of the non-prescription drug beneficial? Setsuko Tomioka, Hyperplasia Naomi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011. |
|---|
|
|
Action to the voluntary report promotion of the side effect using a medicine notebook Shinsuke Yuasa 1, Ryota Murayama 2, Yamamoto High School size 3, Daisuke Matsubara 4, Yumi Tanaka 5, Paulownia Yoshie Hayashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2011. |
|---|
|
|
Is the antimicrobial agent registration system necessary in the institution with the infection control working full time staff? Shingo Takubo 1, Yoshiko Takahashi 1, Yoshio Takesue 2, Mizuho Murakami 1, Mika Ishihara 1, Takashi Ueda 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011. |
|---|
|
|
Vancomycin hydrochloride powder daily doses standardization and evaluation of the efficacy with it Nobushi Yamamura, Tomoko Kitamoto, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011. |
|---|
|
|
Attitude survey of patients with diabetes that a specialist recognized education hospitalization to be need Hiroko Akasaka, Myoudani Sanae, Tajima Keiko, Kenzo Senzaki, Kayoko Ihara, Seki Kyoko, Takayuki Mizoguchi, Tomoko Nagata, 鹿間良弥, Takashi Inoue solstice, Tadaaki Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011. |
|---|
|
|
The need of the HMG-CoA reductase inhibitor for the acute myocardial infarction patients Yuki Meishin, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011. |
|---|
|
|
Investigation about the aprepitant proper use of this hospital 宅和真由美, Yoko Imoto, Kenji Murakami, Goto sheath, Keiko Sano, Noriko Otomo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2011. |
|---|
|
|
International comparison ... of problems - attachment document of alerting it of the high-risk drug interaction Riyo Yamaguchi 1, Yoshiyuki Ono 1, Gutter slope Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011. |
|---|
|
|
Effect - second report - that the combination of clopidogrel and proton pump inhibitor in the coronary-artery stenting patients gives to a clinical outcome Masayuki Tanaka, Yukiko Inui, Haruna Kita, Yuko Kuhara, Aya Nakano, Asami Miura, Hiromi Utsumi, Ryohei Fujii, Atsuko Utsunomiya, Yuko Adachi, Nishiyama rich person, Mayumi Inoue, Furunaga Ikumi, Hisayo Kadoi, 打谷和記, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011. |
|---|
|
|
The effect that steroid administration gives for anticoagulant effect of the Warfarin in large quantities in the malignant lymphoma Kentaro Tani 1, Ikuyo Ota 2, 桂行孝 2, 吉田近思 2, Haruo Iwase 1, Takuya Yoneno 2, Yamanoi Kenichi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011. |
|---|
|
|
Pharmacokinetic model analysis of the interaction of phenytoin and capecitabine Hiroki Sato 1, Shohei Miyazaki 1, Pond Masayuki Nishi 3, Miyuki Sakurai 5, 林口剛泰 3, Masatoshi Sano 3, Mutsumi Ueda light 3, 樽野陽亮 4, Kaori Kawahara 5, Rie Ueda 5, Ryuhei Yamada 6, 大鳥徹 7, Kenji Matsuyama 7, Akiko Miki 1, Moat foster child 1, 2, Eiji Fukui 5, Eitaro Nakatsuka 3, Yasufumi Sawada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011. |
|---|
|
|
Case of the serotonin syndrome that was thought to become severe by combination of amantadine and fluvoxamine Tetsuro Koide 1, 2, Takuya Iwamoto 2, 3, Katsuhiro Tanaka 4, Kaoru Kuroki line 4, Masatoshi Muramatsu 4, Shinko Okuda 2, 3, Keiko Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2011. |
|---|
|
|
Induction of the cervical cancer prevention vaccine for the staff and side reaction survey Fumiko Kato 1, Fukuda incense ear 1, Yuka Tsutsui 1, Tatsuhiko Kitamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011. |
|---|
|
|
Study on clinical response - first report - of the new bisphosphonate preparation minodronate in patients with primary osteoporosis 廣瀬正幸1, 金山康秀2, 竹本雄一1, 土屋廣起2, 高木英希2, 岩田久3, 山田成樹1, 5, 鍋島俊隆4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011. |
|---|
|
|
1 case that investigated dumping syndrome using CGMS (sustained blood glucose monitoring system) Koichi Matsumoto 1, Toshiyuki Takahashi 1, Zennya Katsura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011. |
|---|
|
|
Than an analysis - "standard-like medical examination, health guidance program" interview for lifestyle improvement flow sheet trial manufacture for the pharmacy school lecture teaching materials - Masako Fukuda 1, Masaya Urakami 2, Minoru Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011. |
|---|
|
|
Team approach in medical care of health insurance pharmacy and the hospital for HIV infection Miki Nakamura, 平山淳恵, Kumiko Okuda, Castle Yoshie, Red field Takehiko, Yosuke Kashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2011. |
|---|
|
|
Questionary survey about the action of the present conditions of the TS-1 patient compliance instruction in the health insurance pharmacy and the drug reporting 吉田幹宜 1, Masato Yonemura 1, Yasuhiko Ichida 1, Junko Kitsu 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011. |
|---|
|
|
Trial of the medicine medicine cooperation in the foreign chemotherapy that a treatment diary used "chopsticks" Takahashi sand Yuri, Takeshi Iwasaki, Nabeta Izumi, Kazuyo Nakamura, Hiroaki Utsuki, Midori Kimura, 高橋鉄治, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011. |
|---|
|
|
Medicine medicine cooperation with the (Corp.) Hofu Pharmacist Association in the Yamaguchi Prefectural comprehensive medical care center outpatient department chemotherapy Akihiro Kawanaka 1, 2, Yasuko Matsuura 2, 3, Watanabe Tarou 1, 2, Excellent Wada Kosuke 1, 2, Blunt sword Hiroki 2, 4, It is finally 1 Kuni Isobe, 2, It is still 2 Minoru Yanagi, 5, Katsuhiro Yamada 1, 2, Hiroshi Kimura light 2, 3, Junko Fukuda 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011. |
|---|
|
|
What you should do next to medicine medicine cooperation - reporting means construction in the cancer chemotherapy is some ... Toshiya Goto 1, Kazuaki Hirose 1, Tomomi Matsushita 1, Akira Takada 1, 橋本久敬 2, Noriko Sawai 2, Yoshio Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2011. |
|---|
|
|
Think about the way of pharmacist in the future through disaster medical care; from experience in Minamisanriku-cho after the Great East Japan Earthquake: It is still 1 Takashi Hashimoto, 2, 3, 4, Hiroshi Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011. |
|---|
|
|
About DMAT dispatch of this hospital in the Great East Japan Earthquake Naoki Hara 1, Otsukawa Kazuto 2, Hideaki Murakami 3, Fumiko Mihara 3, Masami Saeki 3, Akie Ijiri 3, Naoto Mita 4, Shinya Hara 4, Kenzo Taguchi 4, 川嵜英二 1, Takashi Toyota 1, 中森智毅 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011. |
|---|
|
|
From the medical support for the stricken area of the Great East Japan Earthquake and establishment of the role -1 first-aid station of the pharmacist to withdrawal - Middle bath Shinji 1, 2, Shozo Tamura 1, Kitada Noriaki 1, 奥貞智 1, Rice corner Toshihiko 1, 濱宏仁 1, Flat field Masaki 1, Up Kazuko 1, Kenji Yamamoto 1, 田中詳二 1, Koichi Ariyoshi 2, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011. |
|---|
|
|
An example of activity and the prescription contents investigation of the pharmacist in the temporary medical office of the stricken area Makoto Nakajima 1, Takuya Goto 1, Takahiro Kumagai 1, Yoshie Nomura 1, Yukiko Shibata 1, Shuichi Matsumoto 2, Nobuyuki Mishima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011. |
|---|
|
|
Formulations and medication counseling - 2011.3.11 Great East Japan Earthquake and massive tsunami disaster ... by the small refuge patrol practice that became the law fast 香取哲哉1, 小川直紀1, 中谷美緒1, 加藤恭平1, 3, 宮坂善之2, 3, 菅原圭司1, 出雲貴文1, 高橋智4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2011. |
|---|
|
|
The present conditions and problem of the infection measures that a pharmacist is concerned with by disaster support Naoki Ogawa 1, Keiji Sugawara 1, Tetsuya Katori 1, Kyohei Kato 1, Mio Nakatani 1, Takafumi Izumo 1, Yoshiyuki Miyasaka 2, 3, Satoshi Takahashi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2011. |
|---|
|
|
Comparison of the smoking cessation success rate before and after the instruction system review of the pharmacist Yu Tanabe Takako 1, 2, 3, 4, Takashi Yokochi 1, Aya Uchino beauty 1, Midori Hasegawa 1, Yu Ono Castle 2, Takuya Kudo 1, Chizuko Hamada 3, Noriko Yamagishi 3, Kohei Hashizume 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011. |
|---|
|
|
The pharmacist outpatient who took advantage of medical examination waiting time Junko Onishi 1, 2, Plum Miyoshi 1, Hiroko Nakamura 3, Yoneta lawn cord village 3, Yoshihisa Kitamura 3, Hiromi Kawasaki 2, Humble house net 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011. |
|---|
|
|
Treatment with action ... diagnosis and treatment department cross-sectional cluster ... to education for patients aiming at treatment satisfaction improvement 櫻井洋臣 1, Noriko Beppu 1, Kenichi Ishizaki 1, Sayuri Nishio 1, Kensuke Matsuo 1, Hiroshi Muramatsu 1, Masaya Yamaguchi 1, Shunichi Kawamura 1, Shinichiro Okamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011. |
|---|
|
|
It is ... through a case of the role - lenalidomide + dexamethasone therapy of the pharmacist in the encounter to perform in a physician and a pharmacist Nobuko Takayanagi 1, Masahiro Okuno 1, 久保嘉靖 1, Manabu Nakata 1, Yoshiharu Umetani 1, High cover Toshiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011. |
|---|
|
|
Report about the management of the aim therapeutic range of PT-INR in the warfarin therapy Motoaki Nakao, Hiroshi Kurokawa, Kumi Horikawa, 朴井三矢, Makoto Saito, Toshio Tanaka, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2011. |
|---|
|
|
Acceptability of the GEMOX therapy for the refractory pancreas cancer, biliary tract cancer Toyoji Otani 1, Eiji Hata 1, 涌嶋伴之助 1, Kuniaki Moriki 1, Chisato Iwai 1, Sasaki Nanase 1, Hasegawa general 1, Kainoki Keisuke 1, Yoshikazu Shiiki 1, Hiroshi Takane 1, Kenji Otsubo 1, Kazuo Yashima 2, Naga Takuji 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011. |
|---|
|
|
Relation of the pharmacist to electronic system induction in the cancer chemotherapy 松高吏恵 1, Hamada midsummer 1, Yuka Tsutsui 1, Yosuke Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011. |
|---|
|
|
Action to safety management of the cancer chemotherapy Tomoko Matsumoto 1, Koji Akiyama 1, Mountain Rieko Sawa 1, Motoko Goto 2, Yuka Iwamoto 2, Kumi Azuma 2, Mayumi Ose 2, Junko Tanaka 3, Hideshi Azuma 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011. |
|---|
|
|
Development of injection vial rubber stopper [MOREMASEN] prototype to prevent anti-cancer agent pollution 石渡俊二1, 多賀淳1, 藤田秀樹2, 3, 西田升三1, 喜多綾子1, 杉浦麗子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011. |
|---|
|
|
The present conditions and problem of work environment and the safety measures of the anticancer drug preparation Kazuaki Mori 1, 2, Takahiro Yoshimi 1, Yumiko Fujita 2, Moat foster child 2, 3, Akiko Miki 2, Hiroki Sato 2, Yasufumi Sawada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2011. |
|---|
|
|
Renal carcinoma and 3 cases of the liver cancer that a cutis symptom relieved by reductive sensitizing therapy for polymorphism erythema with sorafenib 久保嘉靖 1, Masahiro Okuno 1, Mai Fujimoto 1, Hiroki Ueyama 2, 金丸聰淳 2, Satoshi Ito 2, Ayaka Sasaki 3, Kaori Nakata 4, Tatsuya Horikawa 4, Yoshiharu Umetani 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011. |
|---|
|
|
Investigation about the expression situation and the adherence of the diarrhea of the sorafenib remedy patients Megumi Maeda 1, Toshiaki Miyazaki 1, Sono Kaji truth 1, Satoko Fujiwara 1, Yoshiko Kitagawa 2, Hitomi Nishimoto 2, Shinichiro Nakamura 3, It is still 1 Matsunaga, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011. |
|---|
|
|
Adverse event investigation of sorafenib in the hepatoma Mayuko Toda, Funasaki Hideki, Shinya Suzuki, Yasuhiko Ichida, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011. |
|---|
|
|
Adverse event investigation of the biliary tract cancer GC therapy in this hospital Asuka Iwamoto, Funasaki Hideki, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011. |
|---|
|
|
Comparison of the dermatopathy onset situation in cetuximab and the panitumumab 塩谷明央, 西山泰史, 阿部武由 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2011. |
|---|
|
|
About an approach of our hospital for the skin toxicity of the panitumumab and the effectiveness 今関稔, 中澤寛仁, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011. |
|---|
|
|
Onset of stomatitis protective efficacy of the Everolimus by the azulene gargle 志田敏宏1, 2, 加藤智幸2, 冨田善彦2, 豊口禎子1, 白石正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011. |
|---|
|
|
Investigation of the regimen reason for change of the mFOLFOX6 therapy Akira Tsujimoto 1, 松野知寛 2, 篠原義剛 3, Kojiro Takahashi 3, Yoko Imamura 1, Yutaka Ueyama 2, Yoshifumi Nakayama 4, Takayuki Torigoe 4, Koji Yamaguchi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011. |
|---|
|
|
Making of the "correspondence booklet for the side effect of the anticancer drug" aiming at the supportive care reactions of drugs solution improvement of the patients by the many types of job Shinya Suzuki 1, Yoko Yajima 2, Takehiko Kobayashi 2, Sonoko Furubayashi 1, Masato Yonemura 1, Reiko Matsui 1, Takashi Uemura 1, Yasuhiko Ichida 1, Ichiji Endo 3, Tahara sincerity 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2011. |
|---|
|
|
Anticipatory evaluation of carboplatin hypersensitivity that assumed an expression level of membrane protein CD203c of the basophils an index Takuya Iwamoto 1, Koji Yuda 2, Tsutomu Tabata 3, Hiroko Sugimoto 1, ガバザ beauty treatment salon van 4, Hiroyuki Hirai 5, Shigeyuki Kojima 5, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011. |
|---|
|
|
Examination of the Japanese GFR estimation-style utility in the gynecologic cancer carboplatin doses setting Tree temple Yasuhiro 1, 2, 中尾將彦 3, Camellia Masahiro 1, 吉長正紘 2, 4, Mariko Nakao 2, 5, Watanabe Mizuki 2, 5, Haruyuki Morimoto 2, 4, Mika Sakano 4, 6, Hajime Asano 2, 5, Liujiang Masatsugu 1, 7, Fujiwara season Yoshiko 2, Masashi Takeuchi 3, 千葉康敬 8, Yuzuru Yamazoe 2, Nishida measure three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011. |
|---|
|
|
Analysis about low K blood disease at the Shakuyakukanzoto administration for paclitaxel-induced peripheral neuropathy in patients with gynecologic cancer 大橋養賢 1, Hideyuki Kawabe 1, 望月敬浩 1, Toshiaki Kato 1, Kazuyuki Ito 1, Yasushi Arata 1, Michihiro Shino 1, Takekuma Munetaka 2, Yasuyuki Hirashima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011. |
|---|
|
|
Effective - for clinical evaluations (the third report) - oral mucositis of the indomethacin water solution preparation 100 Kenji 1, 2, Masato Honma 1, 2, Tree Yoshiyuki Sawa 1, 2, Long Okahiro incense 2, Tamaki Sakurai 2, Yoshiharu Suzuki 1, 2, Tomoki Tsuchiya 2, Yasuyuki Kanbayashi 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2011. |
|---|
|
|
Effect of the mutation in the gene of DRD2 which gives it to antiemetic activity of the prochlorperazine in patients with cancer and adverse effect Masataka Tashiro 1, 2, Takafumi Naito 1, Yoshiyuki Kagawa 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011. |
|---|
|
|
Estimate of the CYP2C19 genetic polymorphism based on pharmacokinetics of clobazam Hiroshi Miyakawa 1, Yoshiaki Yamamoto 2, Shigeko Nishimura 2, Emiko Takao 2, Risa Kasai 2, Seiichi Koyama 1, Kazumi Matsuda 2, Yukitoshi Takahashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011. |
|---|
|
|
It is a randomized controlled trial for "the medical care of the unit" based on the genetic polymorphism in tuberculosis treatment Masako Ono 1, 2, Ryuji Kubota 2, Uemura sheath or 2, Soichiro Yokota 3, Takashi Nagai 4, 露口一成 5, 奥田恭久 6, 藤尾慈 2, Ayaka Maeyama 1, Junichi Azuma 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011. |
|---|
|
|
Association between lung cancer onset risk and drug metabolizing enzyme genetic polymorphism Shinko Hiratsuka 1, Yu Tamaki Ichiro 1, Arai wealth straight 2, Haruhiko Sugimura 3, 平澤典保 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011. |
|---|
|
|
An expression level of Cytochrome P450 and activity increase by gastrectomy Takashi Ishii, Yudai Toda, Taku Hayase, Asano Hotta, 澤谷枝里, Igarashi sincerity intellect, The Ochiai sum, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2011. |
|---|
|
|
Study on expression of ABCB1 gene control structure by microRNA 廣田豪, 安田知世, 山口晃平, 家入一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011. |
|---|
|
|
Application to patients with achlorhydria of the methyl cellulose / alginic acid liquid drug Descent from a mountain Tetsuya, Kunihiko Ito, Person Maki, Kanako Kino, Michiya Kobayashi, Shozo Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011. |
|---|
|
|
Specific phenytoin separation promotion effect ... with the mechanism elucidation (1) - glucose transfusion of the phenytoin injection incompatibility Yoshinori Onuki 1, Kazumi Ishizuka 1, Mayumi Ikegami 2, Kozo Takayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011. |
|---|
|
|
Scientific grounds ... of dilute phenytoin injection being stable with mechanism elucidation (2) - normal saline solution of the phenytoin injection incompatibility Kazumi Ishizuka 1, Yoshinori Onuki 1, Mayumi Ikegami 2, Kozo Takayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011. |
|---|
|
|
Fact-finding of the voluntary recall of the medical supplies by the drug industry in Japan Takuya Ishida, Takashi Osawa, Yamakawa flower Akemi, Takafumi Naito, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2011. |
|---|
|
|
About pharmacist antibiotic chemical treatment practice educational program in the Kansai area Yoshiko Takahashi 1, Yoshio Takesue 2, So Arakawa one 2, Kazunori Asano 2, Hirai green 2, Toshihiko Ishizaka 1, Mutsumi Yoshioka exhibition 1, Yukako Yasui 1, Yutaka Hasegawa 1, Yuichi Koizumi 1, Kazuhiko Yamashita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011. |
|---|
|
|
Fact-finding after the training for the pharmacist trainee specialized in a cancer Reiko Matsui 1, 加藤裕芳 2, Yoshizo Watanabe 3, Naoki Kondo 4, Atsushi Wada 5, Kentaro Yamaguchi 6, Masato Yonemura 1, Satoshi Izumi Shiro 1, Ichiji Endo 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011. |
|---|
|
|
Association to carbohydrate metabolism control through the PKC and MCT4 expression change Sho Otake 1, Katsuya Narumi 2, Masanori Kobayashi 1, Hiroaki Yamaguchi 2, Takeshi Iseki 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011. |
|---|
|
|
Examination of the hyperoxide-producing increase mechanism in the femoral artery of the diabetes model rat and the chronic dosing effect of the pravastatin Moat Hideo 1, 2, 永味千枝 1, Chigusa Kikuchi 1, Masayoshi Takeuchi 3, 松永民秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011. |
|---|
|
|
Search of ingredients made specially in Aomori showing hypotensive effect Shiro Itagaki 1, Descent from a mountain Ritsuko 1, Michiko Uchiyama 2, 3, Early hunting truth 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2011. |
|---|
|
|
Action to long-term business training in the Hyogo Prefectural hospital pharmacy Junko Hyodo, Kyoshi, Kashima, Kimiko Yasuda, Toshiaki Matsumoto, Eiji Fukui, Hitoshi Okugawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011. |
|---|
|
|
Action of the medical safety education that featured the theme of the KCL note for the pharmacy school six years system 狩谷佳寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011. |
|---|
|
|
Analysis of the business training result in the Yokkaichi social insurance hospital Saori Kojima, 片山歳也, 野々部崇哉, Mitsuru Fujioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011. |
|---|
|
|
Role of the pharmacist resident as the Preceptor in the pharmacy business training 奥貞佳奈子, 薩摩由香里, 高瀬友貴, 原田奈生子, 小西絢子, 中西真也, 神垣有美, 今村早苗, 奥貞智, 北田徳昭, 田中詳二, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011. |
|---|
|
|
It is by Tal, cardiopulmonary resuscitation, side effect management result and a problem of the prior training to breed the clinical thought of the pharmacy student, and to connect with business training Shiho Terada 1, It is still 2 Takashi Hashimoto, 4, 8, Takayoshi Okubo 2, 6, Nobuyuki Takahashi 2, Yuriko Murai 2, 5, Keiko Sato 1, Metoki Konin 3, Masahiro Kikutani 2, 平澤典保 2, Yoshihisa Tomioka 2, Masatoshi Ohba 7, 8, Jun Imai 2, Hiroshi Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2011. |
|---|
|
|
Reactions of drugs that a nurses' aide is good at and reactions of drugs that we do not like Ide Wakana 1, 2, 高橋眞生 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011. |
|---|
|
|
Practice of the clinical meeting by the pharmacy student which experienced business training Tomoji Yoshiyama 1, Fumiya Imai 1, Miki Shimizu 1, Tanaka evening K 1, Takahiro Oshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011. |
|---|
|
|
Attitude survey by the questionnaire of the simulated patient in Kobe College of Pharmacy Yukie Okumura 1, Ikuko Yokoyama 2, Aya Ino 2, Chikako Numata 2, Tsuneo Hamaguchi 2, Yasuyuki Kondo 1, 三木生也 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011. |
|---|
|
|
Through embarrassment - steroid of the student by the difference in drug purpose of use in university education and the business training - 笠原優瑠 1, Ayako Tada 1, 鈴木渉太 1, Shoji Kochi 1, 2, Yutaka Hasegawa 2, Chikako Numata 2, Yasuyuki Kondo 1, 三木生也 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2011. |
|---|
|
|
An action and evaluation of "the pharmacist outpatient department" in the cancer chemotherapy Yumiko Furuno 1, Persimmon former Mino 1, Muller Kana beauty 1, Hiroshi Masuda charges 1, Shinmura green 2, Tanegashima Iwao 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011. |
|---|
|
|
It is ... from the record of the intervention - outpatient department drug instruction management book of the hospital pharmacist for the foreign cancer pharmacotherapy Yoichi Nakajima, 葉田昌生, Tadashi Mikami, Yoshiko Murakami, 山方志築, Wataru Shiraishi, Ikuhiro Nose Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011. |
|---|
|
|
Flow chart making for the expression situation of the diarrhea with the foreign chemotherapy and safe correspondence Noriaki Kitami 1, Masato Yonemura 1, Mai Itagaki 1, Yoko Yamaguchi 2, Yasuhiko Ichida 1, Koichi Goto 2, Satoshi Izumi Shiro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011. |
|---|
|
|
Examination about "the thing anxious" in patients who received foreign chemotherapy Makoto Hayashi 1, Hayato Sugimura 1, Akemasa Yamaya 1, Aspect shrine Koji 1, Kiyomi Sakakura 2, Yayoi Hoshiba 2, North Toshiyuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011. |
|---|
|
|
The actual situation of the fever consultation in the foreign chemotherapy hot line and investigation for pharmacist Motoko Kaneko, Masato Yonemura, Mai Itagaki, Yasuhiko Ichida, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2011. |
|---|
|
|
Examination of the exposure situation at anticancer drug preparation by the simulation using the fine particles visualization device Anna Kubo 1, Takeo Shimazaki 2, Hideo Tanaka 1, Takahiro Okamoto 3, 坂本数彦 3, Yuji Kawakita 3, Motoo Ryoji 2, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011. |
|---|
|
|
Evaluation of the small quantity of portable constant infusion pump packing and flow in the FOLFOX/FOLFIRI therapy Eiji Fukada 1, Small Ido Keiichi 1, 牧野好倫 1, 2, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011. |
|---|
|
|
Association with fact-finding of the dysosmia in patients who received cancer chemotherapy using the simple type olfactometry kit and the nutritional status Kan Yukio 1, 2, Yuri Sakaguchi field 1, Junko Ishizaki 1, 崔吉道 2, Kenichi Miyamoto 2, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011. |
|---|
|
|
Development of communication skill training (CST) which adopted SPIKES for pharmacists corresponding to patients with cancer Yoshihiro Noji, 半谷眞七子, Mayu Sakurai, Yukari Yoshioka, Hiroyuki Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2011. |
|---|
|
|
Usefulness of insulin continuous subcutaneous infusion therapy with insulin lispro : Comparison of insulin frequent injection therapy by detemir 早川太朗1, 3, 中山英夫1, 石井通予2, 神内謙至2, 磯野元秀2, 西村亜佐子3, 芝田信人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011. |
|---|
|
|
Comparison of three kinds of needles for the pen type insulin injector by the pharmacist Chigusa Kikuchi 1, 永味千枝 1, Akira Saka exhibition 2, Mikiya Watanabe 3, 鐡野敦司 4, 松永民秀 1, Tadashi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011. |
|---|
|
|
Insulin injector choice for that the patients with eye disease, visual disturbances feel relieved, and unit setting operation is possible Hiroyuki Nishimura 1, Yoichi Ishizuka 2, Yoshida positive 1, Asako Eguchi 1, Kumiko Tsuruta 1, Mitsuru Irikura 2, Toru Irie beauty 2, Fumio Miyamoto 3, Japanese barnyard millet island state male 4, Keizo Kajiwara 4, Tomio Jinnai 4, Hideaki Jinnai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011. |
|---|
|
|
Examination about the pollution at microbial mixture to GLP-1 analog preparation Hitomi Karasawa 1, Toshinari Asakura 1, Emi Kawasaki 1, Takeshi Kono 2, 齊藤幹央 1, Manabu Abe 1, Miho Kageyama 1, Hiroshi Urakami 3, Noriaki Yokou 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011. |
|---|
|
|
Relations - of examination - storage environment and the mixture method about the suspensibility of the suspension insulin preparation in the clinical use Toshinari Asakura 1, Emi Kawasaki 1, Hitomi Karasawa 1, Miho Kageyama 1, Manabu Abe 1, 斎藤幹央 1, Noriaki Yokou 1, Hiroaki Seino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2011. |
|---|
|
|
Action of the dispensing error prevention in the generic medicine compounding of medicines Naoko Yamauchi 1, Usutani Eri child 1, Shinya Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011. |
|---|
|
|
The generic drug promotion plan by the hospital pharmacist and the evaluation Masayuki Wakita 1, Tomomi Hoshino 1, 波能満理惠 1, Maki Tanada 1, Hiromi Fujioka 1, Rokuro Yoneyama 1, Risa Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011. |
|---|
|
|
For the reliable use promotion of the generic drug (the second report) The Ishikawa immensity, 後藤志央, Shrine Akihiro Ichiro, Maruyama Akina, 末安由拓, Tatsuya Sasaki, Kaifu Masayo, Akihiro Kai, Prince Taniguchi chapter, Keiko Kitajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011. |
|---|
|
|
Examination about efficacy, the safety of the cyclosporine generic drug in patients with collagenosis Sone book Emi 1, Nozomi Iwanaga 2, Tomori Kamiya child 1, Yasuhiro Tsuji 1, Kaoru Terada 2, Hironobu Sato 2, Yukitaka Ueki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011. |
|---|
|
|
Transduce differentiation before operational ... hospitalization of the bringing medicine in this hospital; and ... Yuta Sato 1, Miyoko Narita 1, Maiko Takahashi 1, Junko Ohara 1, Aoi, Tamura 1, Masayuki Ohara 1, Masato Kojima 1, Takahashi good luck 1, Masanori Sasaki 1, Shinji Ogawa 1, Masayuki Kimura 1, Hiroki Kawamura 1, Hitoshi Fujiwara 1, Etsuko Akatsuka 2, Yuko Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2011. |
|---|
|
|
Examination about the use situation and the proper use of the carbapenem-based antimicrobial agent in this hospital Katsuya Nakano, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011. |
|---|
|
|
Effect to carbapenem-based medicine proper use by the all cases grasp by the ICT Hiroshi Hara person, Toru Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011. |
|---|
|
|
Analysis of the clinical response based on the Time above MIC of the beta-lactam system antimicrobial agent with antiPseudomonas aeruginosa activity Jitsukawa Orient 1, 4, Keiko Fukuda 1, Teruko Yagishita 2, Takayoshi Wakamatsu 2, Mitsunori Hino 3, Takahiko Aoyama 4, Yoshiaki Matsumoto 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011. |
|---|
|
|
Action for the practice of the use of appropriate dose, antimicrobial agent by the dosage interval Takeshi Kimura 1, 2, Worth Chongwen 1, 2, Saikai life 2, Former river Rie 2, Masako Tsukada 2, Kimura Shuya 2, Naoko Takahashi 1, 3, Toru Miyakawa 1, 4, 源吉顕治 1, 5, Hidemi Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011. |
|---|
|
|
What we learned from the vancomycin-resistant enterococci (VRE) outbreak case : The role of the pharmacist at the time of outbreak 柳橋秀行1, 宮内智行1, 松井奈美2, 郡隆之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2011. |
|---|
|
|
Quinolone for the Helicobacter pylori control-sensitive surveillance Yutaka Bando 1, 三木生也 1, 2, Yasuyuki Kondo 1, 2, Hiroshi Uehara 1, Shigeto Mizuno 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011. |
|---|
|
|
Analysis of efficacy and the gyrA mutation of levofloxacin in the Helicobacter pylori re-sanitization therapy Hiroshi Uehara 1, 三木生也 1, 2, Yasuyuki Kondo 1, 2, Yutaka Bando 1, Shigeto Mizuno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011. |
|---|
|
|
Start an infection round; and action ... in the ... Komaki Municipal Hospital Junpei Utsunomiya 1, 2, Daisuke Tsuchimoto 1, Ryutaro Kawamoto 1, Yasuhiro Toda 1, 2, Yamada Toru 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011. |
|---|
|
|
Examination about candidemia treatment in the hospital attached to the Tottori University School of Medicine Yukiko Miyoshi 1, Hiroshi Takane 1, Hiromitsu Fujiwara 2, Katsuhiro Ogawa 1, Yoshikazu Shiiki 1, 堀井俊伸 3, Kenji Otsubo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011. |
|---|
|
|
The use situation of the liposomal amphotericin B preparation Hiroshi Tanaka period 1, Kazumi Taguchi 2, Ayako Suzuki 3, Mari Hirabayashi 3, Mikako Namiki 3, Your forest sect 4, Toshitaka Takenouchi 3, Junichiro Murayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2011. |
|---|
|
|
In participation in psychology education report - family psychoeducation for the patients with ambulatory schizophrenia family, a pharmacist is ... with the role to achieve Tomoko Nakagawa, Naomi Miyamoto, Kenji Muta, Tomomi Ariyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011. |
|---|
|
|
1 case - that we introduced role - risperidone sustained release injection of the pharmacist for the schizophrenia patient of the poor medication adherence Ippei Takeuchi 1, 2, Hiroyuki Kamei 1, Tomoya Asahi 1, Akihiro Iida 1, Tsutomu Yoshida 1, Tadashi Nagamatsu 1, Junji Uno 2, Iwata relation straight 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011. |
|---|
|
|
Difference between schizophrenia attitude survey and disease recognition between pharmacy school life, other undergraduates Yamato trunk and branch 1, 2, Hiroko Sakaguchi 2, Tomomi Horino 1, Upper fence 1,000 1, Kitakoji study 1, Sumio Matsuno 1, Mitsutaka Takada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011. |
|---|
|
|
Treatment-resistant schizophrenia treatment, usage of Clozapine 宇野準二, 中田美穂, 東城真一, 山畑佐枝子, 竹内一平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011. |
|---|
|
|
It is ... through the letter which drug instruction ... patients, the bereaved who took in a narrative bay strike medicine gave to me 奥野昌宏1, 高柳信子1, 藤本麻依1, 三浦恵理1, 久保嘉靖1, 梅谷義晴1, 磯部昌憲2, 高宮静男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2011. |
|---|
|
|
Risperdal Consta intramuscular injection patient interviews the results reported in the Kansai youth sanatorium 藤井幸代, 三宅嘉子, 田中由美, 小西和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011. |
|---|
|
|
It is ... from an example of need - out reach of the action of the psychiatric hospitals pharmacist for patients with at-home mental disorder 谷口浩朗 1, 2, Yoshio Akimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011. |
|---|
|
|
Development of the transdermal absorbing form preparation of psychotropic drug milnacipran Shigeko Obata, Satoshi Sano, Watanabe University solstice, Kozo Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011. |
|---|
|
|
Use report of the tolvaptan in our hospital 阿部正樹, 木原理絵, 中筋千佳, 服部雄二, 関本裕美, 山内一恭, 本田芳久, 小森勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2011. |
|---|
|
|
A precision evaluation of the vancomycin TDM analysis support software and examination of the factor which has an influence on the effect of treatment Naoya Ueno, Kamura Motoki, Kioroshi Shiori, Natsuko Hashimoto, Mera spirit Ichiro, Hiroshi Yoshimatsu chapter, Fukushima connection Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011. |
|---|
|
|
Improvement effect by a pharmacist consolidating the TDM of the vancomycin note Waterside Tetsuya 1, Yasuko Nakamura 1, Kenji Kinoshita 1, 松本佳剛 1, Ueda exhibition charges 1, Shinichi Matsuda 2, Kazue Shinno 2, 4, Atsuko Yoshino 3, Noriko Adachi 4, Eiji Yamanaka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011. |
|---|
|
|
Case report - based on examination - regimen about the vancomycin administration for the CAPD patients whom peritonitis developed in 浦嶋和也 1, Kaoru Suzuki 1, Kensho Kataoka 1, Kokichi window or 1, Masami Nishihara 1, Hayato Nomi 2, Haruhito Azuma 2, 瀧内比呂也 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011. |
|---|
|
|
Effect of CYP3A5*3 which gives it to the cross reaction of blood tacrolimus measurements using the CLIA method in renal-transplant recipients Kimiyoshi Hirano 1, Takafumi Naito 1, 見野靖晃 1, Tatsuya Takayama 2, Seiichiro Osono 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011. |
|---|
|
|
Through a comparison with utility -PEDA of TDM analysis software EasyTDM - Masaaki Konishi 1, 2, Takeshi Abe reason 1, 2, 福岡憲泰 1, 3, Toshi Takeuchi oneself 1, 4, 芳地一 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2011. |
|---|
|
|
Relations with a trough level and kidney, the liver dysfunction incidence of teicoplanin given for a long term Shiota history on record 1, 2, 3, Ichihara greens one a month, Kato tree Rie 1, Hiroyuki Mizuno 1, Junko Kuroda 1, Tetsuo Ezaki 1, Atsushi Nakamura 2, 木村和哲 1, 3, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011. |
|---|
|
|
ampicillin/sulbactam proper dosage method under the use of heart-lung machine of the cardiovascular procedures patients Yuta Yokoyama 1, Kazuaki Matsumoto 2, Hiroyuki Yamamoto 3, Shore of well skillful writing 3, Hiroshi Imoto 3, 猪川和朗 4, Norifumi Morikawa 4, Shiro Ishida 5, Yoshiro Okano 5, Eri Watanabe incense 1, 下堂薗権洋 2, Yasuo Takeda 1, 2, Katsushi Yamada 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011. |
|---|
|
|
Evaluation of blood corpuscle transitivity and blood kinetics properties of the bortezomib in patients with multiple myeloma Takashi Osawa 1, Takafumi Naito 1, Takashina Yoshiaki 1, 見野靖晃 1, Kazunori Onishi 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011. |
|---|
|
|
Level of clarithromycin which gives it to a hydrogen peroxide inducer cells disorder in normal human bronchiole epithelial cells and time effect Rocky mountain books for admonition, Design of turbulent waves Ryosuke, Koichi Otaki, Yoshiko Tanbo, 早勢伸正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011. |
|---|
|
|
Antioxidant action evaluation of the hyperuricaemia therapeutic drug benzbromarone Shoichi Sakaguchi 1, Daisuke Kadowaki 1, Yohei Miyamoto 1, Kei Sato wound 2, Toru Maruyama 1, Odagiri A tree 1, 3, Takeki Narita 1, Sumio Hirata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2011. |
|---|
|
|
A fluorouracil plasma concentration and long term prognosis in the esophageal cancer chemoradiotherapy Akiko Kuwahara 1, 2, Mountain Hiroshi Morimoto 1, 2, 三木生也 2, Nakamura job 2, 西口工司 2, Takao Tamura 2, 3, Wasaburo Kataoka 1, Hirai green 2, Sakaeda Toshiyuki 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011. |
|---|
|
|
About the utility with the chronic administration of oral pyrimidine drugs after the colorectal cancer postoperative adjuvant chemotherapy fluoride Kenji Taniguchi, Noriyuki Shimoi, Inaguchi Hiroshi, Keiko Yamamoto, Hiroya Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011. |
|---|
|
|
Examination of the pharmacokinetics of oral beclomethasone (BDP) for the allogeneic hematopoietic stem cell transplantation patients Tadaaki Ito 1, Kana Sunohara 3, History of Hisashi Yamamoto 2, Yumiko Uchida 1, Winnow music Mayumi 1, Masako Furusawa 1, Naoyuki Uchida 2, Masayuki Hashiguchi 3, Tadashi Nishio 2, Hideko Kanazawa 3, Mayumi Mochizuki 3, Shuichi Taniguchi 2, Masahiro Hayashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011. |
|---|
|
|
A preparation of the DOX connotation functionality improvement liposome preparation and examination of the anti-tumor activity of the in vitro liposomal preparation Masaka Wataru 1, 2, Riyosuke Imai 2, Your Koide A 2, River flight 2, Yagi Nobuhiro 2, Yu Yokoyama product 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011. |
|---|
|
|
Examination of the utility of the caffeine/cisplatin combination chemotherapy using the cell line derived from human liver cancer in In vitro Takashi Kawano 1, Yohei Kawano 1, Masashi Mizuta 2, Tomomi Iwakiri 1, Manabu Okumura 1, Kazuhiko Arimori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2011. |
|---|
|
|
Examination about the amrubicin(AMR) administration in the small-cell lung cancer (SCLC) patients Chinami Suzuki 1, Hiura Kazuya 1, Yuka Watanabe 1, Hitoshi Komori 1, Makoto Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011. |
|---|
|
|
It is ... for effective, safe chemotherapy with use and utility - team approach in medical care of the temozolomide worksheet on the electronic chart Kiyoshi Sasayama 1, Yukihiko Mitsuta 2, Chika Nabeshima 3, Reiko Muroi 3, Naoya Fujimoto 1, Keiko Nitta 1, Motoko Funato 1, Masaaki Mori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011. |
|---|
|
|
The one instance case that we managed pharmaceutical for treatment of the myelodysplastic syndrome using azacitidine Akira Yoshida 1, History of moat male 2, Takashina Yoshiaki 1, Yagyu Tomohiro 3, Mitsue Amo 4, Reiko Kikuchi 4, Kazunori Onishi 2, 3, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011. |
|---|
|
|
Search of a causing agent about the intranasal stimulation at breast cancer chemotherapy enforcement and the risk factor Kiyokazu Takada 1, Koichi Tanabe 2, Tomoaki Ikezaki 2, Jun Okubo 2, Birutani Kazuhiko 1, Hidenori Kitazawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2011. |
|---|
|
|
About the use situation and usefulness of the sitagliptin in our hospital 友滝和人1, 田中麻衣子1, 加藤滋宏1, 高木佐苗2, 石川敦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011. |
|---|
|
|
Effect of the patients background in sitagliptin phosphate hydrate tablets 長尾真里子1, 石黒俊明2, 山田成樹1, 和田祐一郎1, 穂積廣1, 竹本雄一1, 坂井裕美1, 寺尾育恵1, 伊藤江里佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011. |
|---|
|
|
1 case that induction of CGMS was useful in the consciousness improvement of patients with diabetes Masami Murakami 1, Keiichiro Fujishima 2, Akiko Mizoguchi 1, Tomori Kamiya child 1, Yasuhiro Tsuji 1, Kazunari Matsumoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011. |
|---|
|
|
Why do the patients with diabetes stop it; reason of the - treatment interruption and tendency -? Toshifumi Nakamura 1, Takafumi Arai 1, Sho Nomura 1, 伊藤稔宏 1, Yoshida lawn 1,000 child 1, Nobuaki Ikegami 1, Akira Ogawa Ichiro 2, Harumi Maeda 2, Misaki Miyata 2, Masanori Yoshida 2, 堀田美知成 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011. |
|---|
|
|
About examination of the clinical condition improvement for the class for diabetics participation patients in this hospital 吉田雅彩, Shigeru Yamada tree, Kana Kato, Nomura connection, Yoichi Sakakibara, Mika Shinoda, Ayumu Ichimura, Masayuki Hirose, Eri Wakita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2011. |
|---|
|
|
Consciousness for the non-prescription drug purchase of remote island inhabitants judging from the comparison between Internet user and nonuser Masahiko Hirayama 1, 2, Hidekazu Tanaka 1, 2, Shintaro Suzuki 1, 2, Hitoshi Omura own 1, Masayoshi Nagase 1, Product former Seiji 1, Masanori Sugawara 2, Toshihiro Kitahara 1, Choichiro Miyazaki 1, Noboru Yamashita 3, Kiyomitsu Yoshitani 3, Hiroki Sato 4, Akiko Miki 4, Moat foster child 4, 5, 6, Yasufumi Sawada 4, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011. |
|---|
|
|
One case that medication counseling using the coating was useful for patients with type II diabetes mellitus that medication adherence extremely had poor Field Masahiro 1, Ikuyo Imai 1, Tsutomu Igarashi 1, 貞廣克彦 2, Tomoki Sato 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011. |
|---|
|
|
Trend of patients with diabetes in the medical treatment type hospital Hiromi Yamaguchi, 平澤佑実彦, Takidani Hiroko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011. |
|---|
|
|
Research design and the Recruit situation of the randomized controlled trial COMPASS project for patients with type II diabetes mellitus Hiroshi Okada 1, Yasushi Nakagawa 1, Katsushi Fukuoka 2, Naoki Sakane 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011. |
|---|
|
|
The instruction to the schizophrenia patient whom type I diabetes mellitus developed in and the evaluation Toshikazu Daito 1, 2, 3, Naoko Yoshida 2, Uyama Miki 2, Atsushi Kubo 3, Tadamichi Yoshimura 1, Yukiko Morita 1, North Keiji 1, Masayuki Uno 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2011. |
|---|
|
|
One patient who continued olanzapine internal use after the gestational diabetes onset Okazawa incense Tsu child 1, 山崎公久 1, Yoshie Nakayama 2, Atsuko Tsubone 2, Shigeru Minami 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2011. |
|---|
|
|
Retrospective investigation about hallucinatory frequency with suspected association with voriconazole in the hematopoietic stem cell transplantation patients and the risk factor Tsu lower Mayumi 1, Daisuke Watanabe 1, Small Ido Keiichi 1, 牧野好倫 1, Nobuaki Yokote 1, Takahiro Fukuda 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011. |
|---|
|
|
Examination of the use situation, a side effect and the interstitial pneumonia case of erlotinib in the Toho University medical center Ohashi hospital surgery department Shinichi Masuda, Kaori Komatsu, 野村充俊, Sumiko Hiura, 加藤裕芳, Toru Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011. |
|---|
|
|
Analysis study of the incidence of adverse events derived from statin drugs inferred by the change of laboratory values Manami Ochiai 1, Masanori Kobayashi 1, Toru Kawagishi 2, Kumiko Kasashi 2, Hiroaki Yamaguchi 2, Takehiro Yamada 2, Takeshi Iseki 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011. |
|---|
|
|
Changes in serum sodium value in our hospital Tolvaptan use patient 長谷川浩司, 幸村瑶子, 冨田健生, 濱口亜紀, 井上久美子, 岩城晃一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011. |
|---|
|
|
Side effect case of gynecomastia to seem according to the morphine hydrochloride Kayoko Iwamoto, Noriko Kaneta, Hiroshi Ota, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2011. |
|---|
|
|
Report of the Tamiflu Relenza prescription patients questionnaire Katsuki Hara, Taro Takami, Taeko Fujii, Tomoyuki Fujimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011. |
|---|
|
|
1 case that pointed out carbamazepine as a cover suspicion medicine for Stevens-Johnson syndrome by remedy history confirmation by the pharmacist Kyoko Nomura, Keiko Ishikawa, Kiyotaka Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011. |
|---|
|
|
Search of the risk factor to give it to the hemoglobin decrease in the patients using fondaparinux after artificial joint replacement Enoki shop Tomoyuki 1, Yuichi Muraki 1, Takuya Iwamoto 1, Masahiro Hasegawa 2, Satoshi Sudo wide 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011. |
|---|
|
|
Relation of the actual situation and the pharmacist of the drug-induced hepatic injury Hashimoto positive 1, Makoto Matsuda left child 1, Shigeru Omori 2, 澤部公子 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011. |
|---|
|
|
Action to the pharmacotherapy duties by the ward permanent residence pharmacist Yuki Nishitani 1, 久岡清子 1, 2, Aida sheath or 1, Kenji Sasaki 1, Naomi Akinaga 1, North residence Miki 1, Interval Chiharu 1, Kanuma Nao 1, Takashi Kameoka 1, Hisayuki Haji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2011. |
|---|
|
|
Correspondence (summary and pharmacy duties system of the 1)-earthquake disaster and support situation - to the various quarters of the Tohoku University hospital pharmacy in 0001 Great East Japan Earthquake Mayumi Sato, Kanehiko Hisamichi, Yasushi Wagatsuma line, Yuriko Murai, Miki Shimada, Hiroki Nakamura, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011. |
|---|
|
|
Correspondence (rebuilding - of failure and the outpatient clinic system of the 2)-communications network of the Tohoku University hospital pharmacy in 0002 Great East Japan Earthquake Yasushi Wagatsuma line, Kanehiko Hisamichi, Mayumi Sato, Yuriko Murai, Miki Shimada, Hiroki Nakamura, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011. |
|---|
|
|
Correspondence (securing of medical supplies - for maintenance and the stricken area support of the practice system of the 3)-senior Pope of the Tohoku University hospital pharmacy in 0003 Great East Japan Earthquake Kanehiko Hisamichi, Mayumi Sato, Yasushi Wagatsuma line, Yuriko Murai, Miki Shimada, Hiroki Nakamura, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011. |
|---|
|
|
Activity report as the basic hospital for disasters in 0004 Great East Japan Earthquake Noriyuki Kumagai 1, 名倉弘哲 5, Ube Hirohide 1, Hiroshi Tanaka 2, 鵜浦利江 1, Akiko Kikuchi 1, Tomoko Takahashi 3, Eiko Niinuma 1, Chika Ujiie 1, Eri Honma 1, Nanako Takahashi 1, Mitsuru Tamura Expo 4, Taku Kudo body 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011. |
|---|
|
|
About correspondence and anti-disaster measures of the Sendai Municipal Hospital drug department at 0005 Great East Japan Earthquake Soichi Hozumi, Munetaka Hikichi, Tetsu Saeki, Hidetoshi Fukuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011. |
|---|
|
|
About course of the chemotherapy resumption of this hospital after 0006 Great East Japan Earthquake Tomomi Sato 1, Katsuyuki Suzuki 1, Ayumi Yoshida 1, 齋藤京之 1, Mikiko Yoshida 2, Takao Suzuki 3, Hiroyuki Yamanaka 1, 諏江裕 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2011. |
|---|
|
|
Relation of the drugstore in the treatment at home at 0007 earthquake disasters Yasushi Takahashi daylight, Kotaro Kurosawa, Hiroyuki Kosaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011. |
|---|
|
|
The situation and problems of the hospital in Iwaki-shi at 0008 Great East Japan Earthquake Shinichi Yoshikawa 1, 2, 小佐野磨子 1, Takayuki Nagata 1, Yuichi Hasegawa 1, Susumu Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011. |
|---|
|
|
A problem and the action that we faced after the Great East Japan Earthquake in 0009 this hospital drugs department for two months 秦圭資, Naoko Toyoshima, Noriko Nikaido, Yasutomo Goto, Italy Hiroe Azuma, Shiori Kaneko, Kana Kimura, Hiromi Daicho, Akiko Ogata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011. |
|---|
|
|
Role of the pharmacist in the disaster medical care support activity for 0010 Great East Japan Earthquake Step Masaaki Hayashi, Shogo Nakamura, 杉本更絵子, Yukihiro Hayakawa, Kazue Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011. |
|---|
|
|
Participate in 0011 Showa University medical care rescue parties; and - activity report - Ishikawa mere beauty 1, 2, 3, 4, 5, 6, Jun Kawazoe 2, Ayumi Tsuchiya 3, Kazuhiro Shiota 4, Yagi Satoshi 4, 5, Ayako Ishii 1, 5, Fumiko Koizumi 1, Tatsuya Kurihara 5, 渥美聡孝 5, Tomoko Handa 5, Hitomi Hasegawa 5, Kajiwara flatters it; lawn child 5, Junna Ogiwara 5, Hideto Kuroiwa 5, Junko Minemura 2, Yuji Kiuchi 5, Yumi Kamijo 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011. |
|---|
|
|
Inflection of the pre-medicine manufacture for the children in the medical relief squad of 0012 Great East Japan Earthquake Hideaki Tokushima, Kazuhiro Hirano, Koji Takeuchi, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2011. |
|---|
|
|
Role of the pharmacist in 0013 relief squads Shuji Endo, Tomoko Hiraiwa, Keita Ichikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011. |
|---|
|
|
Activity of the Haneshima Municipal Hospital in the Gifu medical care relief squad by 0014 Great East Japan Earthquake and role of the pharmacist Eiji Yamamoto 1, 中尾真隆 1, It is still 1 Suguru Nishimura, Yasushi Watanabe 2, Taichi Muto 3, Yoshiaki Ouchi 4, Shiro Omiya 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011. |
|---|
|
|
Correspondence of the Fujinomiya Municipal Hospital in earthquake (3/15) which assumes 0015 East Shizuoka cause Osamu Kitamura 1, Kazuo Katsumata 1, Hiroshi Kawaguchi true 1, Yoshinori Kobayashi 1, Yutaka Kobayashi 1, Akira Komiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011. |
|---|
|
|
Pharmacist activity report to stricken area medical care support in 0016 Great East Japan Earthquake Akazawa wing, Katsuumi studies, Takao Sawai, Atsushi Kubota, Koichi Mizuno, Jiro Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011. |
|---|
|
|
Stricken area medical care support in 0017 Great East Japan Earthquake Daigo Suzuki 1, Keisuke Watanabe 2, Wataru Nagashima 2, Hiroyuki Matsubara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011. |
|---|
|
|
The role of the pharmacist in the DMAT activity with 0018 Great East Japan Earthquake and future problem (comparison medical for an acute phase and a sub-acute phase) Hidehito Takano, Hirokazu Ishizuka, 小守陽介, Morizaki くりみ, Junko Nagai, Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2011. |
|---|
|
|
Go around role - Iriya, Minamisanriku district of the pharmacist in the regional medicine system convalescence in 0019 Great East Japan Earthquake, and give medical care; and ... It is still 1 Asano, 2, Kotaro Kawamoto 1, Shiyo Yamada branch 1, Your Sekine existence 1, Tatsuro Fujii 1, Ayako Kato 1, Tomoko Suzuki 1, Seina Noda child 1, Kadomura Shota 1, Mina Takeuchi 1, Yuko Fukuda 1, Tatsuya Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011. |
|---|
|
|
Role of the pharmacist in the disaster medical assistance team after 0020 Great East Japan Earthquake Satohiko Akamine 1, Toshiko Sasaki 2, Masahiro Kobayashi 2, Jun Kainuma 2, Miyuki Takahashi 1, Mariko Arai 1, Shingo Konno 4, Kazuo Yago 2, 3, Masaichi Kuroyama 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011. |
|---|
|
|
Relief activities report of the pharmacist in 0021 Great East Japan Earthquake Toru Hasegawa, Kazuyuki Ito, Jun Hisada life, Keita Urasaki, Satoshi Isotani, Takamitsu Akita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011. |
|---|
|
|
It is = for risk and measures = great scale disaster at 0022 rolling blackouts development 高橋眞生 1, Masumi Koda 1, Wakana Ide 1, Mitsuo Kuroki 1, Hisashi Iijima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011. |
|---|
|
|
The effect that a blackout caused by 0023 Great East Japan Earthquake and rolling blackouts resulted in in the healthcare setting Relation bowl Hideo, Yoshiyuki Miyasaka, Cheap Takeo, Akira Sekiguchi I Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011. |
|---|
|
|
Examination of the hospital stock administration for 0024 disaster development Yuki Yamazaki 1, Yasuhiro Ujiie 1, History of laboratory of origin of soil 1, 飛川昭雄 1, Reiko Yasuda 1, Hideki Koyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2011. |
|---|
|
|
Discussion about the inflection of the medical supplies management at 0025 large-scale disasters and the drug information 村田実希郎, Masaki Takenouchi, 永瀬怜司, Jun Takimoto, Hiroshi Sugano, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011. |
|---|
|
|
About the choice and the disaster pharmacist activity of the disaster relief medical supplies for the reserve relief squad in 0026 this hospital Miyanaga Minoru Miyuki 1, 市川騰 1, Shuji Endo 1, Stone Yoshiki Kubo 1, Tomoko Hiraiwa 1, Keita Ichikawa 1, 松本賢芳 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011. |
|---|
|
|
Medical support ... from pharmacist activity report (1) - acute phase in the Aichi Medical University Hospital in 0027 Great East Japan Earthquake to a sub-acute phase Masayuki Takeuchi 1, Yukio Toyama 1, Hiroyuki Shimada 1, Akiko Tsukada 1, Kato Takahiro 1, 2, Yasushi Yamamoto University 1, Hiroko Saito 1, Takaaki Hasegawa 1, Yoshihiro Yamada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011. |
|---|
|
|
Medical support ... from pharmacist activity report (2) ... sub-acute phase in the Aichi Medical University Hospital in 0028 Great East Japan Earthquake to a chronic stage Akiko Tsukada, Yasushi Yamamoto University, Kato Takahiro, Hiroyuki Shimada, Masayuki Takeuchi, Yukio Toyama, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011. |
|---|
|
|
From 0029 sub-acute phases through the disaster medical care support activity in role - Kesennuma-shi synthesis gymnasium of the pharmacist at the large-scale refuge in the chronic stage - Tomoki Kagiyama 1, Katsunori Shinohara 1, Hiroyuki Nagano 2, Suzuki good tree 2, Takao Asami 3, Junichiro Fukuhara 3, Takaki Kitazawa 2, Toru Kishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011. |
|---|
|
|
Compare the Great East Japan Earthquake with the medical supplies demand - Niigata Chuetsu earthquake in the relief activities at 0030 stricken areas; and ... Kuniyoshi Tanaka, Masahiro Nakayama, Tsuyoshi Azuma, Takeshi Nakamura will, 室親明, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2011. |
|---|
|
|
Role ... of the pharmacist in disaster hospital practice report - disaster medical care in 0031 Great East Japan Earthquake 阪上倫行, Kazuhiko Yamashita, Hideaki Daimatsu, Atsushi Wada, Kenta Tanaka, 熊岡穣, Hoshino Kengo, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011. |
|---|
|
|
The relief activities that a pharmacist of the Kobe Red Cross Hospital in 0032 Great East Japan Earthquake conducted Yamagishi male good luck, Masaki Horibe, 池井健, Koichi Murakami, Asuka Ushio, Hideki Adachi, Teruhisa Matsubayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011. |
|---|
|
|
About medical support activity for the Great East Japan Earthquake as 0033 Hyogo Hospital Pharmacist Association and a future action Tatsuya Ono 1, 2, Satoko Katsuragi 1, 3, Tsuneo Hamaguchi 1, 4, Tsuyoshi Hirano 1, 5, Teruhisa Matsubayashi 1, 6, Yoshihisa Takao 1, 7, Yukiko Kawamoto 1, 8, Toru Hashida 1, 9, Hirai green 1, 5, Hideyuki Nishida 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011. |
|---|
|
|
Activity - logistical support of the virtue bank meeting medical care support corps in 0034 Great East Japan Earthquake arranges a pharmacist and medical supplies quickly how; or - Satoshi Takahashi 1, Yoshiko Tosa 1, Yoshiyuki Miyasaka 2, 6, Tsutomu Ogata 3, Takafumi Izumo 4, Hiromitsu Arakawa 5, Relation bowl Hideo 6, Takuya Kudo 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011. |
|---|
|
|
Role ... of the pharmacist as the logistics in activity - advance party of the virtue bank meeting medical care rescue party in 0035 Great East Japan Earthquake Hiroyuki Goto 1, 5, Yoshiyuki Miyasaka 2, Takuya Kudo 1, Relation bowl Hideo 2, Tsutomu Ogata 3, Satoshi Takahashi 4, Yoshiko Tosa 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011. |
|---|
|
|
Importance ... of the pharmacist in activity report - reconstruction aid period (development one month later) of the pharmacist in the virtue bank meeting medical care rescue party of 0036 Tohoku great earthquake disasters 阪井田哲 1, 福井圭亮 1, Takashi Suzuka daylight 1, Yoshiyuki Miyasaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2011. |
|---|
|
|
Activity ... in Ofunato-shi, Iwate of activity ... sub-acute phase of the virtue bank meeting medical care rescue party in 0037 Great East Japan Earthquake 福井宗憲 1, Shingo Onuma 2, Takamitsu Negishi 3, Takafumi Izumo 4, Yoshiyuki Miyasaka 5, Satoshi Takahashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011. |
|---|
|
|
It is activity ... of the reconstruction aid period from the sub-acute phase in activity - Kesennuma-shi Motoyoshi district of the virtue bank meeting medical care support corps in 0038 Great East Japan Earthquake Kazuko Tateishi 1, Yuka Masuyama 1, 興田賢作 2, Kyohei Kato 3, Keiji Sugawara 3, Yutaka Shinohara 4, 川那邊絵里 5, Midori Araki 4, Yoshiyuki Miyasaka 4, 6, Satoshi Takahashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011. |
|---|
|
|
Role ... of the pharmacist in the upstairs district of activity ... sub-acute phase of the virtue bank meeting medical care rescue party in 0039 Great East Japan Earthquake 萩原省武 1, Yoshiyuki Miyasaka 2, Masaaki Hirakawa 1, Satoshi Takahashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011. |
|---|
|
|
Medical supplies classification ... at role, disaster of the pharmacist in activity ... sub-acute phase / Minamisanriku-cho of the virtue bank meeting medical care support corps for 0040 Great East Japan Earthquake Hiroko Nomura 7, Wakugawa just the morning 1, Islet reason princess 2, 廣本昌英 3, Yuji Meguro 4, Kazuo Takayama 5, Masaaki Hirakawa 1, Yoshiyuki Miyasaka 6, Satoshi Takahashi 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011. |
|---|
|
|
Action of this hospital which is hard to obtain medical supplies caused by 0041 Great East Japan Earthquake, and faces each other Rie Tsuchimoto 1, 2, Hirotsugu Kita 1, Yukiko Kita 1, Takami indigo plant 1, Chiharu Uehara 1, Shinya Watanabe 1, Ryota Nakamura 1, Yuta Komai 1, 櫻間和紗 1, Morimoto wish 1, Hilum three Mizuho 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011. |
|---|
|
|
Difference ... Myanmar, Republic of Haiti of the medical supplies demand in the disaster support activity inside and outside 0042 countries, Tohoku district Pacific offing ... Haruhiko Sato 1, 3, Koichi Ikehara 3, 4, 渡慶次賀博 3, 4, 伊禮武 2, Katsuyo Uehara 1, 2, 知花幸仙 2, 伊波潔 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2011. |
|---|
|
|
Problems ... about the prescription at activity - disaster of the virtue bank meeting medical care support corps in 0043 Great East Japan Earthquake Sawa Takahashi person 1, 福井宗憲 2, Takamitsu Negishi 3, Yoshiyuki Miyasaka 4, Satoshi Takahashi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011. |
|---|
|
|
Role ... of the pharmacist in activity - medium-and-long term disaster support of the virtue bank meeting medical care support corps in 0044 Great East Japan Earthquake 稲野祥宗 1, Tetsuya Katori 2, Satoshi Kubota 3, Yukiko Inoue 4, Wakugawa just the morning 4, Saori Okuda 5, Satoshi Kataoka 6, Yuka Yoneyama 3, Hiroshi Okuda 7, Yoshiyuki Miyasaka 3, 8, Satoshi Takahashi 9 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011. |
|---|
|
|
The present conditions of the infection control in 0045 refuges Hideki Inagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011. |
|---|
|
|
Role of the pharmacist in "the psychological care team" for the victim of 0046 Great East Japan Earthquake 右川浩, Mieko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011. |
|---|
|
|
Experience 0047 Great East Japan Earthquake; and in the ... Hitachi General Hospital is ... about establishment [pharmacist medicine outpatient department] Masashi Onozaki 1, Yoshifumi Aoyama 1, Sachiko Saito 1, Slightly dried fish Yuka 1, 澤畠孝幸 1, Eriko Terakado 1, Shimazaki incense 1, Wataru Sato 1, Mai Okazaki 1, Ayako Sakamoto 1, Yusuke Terakado 1, Masahiko Nemoto 1, Mai Yamamoto 1, Atsushi Shinagawa 2, Toshiro Kamoshita 2, Masakazu Tsutsumi 2, Tsuneo Fujita 2, Yasunori Watanabe 2, Shinji Hirai 2, 岡裕爾 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011. |
|---|
|
|
The support activity of the pharmacist in 0048 Great East Japan Earthquake and education medical at a disaster Noro shallows Takahiko 1, Seiichi Furuta 2, 早瀬幸俊 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2011. |
|---|
|
|
Experiencing the volunteer activity at the stricken area caused by 0049 Great East Japan Earthquake, and having learned Satoshi Sakurai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011. |
|---|
|
|
Action aiming at anticancer drug mixed preparation perfection enforcement in 0050 pharmacy Masami Maeda, Nishibeppu Hiroko, Tomoji Fushimi, Akiko Mizoguchi, Prince Sawamura will, Yoshiyuki Hotta, Toru Morita, Shun Igarashi, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011. |
|---|
|
|
Frequency and onset time of the adverse event in 0051 hospitalization cancer chemotherapy Chiho Hanaoka, Akira Maeda light, Masahide Matsuzaki, Motoi Ito Expo, Hideko Suzuki, Seiya Mizuno, Michiko Tatematsu, Keiichi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011. |
|---|
|
|
About promotion of a review and the proper use of the regimen in the Fukui that we went from examination of 0052 RDI(Relative Dose Intensity) Prefectural hospital 中村尚未, 坂井伸成, Hideaki Kato, Mitsue Uno, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011. |
|---|
|
|
3 cases (about the intervention of the side effect expression situation and the pharmacist) that was given bendamustine dexamethasone therapy in 0053 metropolitan Komagome hospitals Mariko Matsubayashi 1, Maho Miyazawa 1, Yukihisa Imaizumi 1, Yoshiharu Maeda 2, Rumiko Okamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011. |
|---|
|
|
Investigation of the use situation and the side effect expression of bendamustine in 0054 Katsura, Kyoto Hospital Chiharu Murakami 1, 土手賢史 1, Yuka Kobayashi 1, Ayumu Nozaki 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2011. |
|---|
|
|
A side effect in 0055 bendamustine therapy and the measures Takashi Masuno 1, Hiroyuki Horiguchi 1, Teruo Obata 1, Bank Noriaki 1, Masayuki Tamura 1, Kotaro Toyama 2, Takahiro Jinbo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011. |
|---|
|
|
Examination about the renal failure of cisplatin by 0056 diuretics precedence Short hydration method Yuji Hayakawa 1, Michiko Tatematsu 2, 浦良敬 3, Toshiharu Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011. |
|---|
|
|
Investigation about the renal function of patients who received 0057 Low dose FP therapy Tetsushi Kanematsu 1, Yuki Kanematsu 2, Mitsuru Takai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011. |
|---|
|
|
Nephropathic comparison in the starting medical supplies and generic medicine of 0058 cisplatin Naoko Yasumori 1, Minoru Hayashi exhibition 1, 山中竹治 2, Takashi Seto 3, Ai Nakamura 1, 清水裕彰 1, Tomisawa 4, Takanori Kobayakawa 1, Kenji Sugio 3, Yukito Ichinose 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011. |
|---|
|
|
Change of the antinausea therapy for the childhood cancer chemotherapy after 0059 aprepitant induction Maid of honor さあ village 1, Tsuyoshi Aoyama 1, Kazuo Sugita 1, Yasuhiro Nakano 1, Anna Inoue 1, Kazunori Kawakami 1, Seiichi Matsumoto 2, Toshihiro Hama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011. |
|---|
|
|
Relation (the second report) as the pharmacist to the chemotherapy in 0060 children regions Yuka Tanaka 1, Moat jasmin 2, Yokoyama skillful writing 2, Mari Mori 2, Emi Kadoi 2, Great Xisha cord law of nature 2, Kuni Shinoda University 2, Takao light 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2011. |
|---|
|
|
Investigation of efficacy and the adverse event of the bortezomib therapy in 0061 this hospital Chika Masumoto 1, Mayumi Matsumoto 1, Ryuji Nagae 1, Yuji Okamoto 1, Yuka Takenouchi 1, Ota friend Rie 1, Takahashi sub-Mana 1, Riyusuke Rokusha 1, It is still 1 Tatsu Sada, Kenichi Hasuike 1, Yukiko Uchiyama 1, Keigo Ezaki 1, Nariyama Shinichi 2, Masato Iida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011. |
|---|
|
|
1 case that FOLFOX6/FOLFIRI therapy was provided for a liver metastasis of 0062 rectal cancer in 1 course three weeks, and a good state was able to maintain 林田諭 1, Mayu Inoguchi 1, It is Mari 1 for a country, Naofumi Eriguchi 2, Toru Kume 3, 内藤壽則 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011. |
|---|
|
|
Pharmaceutical management for thrombocytopenia in 0063 carboplatin +TS-1 combination therapy Hirotaka Shimota, Ayumi Sato, Tomohito Nakazawa, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011. |
|---|
|
|
Difference of the antinausea control by the difference in route of administration of the prednisolone in 0064 CHOP therapy 中村宏洋 1, North city Kiyoyuki 2, Masashi Ishihara 2, Iibaru University Minoru 2, It is still picture 3 Goto, Nobuhiro Kanemura 3, 笠原千嗣 3, Katsuhiko Matsuura 2, 3, Kotobuki, Tsurumi, Tadashi Sugiyama 1, Hisataka Moriwaki 3, Yoshinori Ito 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011. |
|---|
|
|
The nutritional status of patients who received DCF therapy for 0065 esophageal cancer and association with the adverse event Sayaka Azuma 1, Yuta Watanabe 2, Katsuya Makihara 1, 山内一恭 1, Yoshihisa Honda 1, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011. |
|---|
|
|
Action of the ward pharmacist for 0066 adult T-cell leukemia / lymphomas Ken Hasuo product 1, 2, 村本慎悟 1, 眞田功 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2011. |
|---|
|
|
Discussion ... from examination - DA-EPOCH therapy about the dose at cancer chemotherapy enforcement for patients with 0067 elderly people malignant lymphoma Yoshiharu Mitsunaga 1, Kazuhisa Fujikawa 2, 趙龍桓 2, Hisae Yokoi 3, Suguru Kasahara Castle 1, Jun Hamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011. |
|---|
|
|
Examination about the change of the laboratory values by drug interactions of 0068 aprepitant and dexamethasone Shizuko Okabe 1, Yoshiaki Ikeda 2, Kazuhiro Mori 2, Kenji Kawata 3, Net Katsuo Oka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011. |
|---|
|
|
Making of the critical path based on the sorafenib side effect analysis in 0069 hepatocellular carcinomas Yukiko Kanbara 1, Sachiyo Morita 1, Katsuyasu Tsuda 1, Jun Suwaki three 1, Toshiyuki Takagi 2, Shinichi Fujioka 2, Shunya Osawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011. |
|---|
|
|
The intervention that we made use of the specialty of 0070 cancer pharmacotherapy authorization pharmacists in Upper Tsu Saori, Kazufumi Iwata, 合澤啓二, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011. |
|---|
|
|
About a utility of needs and the information sharing for the pharmacist of the nurse in 0071 cancer chemotherapy Corner Yoshiaki, 多賀允俊, Mikako Nishikawa, Yuka Tanimura village, Hiroyuki Totsuka, 高橋喜統, Small Masaru Hori, Koji Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011. |
|---|
|
|
Research about the side effect expression situation every 0072 malignant lymphoma chemotherapy regimens 政賢悟 1, Kano Tomoko 1, Ibara country charges 2, Nosaka straight volost 3, Hiroaki Mitsuya 3, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2011. |
|---|
|
|
It is investigated a side effect of doxorubicin liposome for 0073 recurrence ovarian cancer, peritoneal carcinoma Kamai Satoko, Tomohito Nakazawa, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011. |
|---|
|
|
0074 Activities in the drug unit in the EMEND capsules adoption 芦崎雅之1, 室田裕大1, 沖山かおり1, 永村陽一郎1, 柴崎功1, 堀治1, 植野由記子2, 山崎龍王3, 中根実4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011. |
|---|
|
|
Effect of aprepitant on acute emesis in 0075 breast cancer EC therapy Hiroshi Fukuma 1, Yukari Hara 1, Masayuki Itakura 2, Nobuhiro Nishimura 1, 直良浩司 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011. |
|---|
|
|
An antinausea effect of aprepitant in the outpatient who received 0076 moderate degree emetogenicity cancer chemotherapy and effect on quality of life Corner Shintaro 1, Child 1 too rare Mochinaga, Arrow ケ part Tomomi 2, Naoko Arakane 3, Ability castle Hirokazu 2, Shinya Kimura 3, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011. |
|---|
|
|
Three cases that introduced aprepitant into patients with 0077 pediatric malignancies chemotherapy, and succeeded Hiroki Yoshida 1, Tree Masaji 1, Now Yoshiko Takada 1, Mutsuo Ishii 2, Kenji Tokui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011. |
|---|
|
|
An effect of aprepitant in 0078 hematopoietic tumors and safe examination Uchida まやこ 1, 2, 3, Kimiko Ichinose 2, Hiromi Hiraiwa 2, Asako Sakurai 2, Koji Kato 3, Miyamoto Toshihiro 3, Pond end Hiroaki 1, Masanori Sueyasu 1, Nobuaki Egashira 1, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2011. |
|---|
|
|
Aprepitant which we added 0079 nutritional status evaluations and performed, examination of the utility for the moderate emetogenic risk of palonosetron Eri Kurosaki 1, Yoichi Tanaka 1, 2, Kiyoshi Shibuya 1, 2, Jun Shibazaki 1, Rieko Hoshino 1, Akiko Nomoto 1, Hideyuki Nagashima 1, Yuka Kobayashi 1, Yasushi Kondo 3, Takako Komiyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011. |
|---|
|
|
Examination about nausea, the vomiting reduction effect of the antiemetics in patients receiving 0080 altitude emetogenicity anticancer drugs Naoki Matsuzawa 1, Yasuyuki Momose 1, Satoru Koizumi exhibition 2, Hanako Momose 3, 1, Sakae, Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011. |
|---|
|
|
Efficacy of aprepitant for the high and intermediate emetogenic platinum-induced digestive symptom in 0081 gynecology ward inpatients Hikaru Otsuka ear 1, Noriko Miyazaki 3, Rei Asai name 2, Taeko Higuchi 3, Yumiko Komori 1, 二改俊章 1, Kiyobumi Yamada 3, Yukihiro Noda 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011. |
|---|
|
|
It is ... on the occasion of action ... aprepitant of the antiemetics standardization in 0082 registration regimen, palonosetron induction Makoto Hosomi 1, Aimi Goto 1, Masami Nishihara 1, 瀧内比呂也 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011. |
|---|
|
|
Examination of efficacy and the adverse event of the aprepitant palonosetron combination in 0083 cisplatin (CDDP) treated patients Usui Naoko 1, Gilt bronze Yoko 1, Tomonori Hirashima 2, Masashi Kobayashi 2, Naoko Morishita 2, Norio Okamoto 2, Hidekazu Suzuki 2, 田宮基裕 2, Yuka Matsuura 2, Shangdong Masumi 1, Yuya Fukuchi 1, Kazuko Shimura 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011. |
|---|
|
|
Examination of the pre-medication for the anaphylactic expression in the docetaxel administration that used 0084 aprepitant together Sanae Miyano, Tatsuya Mori, Chiaki Ogawa, Hiroshi Kudo, Megumi Yatabe, Makoto Kobayashi Sachimi, Keiko Yoshino, Miyashita Kyuutoku, Yasuo Ide, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2011. |
|---|
|
|
Standardization and evaluation of 0085 antiemetics proper use guidelines 芦埜和幸, Takeshi Shibazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011. |
|---|
|
|
Comparison in approximately the antinausea therapy guidelines rule in the two-drug chemotherapy containing 0086 carboplatin Mariko Jinnai 1, Shinji Kimoto 1, Nishimura A 1, Toru Ohori 1, Hisashi Morikawa group 1, Mika Hoshino 2, 穴沢予識 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011. |
|---|
|
|
Examination in the examination (1) severity of the Infusion Reaction expression factor with 0087 rituximab administration Masahiro Kawai 1, Shinichiro Suzuki 1, Hidetomo Yasujima 1, Hiroyuki Hayashi 2, Body marsh Masami 3, Hitoshi Nakamura 3, Akio Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011. |
|---|
|
|
Examination in the examination (2) expression symptom of the Infusion Reaction expression factor with 0088 rituximab administration Shinichiro Suzuki 1, Masahiro Kawai 1, Hidetomo Yasujima 1, Hiroyuki Hayashi 2, Body marsh Masami 3, Hitoshi Nakamura 3, Akio Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011. |
|---|
|
|
Comparative study of the side effect of difference in previous history of treatment (sorafenib and sunitinib) expression of 0089 renal cell carcinoma therapeutic drug Everolimus situation 角川幸男1, 木村貴1, 下辻恒久1, 望月千枝1, 中多陽子1, 丁元鎮1, 桝喜惠1, 武田健2, 垣本健一2, 新井康之2, 西村和郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011. |
|---|
|
|
Side effect expression situation investigation in the Everolimus treated patients for 0090 renal cell carcinomas 沖野真季1, 河崎陽一2, 前田恵2, 八木健太1, 小松仁美1, 田坂健2, 松水尚1, 2, 千堂年昭1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2011. |
|---|
|
|
Relation of the pharmacist for the dermatopathy of 0091 panitumumab 増田博也, 田中こずえ, 阪井田哲, 木田朋子, 福井圭亮, 伴さやか, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011. |
|---|
|
|
Hypomagnesemia and patients background by 0092 panitumumab 世古口眸, 佐久間隆幸, 中村昭宣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011. |
|---|
|
|
Examination about the utility of skin reaction preventive therapy and the skin care instruction for 0093 antiEGFR antibodies therapy Kondo ten thousand Yumi 1, 正置耕一 1, Old upturn child 1, Shibuya Nao 1, Shie Nakagawa 1, Mutsumi Yoshioka exhibition 1, Aiko Sakaguchi 2, New book Toshie 2, Norihisa Yamamoto 3, Jin Yoshizaki paternal blood 3, 渡雅克 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011. |
|---|
|
|
The side effect situation in 0094 cetuximab administration Yamada cherry tree, Motoi Fujii Expo, Tomomi Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011. |
|---|
|
|
The onset of nausea, vomiting symptom situation in the oxaliplatin base regimen for 0095 colorectal cancer Yosuke Ando 1, Hideki Ota 1, Kaori Ito 1, Satomi Kumazawa 1, Maiko Ando 1, Fukuura Kumiko 1, Hiroaki Yano 1, Hiroshi Matsuoka 2, Kotaro Maeda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011. |
|---|
|
|
Investigation about the side effect expression of the panitumumab therapy in 0096 Shimane Prefectural center Hospital 島林逸人, 頼光翔, 新山哲央, 原弓美, 原和輝, 園山智宏, 金子奈緒美, 平野榮作, 後藤澄子, 今岡友紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2011. |
|---|
|
|
follow-up investigation after the allergic onset situation with 0097 oxaliplatin administration and the onset Yohei Ikeno 1, Daisuke Arii 1, Kunihiko Murooka 1, Michi Nojima husband 1, Akio Kidokoro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011. |
|---|
|
|
Effective case of pregabalin for the peripheral nerve symptom to come from 0098 oxaliplatin Your Tsuyoshi Ito 1, Mayumi Yabuki 1, Seki Daisuke 1, Yoshiba Mayumi 1, Haga Shizue 1, Akito Mitsuoka 2, Hiroshi Kuwahara 2, Toru Hibi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011. |
|---|
|
|
Examination for the reduction effect of Oxaliplatin-related peripheral neuropathy with 0099 Ca/Mg preparation administration Keiki Mori 1, 2, Yoko Hamaguchi 1, Kyoko Tadokoro 1, Tomohiro Miyake 1, Manabu Tanimura 1, Koji Fujii 2, Hiroshi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011. |
|---|
|
|
One case that preventive treatment for the vascular pain of 100 oxaliplatin succeeded Kabayama Tomoichi 1, Atsushi Shimizu 2, Hiroshi Morita 1, Katsumi Kurihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011. |
|---|
|
|
Examination of the factor involved in the protein urine expression in patients receiving 0101 bevacizumab Teruo Tsuchiya 1, Hitomi Shiga 1, Masahiro Yasuda 2, Osamu Umeda 2, Akira Tamura person 1, Natsuki Komada 1, Taku Ota rare 1, Tatsuya Takahashi 1, Tomoya Tate 1, Senju Goto 2, Teramachi eyes 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011. |
|---|
|
|
Effect to give renal function of bevacizumab in 0102 colorectal cancer chemotherapy Yuji Shirai 1, Nao Yamada 1, Saori Tsuchida 1, Rie Matsunaga 1, Eri Kodaira 1, Masayuki Morita 1, Hiroaki Aoki 2, 横田徳靖 2, Hideaki Kurihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2011. |
|---|
|
|
Side effect expression of sorafenib situation - in chemotherapy - hepatoma patients for 0103 liver cancer Yoshie Isobe, Sei Suzuki, Kenta Sumiyoshi, 山口佳津騎, Takashi Motoki University, Naoki Shinohara, Masato Kachi, Shinji Kosaka, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011. |
|---|
|
|
Side effect expression investigation in patients receiving 0104 sorafenib Yagi Kenta 1, Yoichi Kawasaki 2, Natsu Takemura Kei 1, Maki Okino 1, It is still 2 Matsunaga, Sendo Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011. |
|---|
|
|
Examination about the antinausea effect of Granisetron 3 mg and Palonosetron 0.75 mg on 0105 FOLFOX enforcement case Jin Kimura 1, 2, Yuko Kudo 1, Yutaka Ishikawa 1, Toshiaki Kato 1, Michihiro Shino 1, Kentaro Yamazaki 2, Hiroshi Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011. |
|---|
|
|
Comparison about the antinausea effect of Granisetron 3 mg and Palonosetron 0.75 mg on nausea, vomiting at 0106 FOLFIRI therapy enforcement Yutaka Ishikawa 1, Yuko Kudo 1, Jin Kimura 1, Toshiaki Kato 1, Machida wish 2, Hiroshi Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011. |
|---|
|
|
Sorafenib doses for patients with hepatocellular carcinoma in 0107 this hospital and adverse event investigation Katsuyuki Takahashi 1, 2, Mizuho, Nakamura 1, 小池敦資 1, Tokuwa eyes Atsushi 1, Satoshi Ikeura Expo 1, Noriko Kawakami 1, Light river Yasuko 1, Takeshi Nishikawa 1, Katsuya Nagayama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011. |
|---|
|
|
An effect of palonosetron in 0108 outpatient department chemotherapy and examination of the side effect Yoko Suzuki 1, Etsuko Shinohara 1, Sumiko Hiura 2, 野村充俊 2, 加藤裕芳 2, 佐々木英久 1, 松尾和廣 1, Tomoko Watanabe 1, Takashi Yoshio 1, Toru Asayama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2011. |
|---|
|
|
Trial of the pharmaceutical intervention to qualitative improvement of the treatment with 0109 altitude emetogenicity risk anticancer drugs Kanai friend Norie 1, 2, Chika Fujii 1, 2, Misako Fujino 1, 2, Precincts of a shrine Shunji 2, 3, Tomomi Oshiro 2, 3, Yoshiko Hamaguchi 2, 4, Chihiro Iseki 2, 4, 八野芳巳 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011. |
|---|
|
|
Examination of the antinausea therapy in 0110 colorectal cancer chemotherapy mFOLFOX6, FOLFIRI therapy Kazuhito Abe 1, Tetsuya Kajimoto 2, Yukiko Muramatsu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011. |
|---|
|
|
Effect comparison of the 5-HT3 receptor blocker in patients who received induction therapy of 0111 acute myeloid leukemia Foot on the side of a mountain Toshiaki 1, Masahiko Obata 1, Kazuhiro Ozawa 2, Niimi Kansho era 3, Hideki Fujita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011. |
|---|
|
|
Fact-finding of the proper use of antiemetics in the cancer chemotherapy of 0112 gynecology regions Star madder 1, 2, Iga Yukako 1, Hiromi Zama 1, Hisashi Shimizu example 1, Miki Morioka 3, Junichiro Murayama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011. |
|---|
|
|
Evaluation - using evaluation -VAS of the antinausea therapy by the difference in 0113 cancer chemotherapy regimen Mina Yanai 1, Noriko Yamashita 1, Midori Nishikawa 1, Sumiyo Tatsumi 1, Takeshi Kimura 1, Noboru Okamura 2, Toshihiko Tomita 3, Hiroto Miwa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011. |
|---|
|
|
Evaluation - using intervention -VAS of the pharmacist to supportive care for nausea with 0114 cancer chemotherapy Noriko Yamashita 1, Mina Yanai 1, Midori Nishikawa 1, Sumiyo Tatsumi 1, Takeshi Kimura 1, Noboru Okamura 2, Toshihiko Tomita 3, Hiroto Miwa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2011. |
|---|
|
|
Relation of the ward pharmacist in the antinausea therapy adequacy promotion by 0115 gynecologic cancer chemotherapy Yasushi Yamamoto University, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011. |
|---|
|
|
Comparison of the antinausea effect before and after the use of aprepitant in Carboplatin-based chemothrapy in patients with 0116 non-small cell lung cancer First mountain Tae, Miyamaru Akina, Keisuke Otsu, Kengo Umehara, Yoshiko Wada, Young book Azusa, Hideki Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011. |
|---|
|
|
Nausea and vomiting depression effect evaluation after the transplant pre-treatment regimen review based on 0117 antiemetics proper use guidelines Sanae Watanabe, Kana Okamura, Koichi Tamai, 田渡智子, Satsuki Kubo, Tomohisa Kurata, Takeshi Okutsu, Junko Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011. |
|---|
|
|
We look at the rear about the malaise onset in the high-risk group of 0118 antiemetics proper use guidelines and examine a mark Flood Mutsuko, Hiroshi Ueda, Osawa Machi child, Satomi Chihara, Tsutomu Igarashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011. |
|---|
|
|
Examination of antiemetics for 0119 Low dose FP therapy Yuki Kanematsu 1, Risa Omori child 1, Tetsushi Kanematsu 2, Chinatsu Hasebe 1, Yoshiyuki Miyabe 1, Takehiko Kashiwa 1, Mitsuru Takai 2, Kazuko Hotta 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011. |
|---|
|
|
0120 emetic risks are the onset situation of nausea, vomiting of the cancer chemotherapy with moderate degree, the injection classified mildly Tomohiro Kakimoto, 野間口寛, Reiko Kirino, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, West Kyoko Tsuji, New top Kanako, Hiramatsu sheath, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2011. |
|---|
|
|
Investigation about the use situation and the effect of palonosetron which we looked at according to 0121 emetic risks Naoya Uto 1, Kei Yamaguchi Taro 1, 北森靖隆 1, Shinichi Akaboshi 2, Yasushi Yoshida 2, Ichimura line celebration 1, Kazuhiro Yasukochi 1, Katsuhiko Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011. |
|---|
|
|
Investigation about the utility after the palonosetron induction in 0122 middle and high schools emetic risks regimen 永瀬怜司 1, Tomohiko Harada 1, Nanako Kashiwagi 2, Tomohisa Egawa 3, 赤瀬朋秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011. |
|---|
|
|
Nausea, vomiting at 0123 chemotherapy and examination of the efficacy of Inge Seto Ron hydrochloride tablets for the diarrhea Yoko Iwanaga 1, Keisuke Kakihara 1, Tomoyuki Inoue 1, Hirakawa Tomonori 1, Flat defense of a castle 2, Kyoko Koga 3, Masako Inoue 4, Keiko Morita 5, Kunio 1 between the fronts, Hidenori Harada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011. |
|---|
|
|
Palonosetron in the antinausea therapy this hospital in the treatment with 0124 anticancer drugs stands and tests a position and an effect Kumi Nakamura, Ogre Toshihide Kubo, Masato Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011. |
|---|
|
|
Action to antiemetics proper use in 0125 chemotherapy Tomomi Saito 1, Kaoru Suzuki 1, Hiroki Ono 2, Toshiko Hosoya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011. |
|---|
|
|
Examination of the need of the 5-HT3 receptor blocker for 0126 mild (emetogenicity) risk anticancer drugs Atsuko Hosokawa, Yoshimichi Ogawa, 中島寿久, Shizue Kimoto, History of pail east love, Kazuhiro Ozawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2011. |
|---|
|
|
Examination of short hydration using the Mg in 0128 CDDP administration case Sawa draw, 藤元彬宏, 平郡薫, Sayuri Sakura, Kaori Kawahara, Tatsuhiko Ishida, Rie Ueda, Miyuki Sakurai, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011. |
|---|
|
|
Evaluation of the effect that the in-hospital unification of the moisture load method at 0129 cisplatin administration gives for renal function Nakagawa Takehiro 1, Takashi Goto 1, Keita Uchino 2, Makoto Ishibashi 1, Naotaka Sakamoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011. |
|---|
|
|
Risk factor search of the side effect expression of the GC (Gemcitabine Cisplatin) therapy in 0130 urology department regions Fukunaga Toyomi 1, Masayuki Nishihara 1, Description of Morikawa way 1, West storehouse Noriko 1, Hara University truth 1, Tomoya Tanabe 1, Koji Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011. |
|---|
|
|
Appropriate evaluation of the renal function using a serum albumin level in patients with 0131 head and neck cancer Eri Yajima 1, 3, 植沢芳広 1, Reiko Nozawa 1, Chiaki Ogawa 2, Megumi Yatabe 2, Naoki Kondo 2, Shinichiro Saito 2, 4, Yoshihiko Suzuki 2, Mori Kiminori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011. |
|---|
|
|
Action for the proper use of 0132 zoledronic acid hydrate Kentaro Okita, Yoko Nagao, Kazuhiko Tamura, Ayako Moriyama, Nakajima A Ichiro, Mie Ogata, Shinseki green, Kazuhiro Kondo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2011. |
|---|
|
|
The need of the levofloxacin doses setting in consideration of renal function degeneracy after 0133 anticancer drug administration Fumiko Imai, Shinichi Hikasa, Mina Yanai, Maemura finding, 荻有希恵, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011. |
|---|
|
|
One patient who received GEM+CDDP therapy for the renal pelvic carcinoma metastases to lung of 0134 hemodialysis patients Teruhiko Kamiya 1, Shunichi Endo 1, Tabei spirit city 1, 奥木宏延 2, Hiroshi Okazaki 2, Toshiyuki Nakamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011. |
|---|
|
|
Adverse event investigation by the difference in GFR calculation method at 0135 carboplatin optimal dose calculation 和賀信継, White field Masanori, Taeko Saito, Miyuki Minamikawa, Toshihiro Kumagai, Mt. Chiba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011. |
|---|
|
|
Examination about the myelosuppression at the gemcitabine administration in 0136 renal function degeneracy patients Yuko Date 1, Minoru Hayashi exhibition 1, 清水裕彰 1, Tomisawa 2, Takanori Kobayakawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011. |
|---|
|
|
Present conditions investigation of the expression situation and the symptom measures of the hand-and-foot syndrome with capecitabine in 0137 patients with breast cancer Hata Kojiro 1, Ryoko Udagawa 1, Ryuuto Yasuaki 1, 牧野好倫 1, Nobuaki Yokote 1, Yasuhiro Fujiwara 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011. |
|---|
|
|
The onset of cutis symptom situation and measures by 0138 Cetuximab Bell book Naoya, Landowner Takafumi, 吉嶋抄苗, Yuko Watanabe, Yoshiko Sasaki, Tomoaki Hatakeyama, Maiko Tokumura, Shohei Kawahara, Makoto Takahashi, Masaomi Tanaka, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2011. |
|---|
|
|
Eruption measures of the case that panitumumab +FOLFOX4 therapy was provided for the liver metastases that occurred postoperatively, and hepatectomized 0139 colon cancer 中村美樹, 平田和也, 松本直之, 鈴鹿修平, 多胡和樹, 大津山裕美子, 堀家有美子, 黄前尚樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011. |
|---|
|
|
Retrospective fact-finding about the rash with 0140 pemetrexed 廣上典和 1, Tomoko Ishikawa 1, Fukutake Junko 1, Stone Senmi Kei 1, Yoshihisa Ishiura 2, Takayuki Inao 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011. |
|---|
|
|
It is examined the supportive care for a hand-and-foot syndrome, stomatitis in doxorubicin 0141 liposome Keiichiro Matsuda, Yabuki gets along with each other, Nobukawa Masao, Hiroyuki Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011. |
|---|
|
|
Onset of eruption investigation at the gemcitabine hydrochloride / paclitaxel combination therapy enforcement in 0142 patients with breast cancer Kanako Nakayama, Sachiko Izumi, Masahiro Ueda, Middle side Seiichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011. |
|---|
|
|
Side effect report ... of the PLD therapy in the hospital attached to chemotherapy - Kagawa University School of Medicine for 0143 recurrence ovarian cancer Nami Minagawa, Sei Suzuki, Chihiro Okada, Rie Yamamoto, Hot water wisteria Yuko village, 藤本高成, Tatsuya Inoue, Masato Asakura, Sumio Kimura, Shinji Kosaka, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011. |
|---|
|
|
Examination of the eruption onset time of IMiDs in 0144 multiple myeloma treatment Ayumi Nakamura, Koichi Nagaoka, Toshiharu Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2011. |
|---|
|
|
About an onset of skin reaction factor with the docetaxel administration in 0145 Kure medical center breast surgical patients Yoshimichi Ogawa 1, 中島寿久 1, Atsuko Hosokawa 1, Shizue Kimoto 1, Kazuhiro Ozawa 1, Hitoshi Taniguchi 2, China Ogura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011. |
|---|
|
|
It is ... mainly on side effect investigation - hand-and-foot syndrome about the oral medicine of 0146 anticancer drugs Grass sincerity Harumi, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011. |
|---|
|
|
Examination of side effect of Bendamustin measures for the purpose of the maintenance of 0147 quality of life Hiroshi Kudo, Tatsuya Mori, Naoki Kondo, Sanae Miyano, Chiaki Ogawa, Keiko Yoshino, Makoto Kobayashi Sachimi, Megumi Yatabe, Miyashita Kyuutoku, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011. |
|---|
|
|
The expression situation of the vascular pain with the intravenous 0148 anticancer drugs and the actions to be taken Eri Konno 1, Reina Nishigaki 1, 牧野好倫 1, Koji Murakoshi 2, Nobuaki Yokote 1, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011. |
|---|
|
|
Investigation of the protective efficacy with NSAIDs for the vascular pain with 0149 GEM intravenous administrations and opioids Yuri Sakaguchi field 1, Kan Yukio 1, Junko Ishizaki 1, 崔吉道 2, Kenichi Miyamoto 2, Arai country three 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011. |
|---|
|
|
Safe examination of the meloxicam combination at 0150 pemetrexed (PEM) administration Daisuke Nakanishi 1, Mutsumi Daimon 1, Ayako Deguchi 1, 畑地治 2, Fumihiko Komada 2, 柳川泰裕 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2011. |
|---|
|
|
Examination about the initiation time of 0151 pemetrexed pre-medication Shinohara Keisuke Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011. |
|---|
|
|
The directionality of side effect measures of the cancer pharmacotherapy is ... about antihypertensive medications to use for hypertension treatment of obtained example - bevacizumab by 0152 cancer boards Masahide Matsuzaki, Akira Maeda light, Tomoya Nagase, Noritake Kana, Michiko Tatematsu, 水谷旭良, Keiichi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011. |
|---|
|
|
Adverse event investigation in 0153 this hospital bortezomib decaDelon therapy 斉藤匡昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011. |
|---|
|
|
It is compared the onset of peripheral neuropathy by the administration a week with the administration for every paclitaxel three weeks in 0154 this hospital Misa Matsubara 1, 2, Harada sheath or 1, 2, Hidenori Ogawa 1, 2, Keiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011. |
|---|
|
|
0155 Usefulness of Lafutidine prophylaxis against peripheral neuropathy with Oxaliplatin 三本松泰孝1, 平田力1, 棚谷貢1, 高橋理絵2, 丸山卓哉1, 手塚悠希1, 稲垣育宏1, 青木貴徳3, 須野学4, 松原和夫4, 柴波明男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011. |
|---|
|
|
Hypomagnesemia with 0156 cetuximab worsens peripheral neuropathy of oxaliplatin Machiko Satomi 1, Toru Kawano 2, Yoshiaki Ebisawa 2, Chisato Naoyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2011. |
|---|
|
|
Examination for the onset of acute Colin symptom case with 0157 hydrochloric acid irinotecan Masahiro Yasuda 1, Osamu Umeda 1, Hiromi Ishihara 2, Michiko Hayashi 2, Yasushi Matsui 3, Senju Goto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011. |
|---|
|
|
A present conditions investigation and analysis of the taste disturbance with 0158 chemotherapy Yoshihiro Yamanaka 1, Nabeta Izumi 2, Midori Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011. |
|---|
|
|
Side effect onset in the lapatinib capecitabine combination therapy of 0159 progress, recurrent breast cancer and examination about the treatment continuity Daisuke Ito, Mina Iwai, Okada sum intellect, 宇佐美英績, Michio Kimura, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011. |
|---|
|
|
Difference in adverse event expression ... by examination - epirubicin (EPI) dose in 0160 breast cancer chemotherapy Kaori Matsumoto 1, South Takayuki 1, Junichiro Wakatsuki 1, Mountain Kuni Shimoshige 1, Seiichi Yamamoto 1, Tahara child 1 in total, Kazushige Furuya 2, Hiroshi Nakagome 2, Yoshio Kanemaru 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011. |
|---|
|
|
The combination situation of the antimicrobial agent for 0161 cancer chemotherapy patients and the metal cationic preparation and the onset of fever situation Yukari Ono, Tetsuo Yamaguchi, Naomi Mizuta, Hideaki Daimatsu, Atsushi Wada, Manabu Kume, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011. |
|---|
|
|
Examination of a use situation investigation and the proper use of the filgrastim in 0162 Katsura, Kyoto Hospital blood internal medicine Tortoise rank Kohei 1, 土手賢史 1, Ayumu Nozaki 1, Yuka Kobayashi 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2011. |
|---|
|
|
Premedication - for action - sweating prevention to 0163 colorectal cancer chemotherapy 1 that is Zao, Lower morning law of nature 1, Miki Takara 1, Tokuko Sasahara 1, Naoko Komiya 1, Shuichi Iwami 1, Yuko Kubo 1, Yutaka Ogata 2, Mieko Tsuruta 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011. |
|---|
|
|
The examination of the stress caused by 0164 aromotherapy reduction effect and clinical application to side effect measures in the cancer chemotherapy Inferior branch Sadahiko 1, Tomomi Okamura 1, Okazawa incense Tsu child 2, Yoshikazu Seino 2, Hiroki Kubota 1, Natsumi Masuda 1, Saori Nakagawa 3, 大和進 3, Shin Ota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011. |
|---|
|
|
Examination of the utility of the team approach in medical care using the joint ownership sheet between species jobs in 0165 outpatient department cancer chemotherapy 河野優芙 1, Kenjiro Inaba 2, Maho Taguchi 3, Madoka Kita 2, Miyuki Tsukahara 5, Jun Arita 4, Yoshio Sakai 4, Shigeo Nakajo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011. |
|---|
|
|
Stand on the action of the cancer chemotherapy in the comparison - DPC Hospital of the hematotoxicity in 0166 TC therapy and weekly TC therapy; and ... Hironori Matsui, Imamura pasture employee, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011. |
|---|
|
|
Effect of granisetron on vomiting at anthracyclines + cytarabine therapy enforcement in patients with 0167 acute myeloid leukemia Takashi Goto 1, 3, Kazuki Tanimoto 2, 3, Makoto Ishibashi 1, Seiichi Okamura 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011. |
|---|
|
|
Examination of the risk factor of the neutrophil in patients receiving 0168 carboplatin and thrombocytopenia Rie Hirai 1, Kazumasa Koshikawa 1, Isobe mildness 2, Eriko Suzuki 1, Takayoshi Kosugi 1, Sakae Honma 2, Kenji Nishizawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2011. |
|---|
|
|
Relation of a side effect investigation and the pharmacist after the molecular target medicine induction in patients with 0169 renal cell carcinomas 遠原大地 1, Wataru Takahashi 2, Takahiro Wada 2, Masatoshi Eto 2, Tsuyoshi Kojima 1, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011. |
|---|
|
|
Investigation associated with the onset of diarrhea with the triple-drug therapy for 0170 non-small cell lung cancer Mami Kobayashi 1, Keiko Ono 2, Kiyoshi Mizusawa 1, Satoshi Kishino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011. |
|---|
|
|
Side effect investigation of the MAID strange law therapy in 0171 bones soft tissue sarcoma Goto total Taro 1, Shunichi Miyamoto 2, Miyoko Kato 2, Yukihisa Imaizumi 1, Takahiro Gojima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011. |
|---|
|
|
Examination about the hematotoxicity of the Docetaxel, Cisplatin, 5-FU combination chemotherapy (TPF therapy) for 0172 head and neck cancer 牛之濱風見, 二川俊隆, Shogo Masuda, Mariko Ohba, Mina Ushiyama, Junko Arima, Ryuji Ikeda, 下堂薗権洋, Tatsuya Yamaguchi, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011. |
|---|
|
|
Investigation of steroid withdrawal symptoms with 0173 CHOP therapy Hiroki Sugiyama, Seishi Harada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011. |
|---|
|
|
The effect that difference in quantity of hydration at 0174 Cisplatin administration gives for renal function 西村知恭, Megumi Matsumoto, Yoshinobu Saito, Mugwort stand Yoko, 天野賀弘, 崎山晃宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2011. |
|---|
|
|
Evaluation of the supportive care that a pharmacist suggested in 0175 large quantities methotrexate therapy Tsuyoshi Aoyama 1, Hajime Sugiyama 1, Kazuo Sugita 1, Wataru Suzuki 1, Kazunori Kawakami 1, Seiichi Matsumoto 2, Toshihiro Hama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011. |
|---|
|
|
The actual situation of the chemotherapy enforcement for patients with 0176 non-Hodgkin's lymphoma 75 years or older and the cancellation factor Kitazawa sentence 1, Fumitaka Ise 1, Corner proton 1, Kumi Ueda 1, Head of a village intellect 2, Chihiro Shimazaki 2, History of Hisashi Takara 3, Teru Yokoyama reason 3, 杉井彦文 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011. |
|---|
|
|
About an effect of pregabalin on peripheral neuropathy with 0177 cancer chemotherapy Shinichi Kitamoto, Yuko Yanagida, Shizuka Fujii, Tomohiro Furuya, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011. |
|---|
|
|
Promotion of a use situation investigation and the proper use of the G-CSF preparation in 0178 cancer chemotherapy Okazaki summer true 1, Yasuhiko Sakata 1, Toshiharu Matsumoto 1, Shinichi Miyamori 1, Yasuo Iwamoto 2, Motoki Ninomiya 3, Open Koichi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011. |
|---|
|
|
Fact-finding - of the emergency visit consultation by the adverse event expression of 0179 - cancer chemotherapy patients Norifumi Miyamoto 1, Yutaka Takahira 1, Yusuke Takada 1, Satoshi Tanaka 1, 服部暁昌 1, Teruo Tanaka 1, Kazu Kobayashi truth 2, Crossroads daylight kernel 2, Morita Zhuang Jiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011. |
|---|
|
|
Side effect expression of 0180 Doxil situation investigation 小松香織, 野村充俊, 木村麗砂, 増田信一, 日浦寿美子, 加藤裕芳, 浅山亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2011. |
|---|
|
|
0181 docetaxel, investigation about infection measures at the cisplatin combination therapy Yasushi Habu 1, Fumiko Onizuka 1, 深津祥央 1, Ikuko Yano 1, Shield Ichiro Tani 2, Juichi Ito 2, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011. |
|---|
|
|
One case that developed hyperammonemia by 5FU and anaphylaxis with cetuximab in 0182 colorectal cancer chemotherapy, and suffered from treatment 岩下佳敬 1, Naomi Hasegawa 1, 中尾承司 1, Kimiyoshi Iwasaki 1, Yukiko Narumi 1, Kanae Nakayama 1, Akihiro Sonoda 1, Horai Mai 1, Kazuhisa Ishida 1, Akihiko Sakamoto 2, Hiroshi Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011. |
|---|
|
|
About the side effect expression of 0183 lenalidomide situation Chikako Shimokawa, Yukiyo Kinoshita, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011. |
|---|
|
|
Retrospective investigation about the expression situation of the side effect "diarrhea" in patients receiving 0184 lapatinib and the use situation of the antidiarrheal drug Junya Tsutsui 1, Michiko Tatematsu 2, Masahide Matsuzaki 2, Koji Iwata 3, 室圭 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011. |
|---|
|
|
Mainly on adverse event measures - supportive care medicine explanation brochure in 0185 pharyngeal cancer chemoradiation treatment - Yasushi Aida 1, Adachi texture 1 to praise, Fence tail Naomi 1, Junko Tsujimoto 1, Takashi Nishio 1, Shuko Hashiguchi 2, Setsuko Nishioka 2, 岩江信法 3, Shunsuke Soejima 4, Hitoshi Okugawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011. |
|---|
|
|
The case that camostat mesilate mouthwash was effective for stomatitis with 0186 molecules target medicine Naoko Ishii 1, 3, Kazuko Sugano 1, Seiki Fujii 1, Ryuzo Okuda 1, Yotaro Aida 1, Megumi Ogawa 1, City Toei three stones 1, Hamano reason Takako 1, Mikako Matsumoto 1, Osamu Suzuki kernel 2, Komoda Masayo 3, Kimiko Makino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2011. |
|---|
|
|
The present conditions of this hospital in the cardiac activity evaluation at 0187 trastuzumab administration and new action Harada sheath or 1, Misa Matsubara 1, Hidenori Ogawa 1, Toshihiro Kawaguchi 1, Toshi Takao Mie 2, Keiko Tanaka 3, Yasushi Irie 4, Yoshihisa Tanaka 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011. |
|---|
|
|
Construction of the in-hospital system about the oral antimicrobial agent as 0188 febrile neutropenia measures Fence tail Naomi 1, Naoko Shibata 1, Keiko Maruoka 1, Yasushi Aida 1, Junko Tsujimoto 1, Takashi Nishio 1, Saori Miyamoto 2, Chinami Hino 2, Mitsunobu Matsumoto 3, 根來俊一 3, Hitoshi Okugawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011. |
|---|
|
|
Medication history management induction of the cancer pharmacotherapy including 0189 oral anticancer drug monotherapy and the effect Koichiro Iwata 1, Masatoshi Saito 1, Yoshikazu Kobayashi 1, Kazue Soda 1, Yuko Sudo 1, Shinya Abe 1, Shinobu Matsumoto 1, Masayoshi Nishi beauty 1, Futoshi Saito 1, Kotobuki, Koji Masubuchi 1, 椎崇 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011. |
|---|
|
|
Making of the side effect assessment sheet at 0190 outpatient department cancer chemotherapy Landowner Takafumi, Naoya Suzuki, Yoshiko Sasaki, Yuko Watanabe, 吉嶋抄苗, Tomoaki Hatakeyama, Maiko Tokumura, Shohei Kawahara, Makoto Takahashi, Masaomi Tanaka, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011. |
|---|
|
|
Relation of the pharmacist in 0191 outpatient department chemotherapy Yasuhiko Sakata 1, Takafumi Sugawara 1, Shingu flower gathering 1, Okazaki summer true 1, Toshiharu Matsumoto 1, Shinichi Miyamori 1, Yasuo Iwamoto 2, Motoki Ninomiya 2, Open Koichi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011. |
|---|
|
|
About the evaluation of the checking prescription method of 0192 oral anticancer drugs and a utility of the pharmacist outpatient department 田瀬徹, Hidetaro Higuchi, Satoshi Azuma one, Takashi Yokokawa, Yoshiko Shibata, Yuko Hoshino, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2011. |
|---|
|
|
Action to effective doubt inquiry enforcement in 0193 outpatient department chemotherapy Satoko Yoshimura, Takahiro Ibaraki, Sangayama Hiroki, Pine Satoko Muro, Nishida sheath, Chikako Fukunaga, Hiroshi Tomita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011. |
|---|
|
|
About participation in foreign cancer chemotherapy by the pharmacist in 0194 this hospital Excellent Wada Kosuke 1, Akihiro Kawanaka 1, Watanabe Tarou 1, Kazuhiko Morita 1, Yoshiko Murata 2, Emiko Kuroki 2, Kazuko Yasumura 2, Ryuichiro Sudo 3, Katsuhiro Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011. |
|---|
|
|
Inflection of monitoring and the oral medicine check list of the side effect of pharmacist situation in 0195 outpatient department chemotherapy Takako Watanabe 1, Aida Toshie 1, Mariko Tachibana 1, Naoto Tanabe 2, 山村康比古 1, Mieko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011. |
|---|
|
|
Action ... in the adverse event correspondence of the outpatient from practice - distant place of the staff collaboration medical care in 0196 local morphology outpatient department cancer chemotherapy Ko Hiraide stone 1, 5, Italy Tetsuya Saji 2, 5, Tadashi Sugiyama child 2, 5, Yasushi Yokoyama 1, Kazu Fujii rare 3, Takako Imazeki 1, Takeshi Kato 1, Yutaka Ozeki 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011. |
|---|
|
|
Examination about the importance of the side effect monitoring in 0197 outpatient department cancer chemotherapy Sayo Maruyama 1, Chikako Matsumura 1, 2, Nobuhiko Nakamura 1, Yukio Aomatsu 2, 3, Akira Takayama 1, Yoshitaka Yano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011. |
|---|
|
|
Evaluation of treatment with anticancer drug diary "chopsticks" in 0198 outpatient department chemotherapy Takeshi Iwasaki, Nabeta Izumi, Takahashi sand Yuri, Kazuyo Nakamura, Hiroaki Utsuki, Midori Kimura, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2011. |
|---|
|
|
Relation of the pharmacist in 0199 outpatient department chemotherapy 中尾真隆 1, Watanabe method man 1, Takuya Yamada 2, Tsutomu Sakai 3, Chieko Fuwa 4, Slope Kimiyo 4, Kato wealth Tomoko 4, It is still 1 Suguru Nishimura, Shiro Omiya 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011. |
|---|
|
|
Role of the patients support task in the foreign chemotherapy room by 0200 pharmacists Yuichi Kinjo 1, Kazuya Yamashiro 2, East Onna Takako 3, Seiji Kinjo 1, Naomi Noguchi 1, Kakazu light Kei 1, Hiroshi Ueda 1, Mina Tamaki branch 1, 久場磨紀子 1, Chika Kinjo 1, Is Kinjo; arrive; 1, Hazuki Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011. |
|---|
|
|
Utility of the pharmacist intervention in 0201 outpatient department chemotherapy room Megumi Yatabe, Chiaki Ogawa, Makoto Kobayashi Sachimi, Hiroshi Kudo, Keiko Yoshino, Sanae Miyano, Tatsuya Mori, Miyashita Kyuutoku, Yasuo Ide, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011. |
|---|
|
|
Good use of instruction support seat in the health insurance pharmacy for patients who received 0202 outpatient department cancer chemotherapy Toshimi Iizuka 1, 2, Kiyoshi Osanai Kei 1, Small Yuta Nozawa 1, Mio Tanaka 1, Masami Horiguchi 1, Tomoji Yoshiyama 2, Hideo Ishizuka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011. |
|---|
|
|
We see the rear about the treatment continuation factor to intervene that a resident pharmacist is effective for 0203 outpatient department chemotherapy room and examine a mark Yusuke Noguchi, Rie Asano, Tile Hiroko, Kiyotaka Omori, Keiji Matsumoto, Yoko Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011. |
|---|
|
|
Medication counseling duties of the foreign cancer chemotherapy in the hospital attached to 0204 Shiga University of Medical Science School of Medicine Sudo Seicho 1, 森井博朗 1, Miki Sakanaka 1, Tetsushi Noda 1, Yoshinobu Wakasugi 1, Fukutake Noriko 2, Yuki Kawai 3, Weight Eiji 3, 寺田智祐 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2011. |
|---|
|
|
... which thinks about a new establishment and the action ... one step advanced pharmacist duties of 0205 outpatient department chemotherapy room to pharmacist permanent residence Yagi Makiko, Masahiro Takada, Kazumi Morishita, Masako Kondo, Noge Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011. |
|---|
|
|
Drug control instruction to 0206 outpatient department cancer chemotherapy patients Megumi Kawamura, 小川智孝, Yuko Soga, Note village Mai, Iwaki Akifumi, Naoki Nishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011. |
|---|
|
|
About the emergency visit of the patients receiving treatment with anticancer drug in 0207 outpatient department chemotherapy center and the consultation situation of the diagnosis and treatment department outpatient department Goji Maeda, Atsushi Suzuki term, Daigo Suzuki, Toshiaki Sawada, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011. |
|---|
|
|
Through role - telephone support (oasis call) of the pharmacist in 0208 outpatient department chemotherapy - Kumagaya 1 required, Toshio Matsunami 1, Kyomi Kaneta 3, Mutsuko Okada 1, Genichi Nishimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011. |
|---|
|
|
Difference - of way - neighborhood health insurance pharmacy of medicine, the medicine cooperation about 0209 oral anticancer drugs and the family drugstore Hiroaki Usui, 野村久祥, 川上英泰, Yuichiro Abiru, Kozue Nakayama, Tadashi Yoshida, Takao Shinohara, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011. |
|---|
|
|
Inflection of the medicine notebook in 0210 outpatient department chemotherapy Minoru Matsumoto 1, Upper pond Kazuko 1, Character Mika Hara 2, Naomi Yamamoto 2, Yano light 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2011. |
|---|
|
|
The use of the QR cord in the communication of 0211 cancer chemotherapy Hama Wuqing example, Nobuhiko Nakamura, Chikako Matsumura, Yoshitaka Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011. |
|---|
|
|
Examination about the incompatibility of 0212 panitumumab 和田敦, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011. |
|---|
|
|
It is ... about trial ... automatic checking prescription systems construction and internal use anticancer drug regimen registration to 0213 internal use anticancer drug proper use 辻井聡容, Kise Daisuke, Tomoko Wada, 中永 fragrance, 花垣徹, Takafumi Ogaki, Shoji Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011. |
|---|
|
|
Insomnia investigation of 0214 outpatient department chemotherapy patients Satoshi Sato 1, 2, History of Sei Koshiba 1, 2, Takuya Uematsu 1, Kazuyo Endo 2, Kan Yutaka Otaka 1, Takafumi Ichida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011. |
|---|
|
|
Examination about the onset of allergic symptom with the anticancer drug in 0215 outpatient department chemotherapy Tomoko Matsuoka, 吉村知哲, Shino Adachi, Okada sum intellect, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011. |
|---|
|
|
One case of progress colorectal cancer which resulted in rapid thrombocytopenia during 0216 mFOLFOX6+Bevacizumab therapy Masatoshi Nakamura 1, Hiroko Takebe 1, Yu Kikuchi season 1, Hikichi hsiang tsai child 1, Seiichi Yasui 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2011. |
|---|
|
|
The onset of peripheral neuropathy situation under the Ca/Mg agent combination in patients who received 0217 XELOX therapy Masahide Sugiyama, Fumi Aoki, Atsushi Miura, Kazumi Yoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011. |
|---|
|
|
0218 A study on the implementation status of XELOX ± Bevacizumab (BV) therapy and mFOLFOX6 ± BV therapy in outpatient 生駒利恵子1, 服部雄一1, 倉持英和2, 奥山隆二2, 川井朋子1, 山崎智司1, 川辺桂太郎1, 水野裕実子1, 伊東俊雅1, 小林恵美子1, 高橋賢成1, 林和彦2, 木村利美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011. |
|---|
|
|
Induction and evaluation of telephone support system (XTRA) in 0219 XELOX therapy Sasaki Noriaki, Junko Takahashi, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011. |
|---|
|
|
Examination of the factor affecting the anaphylactic expression of patients with oxaliplatin administration colorectal cancer using 0220 cluster analysis Horinouchi Hironari 1, 2, Yuki Katagiri 1, 小中健 1, 2, Tsuyoshi Mori 1, 2, Toshi Nakamura oneself 1, 2, Soichiro Tajima 1, Miyoko Yamaguchi 2, Yukiyo Miki 2, Kazuhiko Teraoka 1, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011. |
|---|
|
|
A side effect comparison between 0221 XELOX and mFOLFOX6 and examination of the side effect measures support of XELOX Chiharu Onoda 1, Midori Kimura 2, Nabeta Izumi 2, Hiroaki Utsuki 2, Yutaka Hayashi 1, 河原崎貴伯 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011. |
|---|
|
|
Examination about an effective volume of infusion and the setting of the intravenous feeding time in consideration of nephrotoxicity before and after the administration of 0222 cisplatin 永野俊玲, Hisae Shinichiro, Yusuke Sato, Toshiharu Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2011. |
|---|
|
|
Examination of the side effect of 0223 CDDP combination chemotherapy 薬師寺信匡 1, Flat comb Shinya 1, Koji Moriya 1, Yohei Koorogi 2, 吉岡弘鎮 2, Ko Tokuda period 1, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011. |
|---|
|
|
Nephrotoxic evaluation in the foreign administration of the cisplatin component regimen using 0224 Short hydration Flat comb Shinya 1, 薬師寺信匡 1, Koji Moriya 1, Yohei Koorogi 2, 吉岡弘鎮 2, Ko Tokuda period 1, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011. |
|---|
|
|
Transition to outpatient department chemotherapy of the high-dose CDDP therapy by the short hydration method which used 0225 oral supplementary water liquid OS-1 together Yusuke Kojima 1, 2, Koga good luck greens 1, 2, Castle old daylight 1, 2, Island Emi 1, 2, Seiko Yokota 1, Country east connection 1, 2, Tsukasa Nakatani person 1, Box tree Yuriko 2, Kyoko Amo 2, Futoshi Imada Yoshiko 2, Kusu Tomomi 2, Katsufumi Miyamoto 3, Suguru Matsuoka kernel 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011. |
|---|
|
|
Medication continuation of sorafenib in 0226 progress hepatoma patients and examination of the affector to give to adverse event expression 下雅意彩 1, 2, Fukudo Masahide 1, 深津祥央 1, Ikuko Yano 1, Toshiya Katsura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011. |
|---|
|
|
Example that caused arms peripheral motor neuropathy, haematospermia during 0227 Panitumumab monotherapy enforcement Daisuke Hirate 1, Akiko Higashiya 2, Toru Nakamura 3, Hideto Yahagi 1, Hongo education 1, Seiji Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011. |
|---|
|
|
Adverse event monitoring of pemetrexed using 0228 patients entry type sheet Kenichi Sakamoto 1, Chinami Ueno 1, Yoko Sakai 1, Masako Imada 1, Koji Kashimoto 1, 宅江良隼 1, Kengo Doi 1, Masahiro Yamazaki 2, 小副川敦 3, Tetsuzo Tagawa 5, Koichi Awaya 6, Yukiko Tamaoki 4, Masatoshi Taniguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2011. |
|---|
|
|
One case of postoperative breast cancer that significant phlebitis developed after administration in 0229 docetaxel first time, and presented moderate allergic reaction by administration on the next time 小笠原信敬 1, Koji Okada 1, Akira Masuda 1, Yuji Koyanagi 1, Yuko Furusawa 2, Maki Sasaki 2, Shin Usami 3, Katsuhiko Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011. |
|---|
|
|
Correspondence to allergic reaction of 0230 docetaxel + cyclophosphamide therapy Mieko Kishi, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011. |
|---|
|
|
Fact-finding ... of perionychia, the fissure in the presence or absence of skin reaction - 5-FU combination by 0231 Cetuximab Kaoru Kobayashi, Akira Takagi Kei, Yasuhiko Mimura, Atsushi Kato, Isao Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011. |
|---|
|
|
Examination of the effective usage of 0232 Doxil (R) notes 今村牧夫, 尻無浜未佳, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011. |
|---|
|
|
Investigation of the side effect of bortezomib in 0233 elderly people institutions Naoya Okumura 1, Kazuhiro Fukami 1, Kubokawa Naomi 1, Miki Kobayashi 2, Katsumi chapter 2, Takeshi Noro 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011. |
|---|
|
|
Induction of 0234 oil xanthan gum (R) therapy and the evaluation Yoshiko Shibata 1, Yuko Hoshino 1, Tomoyo Nakano 1, Hidetaro Higuchi 1, Yutaka Kato group 1, Tomoko Takahashi 1, Kazunori Kawakami 1, Yoshinori Ito 2, Toshihiro Hama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2011. |
|---|
|
|
One case that was effective in Gosha-jinki-gan after onset of 0235 neuropathy Yagi Hideaki, Masashi Hashimoto, Higashijima good luck way, Mutsumi Nishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011. |
|---|
|
|
Example that we attended the informed consent of the physician in 0236 outpatient department, and a pharmacist was able to be involved in in therapy for appendix cancer choice 伊與田友和 1, 浦住幸治郎 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011. |
|---|
|
|
About the expression situation and correspondence of hypersensitivity in 0237 outpatient department chemotherapy 小川丈彦 1, 渡壁美香 2, Kazuaki Kawano 3, Naoyuki Miyano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011. |
|---|
|
|
From examination - patients background of the factor which has an influence on the usability of 0238 portable chronofuser - Kensuke Uemura 1, Mitsuru Susa 1, Yasuko Kotake 1, Mitsusachi Suzuki 1, Akiko Tamura 1, Yoshinori Ando 1, Yumi Takahashi 2, Kumiko Horikawa 2, Nobuyuki Musha 3, Teru Honma 4, Tomoteru Kamimura 5, 神田循吉 6, Hiroyuki Wakabayashi 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011. |
|---|
|
|
Use fact-finding of the XC therapy in 0239 this hospital 北森靖隆 1, Naoya Uto 1, Kei Yamaguchi Taro 1, Ichimura line celebration 1, Kazuhiro Yasukochi 1, Hitomi Goto 2, Katsuhiko Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011. |
|---|
|
|
Attitude survey of the medical staff for the psychological care team in 0240 Saga Hospital Masashi Hashimoto 1, Higashijima good luck way 1, 2, Yagi Hideaki 1, 2, Teruyo Hiwatari 1, 3, Akito Enjoji 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2011. |
|---|
|
|
A problem of the psychological care in this hospital judging from the use situation investigation of 0241 opioids and role of the pharmacist Kenta Takahashi 1, 5, Rumi Hiyama 1, Tomoko Matsuura 2, 5, Mayumi Sakagami 2, 5, Shigeto Sakuta 1, Yuichi Sekizawa 1, Kazuya Konishi 3, 5, Hideo Takayanagi 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011. |
|---|
|
|
Relation of psychological care and the ward pharmacist in 0242 Masuda Medical Association Hospital 西迫多重 1, 宅野真由美 2, Yuri Kawakami beauty 2, Bank high Namiko 3, Shinji Hattori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011. |
|---|
|
|
Cooperation systems construction of 0243 psychological care teams and nutrient support team Junko Nakanishi 1, 2, Sachiko Takahara 1, 3, 加福夏織 1, 篠永浩 1, 3, Tsunekazu Harada 1, Tsutomu Kachi 1, Eiji Mukai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011. |
|---|
|
|
Analysis of the psychological care team intervention effect in 0244 this hospital Kazuma Amino 1, 2, Aiko Fujimori 1, 2, Miwako Hayashi 1, Masayoshi Oguchi 1, 浜至寛 1, Osamu Atobe 1, Tomomi Sasaki 2, Mutsumi Hashizume 2, Kenji Takekawa 2, Kotaro Gomi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011. |
|---|
|
|
Medical narcotic proper use by 0245 psychological care team intervention Ryoji Takahashi 1, Shiori Shimada 1, 松本佳剛 1, Ueda exhibition charges 1, Yukiko Yamaji 2, Yoshiyuki Onishi 2, Kazue Shinno 3, Michio Oda 4, Eiji Yamanaka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011. |
|---|
|
|
Action aiming at qualitative improvement of the psychological care in 0246 this hospital Shiho Takamura 1, Tomoyo Miyagi 1, Akiko Kuroda 1, Yumiko Fukui 1, Ueda 11 1, Noriko Terakawa 1, Kazumi Amano 2, Yoshie Fukushima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2011. |
|---|
|
|
It is ... for appropriate pharmacotherapy based on evaluation of the action after 0247 psychological care team operation and future problem - WHO method cancer pain therapy Yumi Matsumoto 1, Yoshihiko Matsuki 1, Toshiaki Onuki 1, Asami Yasuda 1, Tatsuya Suzuki 1, Akiko Shinoda 1, Hiroko Asai 1, Takahashi Yuka 1, Noriko Mishima 1, Noriko Iwasa 1, Arinobu Yumi 1, Kenichi Sugiura 1, Eriko Takahashi 1, Country Yasuhiro tree 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011. |
|---|
|
|
Study on stability of 0248 high dose morphine hydrochloride water Ayumu Fujiwara 1, 2, Imamura pasture employee 3, Naoko Yamada 1, Hironori Matsui 3, Kentaro Katayama 3, Eizo Takahashi 4, Shin Hanioka light 4, 介 4 of Takashi Okamoto, Shizuo Narimatsu 4, 名倉弘哲 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011. |
|---|
|
|
Examination about the drug release of 0249 fentanyl percutaneous absorption type preparation Every field Chieko 1, Masada Kazuki 1, Yuichiro Kayano 2, Toshiaki Nakamura 2, Mikio Masada 2, Etsuko Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011. |
|---|
|
|
Competitive review about an effect, the usability in the fentanyl patch of 0250 two kinds Kusakabe young of sweetfish 1, Bank former Maki 1, Nagasato, Miyazaki child 1, Momoko Fujise 1, Sato Kei sinter 1, Rika Fukui 2, Akeda Katsuyuki 3, Kazuki Kikuchi 1, Many islands Takahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011. |
|---|
|
|
Attitude survey about the fentanyl once a day pasting preparation by the questionnaire for 0251 nurses Keiko Hara 1, Chiyo deferred Takako 1, Shinji Yamaguchi 1, Toru Nakamura will 1, Kazuki Kashimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011. |
|---|
|
|
One case that the number of rescue decreased by the changes from a type preparation to a daily type preparation on attitude survey and 3rd to a nurse after the type preparation induction on 0252 fentanyl 1st Yuichiro Baba 1, Kazuhiko Fujita 1, West Hikari 1, Saori Morita 2, Fumihiko Matsuno 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2011. |
|---|
|
|
Utility of blood fentanyl densitometry in the use of 0253 fentanyl pasting preparations patients Ukuru Watanabe flat 1, Ryoichi Yano 1, Satoshi Takano early 2, 武澤江合子 1, Tomoe mountain path child 1, 根來寛 1, Kawamichi 1, Misato, Takashi Azuma 1, Toshiaki Igarashi 1, Yuichiro Kayano 1, Toshiaki Nakamura 1, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011. |
|---|
|
|
Examination of the utility about the change to the induction of the fentanyl infusion for the patients needing pain relief in 0254 early stages and a fentanyl MT patch Watanabe method man 1, 4, 安村幹央 2, Takuya Yamada 3, Toyoo Nita 3, Shigeru Kiyama 3, Masao Niwa 3, Keiko Yamamura 4, It is still 1 Suguru Nishimura, Shiro Omiya 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011. |
|---|
|
|
About the induction of the fentanyl citrate patch in 0255 this hospital Junko Ishimi, 森睦, Shinobu Arimoto, Yukako Ono, Middle Mie Hama, Yoshie Mori, Yukiko Shiraki, Eriko Harada, Kawabata Noriyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011. |
|---|
|
|
The investigation of the consciousness change for the medical drug for 0256 commoners and examination about the need of the enlightenment Kazuyoshi Manabe, Chikako Matsumura, Naho Matsuoka, 地嵜悠吾, Nobuhiko Nakamura, Akira Takayama, Yoshitaka Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011. |
|---|
|
|
Patient compliance instruction to the use of drug patients for cancer pain in 0257 community pharmacy Naomi Yamaguchi 1, Tomoko Watanabe 1, Toshie Ota 2, Harumi Ito 2, Etsuko Shinohara 1, 佐々木英久 1, 松尾和廣 1, Takashi Yoshio 1, Akito Nonaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011. |
|---|
|
|
A relation and image to the medical drug of the staff concerned with at-home practice judging from 0258 questionnaire results Koji Takizawa, Satomi Nishizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2011. |
|---|
|
|
Cancer pain control in 0260 ward permanent residence Megumi Yoshida, Hiroshi Matsuzawa, Noriko Ishii, Mariko Negishi, Yoshiko Noji, Funatsu Kumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011. |
|---|
|
|
Prescription pulse-taking - according to the drug clinical condition for cancer pain management - medical care in 0261 this hospital Tadami Chieko 1, Shun Ito elegant 1, 2, Katsura, Kawabe Taro 1, Tomoji Yamazaki 1, Mai Ishibashi 1, Toshinori Hirai 1, Maiko Nakao 1, 越智隆揮 1, Masako Miyazaki 1, 高橋賢成 1, Toshimi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011. |
|---|
|
|
About clinical application for the purpose of effect on blood flow in study on 0262 Mohs paste - mouse and the hemostasis - Maho Taguchi 1, Nobuo Izumo 2, Yasuko Takemori 3, Takashi Toyota 3, Satoshi Kaneko 4, Keiko Tsuge 1, Mikio Hayashi 1, Masaki Ishikawa 1, Masato Shigeyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011. |
|---|
|
|
The preparation of the carbamazepine tablets connotation type suppository for the purpose of 0263 inside the hospital formulation and examination of the utility History of Ai Fukushima, Atsuko Saito, Isamu Murata, Yutaka Inoue, Masayuki Kimura, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011. |
|---|
|
|
Nausea, suggestion ... from use experience - this hospital psychological care team of aprepitant for vomiting which was not as effective with the antiemetics of 0264, etc. 南園奈七恵 1, 2, Tsuyoshi Hirayama 2, Katano bare sincerity 2, Shingo Ono 2, Miyuki Kuno 2, Noriko Terakado 2, Naoko Shimazu 2, Toshiyuki Takahashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2011. |
|---|
|
|
Attitude survey results for examination and the use of the use of zoledronic acid at the initial treatment in the bone metastases case for 0265 lung cancer and examination for the change of the consumption Gilt bronze Yoko 1, 田宮基裕 2, Tomonori Hirashima 2, Masashi Kobayashi 2, Norio Okamoto 2, Hidekazu Suzuki 2, Naoko Morishita 2, Yuka Matsuura 2, Shangdong Masumi 1, Yuya Fukuchi 1, Usui Naoko 1, Keiko Fujita 1, Kazuko Shimura 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011. |
|---|
|
|
Examination of the pain intensity at 0266 opioid analgesic initiation Kaoru Kato, Mt. Misen Hideyoshi, Hiroshi Tomita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011. |
|---|
|
|
Clinical evaluation of pregabalin in 0267 cancer pain treatment Takeshi Nakamura will 1, Mikiko Mochizuki 1, Satoshi Fukunaga 2, Sakae, Inui your picture 2, Kazushige Murakawa 2, Takeshi Kimura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011. |
|---|
|
|
0268 One case in which the sense of security, satisfaction could be migrated to the resulting home by pain control using the PCA pump 續木康夫1, 宮井絢美1, 中村慶1, 和田洋忠1, 山内紀美2, 山田麻美子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011. |
|---|
|
|
Examination from the reduced value in 0269 opioids rotations Chinatsu Hasebe, Risa Omori child, Yuki Kanematsu, Yoshiyuki Miyabe, Takehiko Kashiwa, Kazuko Hotta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011. |
|---|
|
|
1 case of the biliary tract cancer that prescribed it for 0270 cancer pain positively, and supported it, and was given opioid combination Kazutaka Hiraga, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2011. |
|---|
|
|
About the fluid therapy for patients with 0271 end-stage cancers Hiroshi Maki tree, Akito Hosoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011. |
|---|
|
|
Comparison of the closed system connection appliance at 0272 anticancer drug preparations Tatsuro Fujii, Tomoko Suzuki, Kotaro Kawamoto, Shiyo Yamada branch, 関根有貴, Ayako Kato, Seina Noda child, Kadomura Shota, Mina Takeuchi, Yuko Fukuda, Asano still, Tatsuya Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011. |
|---|
|
|
0273 Attempt to anti-cancer agents exposure mitigation using the closed-type administration system (Chemosafe (R), ChemoCLAVE (R)) 秦英司, 栢木啓介, 大谷豊司, 椎木芳和, 高根浩, 大坪健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011. |
|---|
|
|
Problems of closed system instrumentation and the sterile preparation treatment charges in 0274 anticancer drug preparations 俣賀隆, Hideki Kinoshita, The Amagasaki path of righteousness Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011. |
|---|
|
|
Examination of the safety improvement at anticancer drug preparation by the use of closed system connection appliance connection of 0275 two species 中山季昭, Tadashi Watanabe, Daisuke Takei, Chiaki Moriya, Toshiki Musha Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011. |
|---|
|
|
Than present conditions and problem - questionary survey of the injectable anticancer drug preparation in 0276 Akita ... 菅原馨悟 1, Katsuhiro Saito 1, Taguchi poetry rare child 1, Jin Yoshida 2, Hisao Kanazawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2011. |
|---|
|
|
Closed quantitative examination second report in 0277 closed system drug mixture appliances 宮松洋信 1, Yoichi Osato 1, Iga Chinatsu 1, Sachiyo Sudo 1, Momoko Tomioka 1, Early part Hiroko 1, Komi Yoshiyuki 1, Fumiko Maruyama 1, Akira Miyazato bud 1, Toshihiko Hirano 2, 横山智央 3, Takao Akashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011. |
|---|
|
|
Anticancer drug exposure to 0278 closed system connection appliances measures by the induction Shuhei Suzuka, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Miki Nakamura, Great Yumiko Tsuyama, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011. |
|---|
|
|
Role of the pharmacy in the closed system device choice at 0279 anticancer drug preparations Hiroko Takahashi, Shiro Hozumi, Nobuaki Miyagi, Hiromichi Sugawara, Hisakazu Sotooka, Takeharu Nakajima, Miho Suzuki, Yokohama Taeko, Takuji Watanabe, Megumi Ota, Rie Shoji, Setsuo Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011. |
|---|
|
|
Attitude survey for 0280 anticancer drug exposures, education for patients Motoi Kurahashi still, 眞継賢一, Yuko Nakao, 上田浩貴, Tomoko Okamoto, Ken Koba, Yasuhiko Tsukamoto, Yoshihiko Hamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011. |
|---|
|
|
Attitude survey about the anticancer drug exposure in 0281 this hospital Tomoya Nagase 1, Akira Maeda light 1, Masahide Matsuzaki 1, 中川千玲 1, Makiko Ohara 2, Kanae Tozaki 2, 水谷旭良 1, Keiichi Kato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011. |
|---|
|
|
About the induction of action - closed system system of preventive measures against 0282 anticancer drug exposures - Naoko Oikawa 1, Kunihiko Chiba 1, Kayoko Yoshida 2, Mayumi Sakamoto 2, 1000, Ibonai Keiko 2, Yumiko Chiba 2, Hiroshi Takahashi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2011. |
|---|
|
|
Need - of the educational intervention about a relation and the prevention of of the pharmacist in 0283 cancer nursing workshops evaluation (the second report) - anticancer drug exposure Masato Wakabayashi 1, Etsuko Hatakeyama 2, Nakazawa one net 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011. |
|---|
|
|
Pollution investigation of the anticancer drug preparation environment at use of 0284 closed system anticancer drug preparation appliance F seal systems Toshihiro Hama, Wataru Suzuki, Kazuo Sugita, Tsuyoshi Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011. |
|---|
|
|
0285 About enlightenment activity of the anticancer agent radiation exposure prevention in Kin-ikyo Central Hospital 菊池健1, 佐藤春香1, 郡淳二1, 瀬戸宏典1, 鶴山辰1, 岡本麻子2, 小澄悦子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011. |
|---|
|
|
A construction and evaluation of 0286 remote anticancer drug mixed injection support systems which we can inspect Koji Okada, 小笠原信敬, Yuji Koyanagi, Akira Masuda, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011. |
|---|
|
|
Construction of 0287 anticancer drug mixed injection inspection systems Shigeru Kuramoto Ichiro 1, Rope book Masami 1, Daisuke Ogawa 1, Kawasaki Genko era 1, Yasushi Ooi 1, Hitoshi Taniguchi 1, 市場泰全 1, 國原将洋 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011. |
|---|
|
|
The present conditions and problems of the regimen system of administration to think about from 0288 change of prescription examples Shinya Tamaki, Shinya Takada, Yoshihiro Naito, Masahiko Takasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2011. |
|---|
|
|
Induction and action of the cancer chemotherapy regimen system in 0289 electronic charts 彌冨恵, Hiroshi Goto kernel, Lesser horn beauty Yuki, Yukiko Komiya, Ichiro Ota, Hirofumi Koike, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011. |
|---|
|
|
Induction of 0290 "drug information offer paper automatic output systems according to the cancer chemotherapy regimen" Tomoko Kawai, Slope Reiko Tanba, We bear the oak shallows, Yuichi Hattori, Yutaka Fukaya, 高橋賢成, Toshimi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011. |
|---|
|
|
Approach toward the in-hospital elimination of the cancer chemotherapy information using 0291 inside the hospital LAN 高橋さおり, 我妻央陽, 大後友紀子, 吉村美恵子, 並木敏明, 桑原國男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011. |
|---|
|
|
Making of the internal use anticancer drug manual to an outpatient being aware of the communication tool with 0292 patients Akihiro Noda, Kazuhiro Yamada, 眞下惠次, Kayo Kimura, Taki Kazuo, Katsuhiko Sakaguchi, Hiroko Hatai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011. |
|---|
|
|
0293 Attempt to degrade various anti-cancer agent that remains using a photocatalyst in a safety cabinet : Usefulness of Chemo clean evaluation 佐藤淳也1, 2, 工藤賢三1, 2, 瀧本功3, 三林正幸4, 梅澤友和5, 雉鼻一郎6, 高橋勝雄1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011. |
|---|
|
|
Action to 0294 cancer chemotherapy standardization Koto Fujiwara 1, 敦見真由美 1, Shinichi Nakamura 2, Hiroya Masuda 3, Nobuko Matsuura 4, Akiko Takagi 5, 更岡学 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2011. |
|---|
|
|
Relation of the pharmacist to cancer chemotherapy in the cottage-hospital out of one of 0295 order ring systems non-enforcement Kumiko Sako, Yoshiki Ayukawa, Tomoko Shiota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011. |
|---|
|
|
Chemotherapy duties ... regimen management using 0296 Microsoft Access and patient compliance instruction ... Tadashi Tazawa, Old Shigekazu Tanida, Hiromitsu Itakura, 円崎信也, Osamu Tomishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011. |
|---|
|
|
Systems construction - using action - spreadsheet for the efficiency of 0297 cancer chemotherapy-related duties 行本拓史, 徳丸茉理子, Yuka Sugimoto child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011. |
|---|
|
|
A tendency and evaluation of the doubt inquiry example in 0298 cancer chemotherapy electronic charts regimen system induction Atsushi Suzuki term, Daigo Suzuki, Goji Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011. |
|---|
|
|
Making of the medication history management paper for anticancer drug checking prescriptions for 0299 injections Masumi Mori, Takeshi Sasao, Hidekazu Sato, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011. |
|---|
|
|
Improvement of 0300 anticancer drug protocol registration methods and criteria for use of food additives Noriko Ishii 1, Osamu Abe Eiko 2, Yoshiko Noji 1, Funatsu Kumi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2011. |
|---|
|
|
The use that made chemotherapy critical path link a cancer chemotherapy support system in 0301 this hospital respiratory apparatus internal medicine Ogiwara enthusiast chapter 1, 神原康佑 1, Keiko Hara 1, 神原弥由 3, Ikuko Nishii 3, Toshiaki Okada 2, Shingo Harita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011. |
|---|
|
|
We estimate it as a construction of the support from 0302 chemotherapy to terminal phase Kenichi Ito 1, Yuki Mihara 1, 秋吉史久 1, Mika Shuto 1, Kaori Miyazono 1, Masanori Komaki 1, Eri Muta summer 1, Shirao uniformity 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011. |
|---|
|
|
Duties improvement - that we utilized anticancer drug injection mixed expansion and safety measures (the first report) - infection link nurse round of conducting affairs in 0303 health longevity medical center Mikio Shirota 1, Shunichi Miyamoto 1, Kaida Kosuke 1, 早舩美保子 1, Masanori Takigawa 1, Period flat Yuichi 1, Kagoshima Momoko 1, Miyoko Kato 1, Nami Tesaki 2, Eriko Kano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011. |
|---|
|
|
It is ... about an effect after the approach (the second report) - a lot of confirmation sheet introduction aiming at improvement of the quality of 0304 cancer chemotherapy prescription checking 星野真之, 小池恭士, 藤田恵子, 郷原哲, 篠塚一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011. |
|---|
|
|
Revision of the drug control instruction blotter of hospitalization, the outpatient in 0305 chemotherapy Hiroyuki Shimizu, Kensuke Hirooka, Eiko Yoneta, Tanaka pine Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011. |
|---|
|
|
About the review of 0306 cancer chemotherapy regimen Takashi Otsuji 1, 胡井俊祐 1, Shuhei Miyakawa 1, Naoki Yao 1, Toshihiko Yoshioka 1, Fumiaki Yotsumoto 2, Takashi Suzuki world 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2011. |
|---|
|
|
Effective regimen examination by the analysis of 0307 chemotherapy registration applications Takahiro Arai, Toshiaki Kogure, Eriko Hiruta, Fumi Mukoda, Aki Kuwahara, Taeko Saito, Yaeko Mishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011. |
|---|
|
|
Significance of the pharmacy leadership in the sectional meeting specialized in 0308 regimen examination Yasuyo Fukuda, Masumi Miyakawa, Nakagawa spring, Osamu Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011. |
|---|
|
|
About the doubt inquiry by the pharmacist in 0309 cancer chemotherapy Mitsue Uno, 坂井伸成, Hideaki Kato, 中村尚未, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011. |
|---|
|
|
Contribution to cancer chemotherapy adequacy judging from the analysis of 0310 doubt inquiry examples Tomohiko Harada, 永瀬怜司, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011. |
|---|
|
|
About a difference of the reception for the patient compliance instruction in patients with 0311 cancers and patients with other disease Utako Iwakiri 1, 2, Toshio Kubota 1, Daisuke Kobayashi 1, Keiji Suenaga 3, Takao Shimazoe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011. |
|---|
|
|
Fact-finding of the doubt inquiry in 0312 cancer chemotherapy Kaori Yamamoto, Yoko Okabe, Chikako Sawada, Yumi Yamada, Seiichi Takamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2011. |
|---|
|
|
Action ... of the evaluation ... regimen system of administration non-induction institution of the utility of the cancer chemotherapy administration management table in 0313 this hospital Tokita spring Ichiro, 眞中章弘, Junichi Higuchi, Yukiko Sahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011. |
|---|
|
|
Offer and feedback ... of action ... patients information of the medicine medicine cooperation in 0314 oral anticancer drugs Naoko Tsuji, Hitomi Kawaguchi, Masaki Manda, Miyuki Miyake, Kaori Ozaki, Keiko Noguchi, Takami Fujii, 野際俊希, Yasuko Takinami, Depths Kahori, Small bath Takako, Shigeo Asai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011. |
|---|
|
|
Medication support to the molecular target drug remedy patients in 0315 ethical pharmacy Asami Takasawa, 小林詩朗, Minako Tsuchida, Naoto Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011. |
|---|
|
|
Discussion - that we saw it from a contribution article to present conditions - Japanese Society of Hospital Pharmacists magazine of the study about cancer medical care of 0316 hospital pharmacists and clinical pharmacy Emiko Okamoto 1, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011. |
|---|
|
|
Examination about the adsorption to the transfusion filter of 0317 anticancer drugs 山之内恒昭, Yasuhiko Mimura, Atsushi Kato, Isao Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011. |
|---|
|
|
Fact-finding about 0318 imatinib doses and proper use 合澤啓二 1, 11, Tomoko Kitaoka 2, 11, Naoya Uto 3, 11, 政賢悟 4, 11, Yasuaki Otsubo 5, 11, It is still 6 Matsunaga, 11, Kondo New Year's Day 7, 11, 濱田哲暢 4, 11, Eiko Fukunaga 1, Toshiyuki Matsuda 8, 11, Hiraga former 9, 11, 寺田智祐 10, 11, Hideyuki Saito 4, 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2011. |
|---|
|
|
Examination of the example that became the disposal after an anticancer drug preparation in 0319 this hospital Yoshimi Eguchi, Korekawa koto picture, Mayumi Hatano, Shigeru Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011. |
|---|
|
|
Fact-finding about the interaction in 0320 warfarin and pyrimidine system antineoplastic combination patients fluoride Kuni Isobe finally, Yasuaki Otsubo, Mayuko Ito, Hiroko Hiraoka, Tomoyuki Oka, Kunihiro Tsukahara, Light end Takayo, Gain Narihiro, Hiroyuki Watanabe, Shiro Mitsubori, Takeshi Yamamoto, 俣賀隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011. |
|---|
|
|
Effect of the rhea apothecaries measure by the difference of the needle at 0321 injection preparations Jun Taga 1, Shunji Ishiwatari 1, Hideki Fujita 2, 3, Nishida measure three 1, Ayako Kita 1, Reiko Sugiura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011. |
|---|
|
|
Analysis and drug control instruction of the adverse event of the lenalidomide therapy for 0322 multiple myeloma Katsuyuki Nakamura 1, Rev. Noda original 1, Yutaka Yasui 2, Hiroshi Ikeda 2, Toshiaki Hayashi 2, Tei Ishida husband 2, 篠村恭久 2, Kazuyuki Murase 3, 井山諭 3, Tsutomu Sato 3, 瀧本理修 3, Small boat Masayoshi 3, Junji Kato 3, Hiroshi Nakata elegant 1, Atsushi Miyamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011. |
|---|
|
|
Examination of weight loss, the cancellation factor of capecitabine in 0323 colon cancer postoperative adjuvant chemotherapy Miwa Yonezawa, Chiyoko Yamada, South Kenichi, 柏原宏暢, Katsuichiro Kamei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011. |
|---|
|
|
It is a 1 case using Mohs'paste for the advanced breast carcinoma that 0324 disintegrated Miho Yamazaki 1, Yukiyo Funakoshi 1, Side Taiken 1, Katsuaki Takeda 1, Yasushi Nakamura 1, Mamoru Takahashi 2, Akira Hirashima straight 3, Akemi Koshino 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2011. |
|---|
|
|
The effect that an assay date and the time lag of the marker date and time give to a marker rate in 0325 Zevalin markers Gain book Shuji 1, Flat comb Shinya 1, 薬師寺信匡 1, Ko Tokuda period 1, 石守崇好 2, Kazunobu Takayanagi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011. |
|---|
|
|
Examination about the effect of the DNA demethylation inhibitor in colorectal cancer cells in consideration of 0326 circadian rhythm Natsuko Matsumoto, 田中章太, Hitomi Matsumoto, 水野顕慶, Mao Ogawa, Mika Ikehata, Kumiko Ueda, Seigo Iwakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011. |
|---|
|
|
One case of the childhood adrenocortical carcinoma that blood level monitoring was useful in postoperative adjuvant chemotherapy with 0327 mitotane Kuniaki Moriki 1, 2, Hiroshi Takane 1, Kazuko Inoue 1, Yoshikazu Shiiki 1, Kenji Otsubo 1, 鞁嶋有紀 2, Keisuke Okuno 2, Junichi Ueyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011. |
|---|
|
|
Example that an erlotinib repeated dose for 0328 lung adenocarcinoma was effective Hitoshi Taniguchi 1, Rope book A true 1, Daisuke Ogawa 1, 市場泰全 1, Keiichi Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011. |
|---|
|
|
Action of the pharmacist for the cancer chemotherapy appropriate management including 0329 internal use anticancer drugs Terumasa Sata 1, 2, Satoshi Yamaji ordinary 1, Kimotsuki Miho 1, Pond increase sweetfish beauty 1, Shrine gate Takanori 1, Kazuko Tanaka 1, 2, 3, Kayoko Maruyama 2, Uemura eyes 2, 3, Hiroyuki Nagahama 2, Hiroshi Nishijima male 2, 3, 前之原茂穂 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011. |
|---|
|
|
Correspondence to the crazing of the transfusion line with 0330 fluorouracil sustained injection Tatsu Sada still, Mayumi Matsumoto, Ryuji Nagae, Yuji Okamoto, Chika Masumoto, Yuka Takenouchi, Ota friend Rie, Takahashi sub-Mana, Riyusuke Rokusha, Kenichi Hasuike, Yukiko Uchiyama, Keigo Ezaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2011. |
|---|
|
|
Fact-finding about 0331 sorafenib doses and proper use Yasuaki Otsubo 1, 11, Toshiyuki Matsuda 2, 11, 合澤啓二 3, 11, 政賢悟 4, 11, It is still 5 Matsunaga, 11, Tomoko Kitaoka 6, 11, Naoya Uto 7, 11, Hiraga former 8, 11, Kondo New Year's Day 9, 11, 濱田哲暢 4, 11, Hiroyuki Furukawa 1, 寺田智祐 10, 11, Hideyuki Saito 4, 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011. |
|---|
|
|
Evaluation of the patient education in consideration for patients costs burden of 0332 antineoplastic Kamura Motoki 1, Natsuko Hashimoto 1, Naoya Ueno 1, Tomoko Kubota 2, Saori Ogata 3, Mera spirit Ichiro 1, Kioroshi Shiori 1, Hiroshi Yoshimatsu chapter 1, 1 which is related to Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011. |
|---|
|
|
Change of the quality of life affector before and after the adjuvant postoperative treatment of 0333 patients with breast cancer Your Onodera evening 1, Tetsu Iwase 2, 3, Takashi Kawaguchi 1, 2, Megumi Umeda 2, Hiroki Takeuchi 1, Yoshinori Nanun 2, 畝崎榮 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011. |
|---|
|
|
Examination about the consumption change of the G-CSF preparation for 0334 colorectal cancer chemotherapy regimens 古元俊徳, Sasaki Noriaki, Junko Takahashi, 宮之下美穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011. |
|---|
|
|
Relation of the pharmacist in the postoperative pharmacotherapy induction of the patient with breast cancer with 0335 underlying disease Hiroshi Hashimoto season 1, Kyoko Shinozaki 4, Ikuko Yamaguchi 4, Takaaki Tanaka 2, 村上通康 1, Shozo Senba 1, Yumi Oshiro 3, Hiromichi Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011. |
|---|
|
|
Than the investigation of cancellation, the change example of comparison ... treatment of 0336 mFOLFOX6 therapy and XELOX therapy ... Katsuya Tanizawa, Makiko Takaya, Keiko Taguchi, Miura A, Koji Matsunami, Hideji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2011. |
|---|
|
|
The present conditions of evaluation criteria of "alcohol irritation" associated with 0337 paclitaxel administration and one discussion Yoshiharu Kuroi 1, Katsuhiro Kondo 1, Junko Kuroda 1, Tetsuo Ezaki 1, Tetsu Kimura sum 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011. |
|---|
|
|
Examination of the utility of eGFR in 0338 zoledronic acid administration situation investigation and renal function evaluation Liujiang Masatsugu 1, 2, Mariko Nakao 3, Fujiwara season Yoshiko 3, Camellia Masahiro 2, Yuji Hirose 1, Tetsuya Morita 1, Yuzuru Yamazoe 3, Nishida measure three 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011. |
|---|
|
|
Examination ... of the cyclophosphamide resolution out of the air with trial - photocatalyst air cleaner of the anticancer drug being bombed reduction of 0339 healthcare workers Kenzo Kudo 1, 2, Junya Sato 1, 2, Takahiro Hirano 3, Takayuki Kuwajima 3, Kazuhiko Sato 4, Katsuo Takahashi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011. |
|---|
|
|
Examination about the white agglutinate removal to occur after 0340 L-asparaginase decomposition 中島寿久, Yoshimichi Ogawa, Atsuko Hosokawa, 森貞尚之, Shuichi Nishizawa, Kazuhiro Ozawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011. |
|---|
|
|
Examination of the risk factor of the onset of hyperammonemia in 0341 mFOLFOX6 therapy 三角紳博, Hiroki Oishi, The Takashi Miyoshi method, Fish well Miyuki, Furumi Kazuhiro, Hiroko Yamauchi, Kazuaki Ueda, Toshihiro Matsumoto, Makoto Ishibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011. |
|---|
|
|
Effect of nonsteroidal antiinflammatory drug (NSAIDs) which gives it to 0342 pemetrexed Masako Ito 1, Masayuki Miyazaki 1, Seishi Kondo 2, Yoshinori Hasegawa 2, Taku Nagai 1, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2011. |
|---|
|
|
Search of the prognostic factor of 0343 erlotinib remedy patients Carpenter Naomi Hara 1, Atsushi Miura 1, 両角延聡 2, Kazumi Yoda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011. |
|---|
|
|
Action for the sorafenib medication continuation to patients with 0344 liver cancer Fujiko 1 between the fortune, 2, Terumasa Sata 2, Satoshi Yamaji ordinary 2, Kimotsuki Miho 2, Pond increase sweetfish beauty 2, Shrine gate Takanori 2, Kazuko Tanaka 2, Kayoko Maruyama 3, Flat Seiya Mine 4, Yoshiro Baba 4, 前之原茂穂 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011. |
|---|
|
|
Onset of myelosuppression and infection situation investigation in patients receiving 0345 lenalidomide Rina Ito 1, 2, Ayumi Nakamura 2, Aiko Fukui 2, Naoki Mukoyama 2, Tetsushi Kanematsu 2, Atsushi Tomita sum 1, 2, Kenji Miyazawa 2, 森章哉 2, Yuka Tanaka 2, Katsuhiko Haneda 1, 2, Yoshiaki Ikeda 2, Satoru Kato next 2, Masao Maeda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011. |
|---|
|
|
Association of leukopenia and the recurrence in the adjuvant postoperative treatment (UFT/LV therapy) of 0346 colorectal cancer Tomiko Sunaga 1, Shuji Suzuki 2, 小池伸定 2, Naramoto under-secretary 1, Yagi Akihiro 1, Harada sincerity ratio old 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011. |
|---|
|
|
It is ... from economic effect - granisetron by the antinausea therapy review of 0347 cancer chemotherapy of 3 mg to 1 mg from economic effect - granisetron by the antinausea therapy review of 0347 cancer chemotherapy Kenji Katsuragawa 1, 牛膓沙織 1, Fumihiko Yoneyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011. |
|---|
|
|
Association between 0348 Body Mass Index and side effect expression in the mFOLFOX6 therapy Keiichi Ono 1, 2, 寺田智祐 1, 3, Toshiya Katsura 1, Kenichi Inui 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2011. |
|---|
|
|
1 case that presented hyperammonemia during 0349 mFOLFOX6 therapy Chisato Kawahata 1, Maiko Akatsu 1, Tsubotani Ayako 1, Hiroshi Matsumoto 1, Shigeo Hatta 1, Yuko Sakashita 1, Kyoji Yamada 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011. |
|---|
|
|
About the anticancer drug doses to 0350 obese patients and association with the adverse event expression Tsuyoshi Miyahara 1, 2, Child 1 too rare Mochinaga, 奥平献 2, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011. |
|---|
|
|
We give R-CHOP therapy in divided doses in patients with malignant lymphoma of 0351 advanced age and are experienced the case avoiding Serious Adverse Event Chika Aruga, Lower Shigemitsu example, 伊與田友和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011. |
|---|
|
|
About the use situation of antiemetics (NK1 receptor blocker and new 5HT3 antagonist) in 0352 this hospital Tetsuya Sakamoto, Tomoaki Toyama, Atsuo Otsuka, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011. |
|---|
|
|
Rituximab + bendamustine combination therapy - for use case study - non-Hodgkin's lymphoma of the new anticancer drug for 0353 blood disorder Koji Moriya, 薬師寺信匡, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011. |
|---|
|
|
Association with time and laboratory values to determine cancellation of 0354 cancer chemotherapy Kazuto Sato 1, Toshiyuki Hirai 1, Seki Toshikazu 1, Kamiga Masahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2011. |
|---|
|
|
Comparison of Relative Dose Intensity in 0355 progress, mFOLFOX6 therapy and XELOX therapy introduced by first-line treatment for recurrent colorectal cancer Kazuyuki Sunada 1, 三阪高春 2, Kishimoto truth 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Yoshimura truth 1, Yayoi Shinmura 3, Zhongcheng Yuki 3, Michiyo Taniguchi 3, Hirofumi Wakamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011. |
|---|
|
|
Quality of life investigation of colorectal cancer hospitalization chemotherapy patients in 0356 this hospital Kensuke Hirooka, Hiroyuki Shimizu, Eiko Yoneta, Tanaka pine Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011. |
|---|
|
|
About the effect that vibration gives to 0357 etoposide crystallization Toshihiro Otani 1, Manabu Hisamatsu 2, Color river Masanori 1, Kondo good luck 1, History of Shigeru Inose 1, Seiichi Shimizu 3, Shinichi Ueno 2, Kenichi Horikoshi 1, Tokiwa English sentence 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011. |
|---|
|
|
Relation of the pharmacist to the lenalidomide remedy patients in 0358 this hospital Kazuhiro Nakamura 1, Hideaki Anzai 2, 井出眞 3, Kawachi Yasunori 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011. |
|---|
|
|
Classification of the chemotherapy regimen by the scoring of the preparation degree of difficulty of 0359 anticancer drugs Yuji Ishio, 谷口亮央, Shigeru Sato, Tokutome chapter, Mari Kashimura, Hatsumi Kikuta, Miki Katsuragawa, Jun Matsunami, Ryu Kobayashi, Hideji Ohara, 目黒亨治, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011. |
|---|
|
|
Making of the drug duties manual in 0360 lenalidomide (Revlimid (R)) treatment Masanobu Ogawa, Tomoki Yoshioka, Takayoshi Tsuruta, Mariko Kinoshita, Ayumi Ozeki, Mayumi Yamashita, Akemi Morita, Quantity lower Hiroko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2011. |
|---|
|
|
About the apoptotic instruction effect of the new Vitamin K3 derivative on 0361 leukemia cell line Takashi Kawakubo 1, 2, Satoru Asami 1, Maya Arai 1, Masaharu Toriyama 1, Zenichi Yoshida 3, Shigeyasu Motohashi 1, Takashi Suzuki 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011. |
|---|
|
|
Fact-finding about 0362 erlotinib doses and proper use Minoru Hayashi exhibition 1, Tomoko Kitaoka 2, 12, Naoya Uto 3, 12, Hiraga former 4, 12, Kondo New Year's Day 5, 12, Yasuaki Otsubo 6, 12, 政賢悟 7, 12, 合澤啓二 8, 12, Toshiyuki Matsuda 9, 12, Takanori Kobayakawa 1, 濱田哲暢 7, 12, It is still 10 Matsunaga, 12, 寺田智祐 11, 12, Hideyuki Saito 7, 12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011. |
|---|
|
|
Reciprocity effect of the curcumin which gives it to 0363 anticancer drug susceptibility Shimada Mikiko, 峯垣哲也, Comb village Rie, Hiroko Kawano, Kana Fujibayashi, Atsushi Mizumoto, Tomoyo Tsuzuki, Tadashi Takashi Sumida, Asuka, Yamamoto, Masayuki Tsujimoto, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011. |
|---|
|
|
Effect of the prescribed drug which gives it to the fall fall accident in patients with 0364 cancers and various kinds of risk factors Keisuke Takahata 1, 2, 植沢芳広 2, Reiko Nozawa 2, Original Hideki Sawa 3, Mori Kiminori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011. |
|---|
|
|
Development of the injectable pirarubicin hydrochloride (for the TERAL vicine injection) dissolving in 0365 normal saline solutions immediately Junichi Kaneshige 1, Teruhisa Yoshizawa 1, Takashi Murata 2, Hisashi Watanabe 2, Daisen truth 2, Masato Ota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011. |
|---|
|
|
Examination of the effective intervention method for the purpose of 0366 carbapenem system antimicrobial agent proper use 舩越真理 1, Yuko Miyabe 1, 森麻巳 2, Masahiro Tsuda 1, Seiko Ono 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2011. |
|---|
|
|
Inspection of carbapenem antibiotics doses judging from 0367 PK/PD 穴田充孝, Kumi Narita, Eri Ishida, Mina Matsuoka, Kunihiko Murooka, Michi Nojima husband Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011. |
|---|
|
|
Action for the proper use of the carbapenem-based medicine antimicrobial agent in 0368 JA Yoshida General Hospital 只佐宣子 1, Chinatsu Shigemori 2, Shinya Kajitani 1, Kazuya Tokumoto 1, 要田芳代 1, Keiko Kawakami 1, Bamboo increase Mayumi 1, Keiko Hirahara 2, Shunji Horikawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011. |
|---|
|
|
Comparison of the survival rate by the difference of the duration of 0369 carbapenem system antimicrobial agent use Ryota Uehara, Rie Kobayashi, Satoshi Otake Noriko, Yuka Kitagawa, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011. |
|---|
|
|
Attitude survey of the prescription situation and the physician of 0370 antiinfluenza medicine Yukako Yasui 1, 2, Takuji Fujimoto 2, Takayuki Okamura 2, 八野芳巳 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011. |
|---|
|
|
We investigate making and an observance rate of the administration guideline for 0371 antiinfluenza medicine proper use Manabu Yokota 1, 2, High Suma Rina 1, 2, Makoto Hashimoto Kiyo 2, Hitoshi Murase 2, Komaki Hirose 2, Yuka Sugiura village 2, Forest good luck 2, Tsuyoshi Takeuchi 2, 松野匡克 2, Terumi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011. |
|---|
|
|
Approach to fact-finding of the use of 0372 peramivir and proper use 米沢牧子1, 2, 一ノ瀬直樹1, 2, 土橋直子1, 3, 小田智三1, 4, 芝崎健志1, 2, 青木茂行1, 5, 小林隆1, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2011. |
|---|
|
|
Intervention effect for the proper use of levofloxacin based on 0373 renal function Shiori Takahashi, Yuji Okamura, Shinichi Ohara, Shiro Itagaki, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011. |
|---|
|
|
Effect of the high-dose preparation (500 mg of Cravit (R) locks) induction to give to the use situation and the chemical sensitivity of 0374 levofloxacin tablets Takayoshi Tsuruta 1, Tomoki Yoshioka 1, Kazuhisa Kinoshita 2, Mariko Kinoshita 1, Masanobu Ogawa 1, Ayumi Ozeki 1, Mayumi Yamashita 1, Akemi Morita 1, Quantity lower Hiroko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011. |
|---|
|
|
Comparison of the effect of treatment for starting medical supplies of the generic medicine in the ciprofloxacin for 0375 injections Aspect shrine Koji 1, Kenji Miyazawa 1, Makoto Hayashi 1, Akemasa Yamaya 1, North Toshiyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011. |
|---|
|
|
Intervention based on the protocol by the pharmacist for 0376 vancomycin hydrochloride proper use and the effect 石川友貴, Izumi Shimada, Naoko Iwaki, Mizuho Onishi, Akemasa Yamaya, Aspect shrine Koji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011. |
|---|
|
|
An action and evaluation of the pharmacy for 0377 antiMRSA medicine proper use Masashi Tomita, Takashi Motoki, Masahiro Takayanagi, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011. |
|---|
|
|
Standardization of administration plan and the proper use evaluation of 0378 antiMRSA medicine 小川智孝, 80 Shizuka Shima, 平野雅予, Yuko Soga, Small wasabi, Akira Iwaki sentence, Naoki Nishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2011. |
|---|
|
|
Pharmacist intervention effect to drug choice in 0379 Clostridium difficile-related diarrhea Koji Fukuda, Ayako Ajioka, Osamu Tomishima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011. |
|---|
|
|
Examination of the factor affecting the full dose of the vancomycin hydrochloride powder in treatment, the sanitization of 0380 Clostridium difficile infection or patients suspected of infection 佐々木雄啓 1, Aya Fujimoto 1, Ayumi Kochi 1, Kosuke Mukoda 1, Masaaki Ikemoto 1, Hitomi Hirata 2, Sawa Akihiro 2, Toyohisa Tsukamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011. |
|---|
|
|
Fact-finding of the prophylactic antimicrobial agent in 0381 laparoscopic cholecystectomy Tomoji Ishizu 1, Mutsumi Yoshioka exhibition 1, New Yasunori 1, Triangular pile Masakazu 1, Spring Fujiwa charges 2, Tamaki Orita 3, 渡雅克 1, Atsuko Kobayashi 3, Masahiko Takenaka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011. |
|---|
|
|
Cerebrospinal fluid transitivity of vancomycin for 0382 bacterial meningitis 山本倫数, Takeshi Morimoto trunk, Mieko Suzuki, The Yasushi Yokoyama method, Naoko Isoda, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011. |
|---|
|
|
Effect of the hearing investigation from the pharmacist by the use of 0383 investigation system to a physician Yumi Kubo 1, 4, Katsumi Hirata 2, 4, Yumi Matsushima 3, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011. |
|---|
|
|
Examination of the factor affecting the treatment of 0384 Clostridium difficile toxin-positive patients and the recurrence Naoko Kanazawa 1, 2, Kazuaki Matsumoto 1, 2, 茂見茜里 1, 2, 郡山豊泰 2, Hiroaki Miyanohara 2, Hideki Kawamura 2, Michiyo Orita 2, Junnichiro Nishi 2, 猪川和朗 3, Norifumi Morikawa 3, 下堂薗権洋 1, Yasuo Takeda 1, Katsushi Yamada 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2011. |
|---|
|
|
Examination about the chemical sensitivity of antimicrobial agent consumption for 0391 proper use and the main clinical separation germ 近藤匡慶 1, Field stake Naoya 1, 菅谷量俊 1, Keiko Ono 2, Satoshi Kishino 2, Kazuya Murata 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011. |
|---|
|
|
An action to 0392 antimicrobial agent proper use and change of AUD by the generic drug induction Yoshiyuki Tate 1, Oyama reason Takae 1, Inside light Mikio 1, Katsumi Asano 1, Eishin Takahata 1, Yuko Muramoto 2, 又野禎也 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011. |
|---|
|
|
We examine result of the use intervention of the report system antimicrobial agent in 0393 ICT 市川騰 1, Tomoko Hiraiwa 1, Yumiko Yano 2, Hisao Takahashi 3, Circle Sumiyo 4, 友安浩 5, Keita Ichikawa 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011. |
|---|
|
|
The injectable use of antimicrobial agent all patients practice by the pharmacist specialized in 0394 of a check and the evaluation Yasutaka Shinoda 1, 3, Takashi Niwa 1, 2, Akio Suzuki 1, Satoshi Omori 1, Mitsuru Yasuda 2, 太田浩敏 2, Ayumi Fukao 2, North city Kiyoyuki 1, Katsuhiko Matsuura 1, Satoshi Murakami male 2, Tadashi Sugiyama 3, Yoshinori Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011. |
|---|
|
|
Relation to the antimicrobial agent proper use by 0395 ICT charge pharmacists Atsushi Ishida world 1, 2, Naomi Nakamura 1, Emiko Kawano 3, Sangayama Hiroki 1, Harumi Takenouchi 2, Hideo Nakaya 2, 4, Hiroshi Tomita 1, Koya Masaki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011. |
|---|
|
|
Injectable antimicrobial agent consumption change and susceptibility rate (from an investigation for 3 years) of 0396 Tohoku District Rousaibyoins Hajime Nakai 1, Kazunari Nakamura 1, Katsuhiro Sekino 2, Koji Ito 2, Takuji Watanabe 3, Setsuo Tsuchiya 3, Tamotsu Terunuma virtue 4, Kazumasa Kaneta 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2011. |
|---|
|
|
We weigh it about change of the use of antimicrobial agent situation in 0397 this hospital and the susceptibility Hironori Seto 1, Haruka Sato 1, Takeshi Kikuchi 1, County Junji 1, Crane mountain dragon 1, Hiroko Morishita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011. |
|---|
|
|
Examination about the efficacy of the cefotiam using local data in 0399 children upper respiratory infection 丹代恭太, Susumu Kudo, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011. |
|---|
|
|
Examination of the effect of treatment of ceftazidime for 0400 febrile neutropenia and the cefepime Kaori Sakurai 1, 森章哉 1, Rika Nakajima 1, Yukiko Kawamura 1, Yuji Bessho 2, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011. |
|---|
|
|
Effect of treatment for a use trend and the pneumonia case of 0401 tazobactam / piperacillin Chie Yamaguchi 1, Shigeki Nakane 1, Kaneji Miyahara 1, Yoshinori Nakata 1, Tomoko Sato 1, Yoko Tawada 1, 石本昌裕 1, Yoshikatsu Mizutani 1, 朝日慈津子 2, Akihiro Matsushita 3, Kazuhiko Machida 3, Masaki Matsuo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011. |
|---|
|
|
We look at the rear about the use actual situation of the tazobactam piperacillin in 0402 this hospital and investigate a mark Mariko Sugita, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2011. |
|---|
|
|
Examination about use fact-finding of 0403 Tazobactam/piperacillin and the proper use The flat tomorrow beauty, It is Sachiko in a camp, Yukino Urata, Lower stone Kazuki, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011. |
|---|
|
|
If the prescription support of the patients with the renal function degeneracy is demanded a new face pharmacist 0404; about administration plan of GFR level in - antimicrobial agent administration and MEPM - Toshihiko Ishizaka, Mika Kimoto, Hamada rabbitfish, Yukari Yoshihara, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Miyatake wish, U.S. Hara non-origin, Haruyo Matsunaga, Tokuyama picture life, Naoki Ogawa, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011. |
|---|
|
|
Use fact-finding of the linezolid in 0405 left ventricle ventricular assist device wearing patients 藤末慎1, 越智裕之1, 和田恭一1, 老田章1, 小原延章1, 藤田知之2, 戸田宏一2, 宍戸稔聡3, 堀由美子4, 瀬口理4, 村田欣洋4, 簗瀬正伸4, 中谷武嗣4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011. |
|---|
|
|
It is a 2 case using the linezolid for the MRSA deep part infection after 0406 spinal operations 迫田菜穂, 永原紀子, 坂口智香, 奥田みどり, 奥田佳子, 吉田正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011. |
|---|
|
|
One case that a blood level increased 0407 Arbekacin after administration in articular muscle Small thicket Makiko, Makoto Ishibashi, Hiroki Oishi, Nozomi Arima, Toshihiro Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011. |
|---|
|
|
The prospects from the use of teicoplanin actual situation in 0408 this hospital It is still the beginning Tsuda, Aiko Onda, Otsuki swamp male, Parent pine Takahiro, 川嵜英二, Takashi Toyota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2011. |
|---|
|
|
Proper use investigation of MEPM using 0409 Time above MIC analysis software Aya Omuro 1, Mt. Kobayashi 1, 2, Kazuhiro Hayakawa 1, 2, Yuichi Yano 1, Mitsuo Sakamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011. |
|---|
|
|
Use situation investigation of the antifungal agent for the candida blood flow infection in 0410 Hiroshima City Hiroshima Municipal Hospital Takafumi Sugawara, 村上礼隆, Nobue Uetake, Toshiharu Matsumoto, Hiroshi Wada, Shinichi Miyamori, Open Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011. |
|---|
|
|
It is ... along antifungal agent proper use - candidemia guidelines in 0411 this hospital Naoko Shirane, Toshiko Ota, Sumiko Hiura, 加藤裕芳, Toru Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011. |
|---|
|
|
Comparison between effect of treatment - oral ivermectin and transluminal administration - for the duration of treatment in 0412 scabies treatment Naoaki Shimizu 1, Masahiro Yasue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011. |
|---|
|
|
Present conditions investigation of 0413 drug resistance gram-negative bacilli 滝波昇悟, Auditor Hideo, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2011. |
|---|
|
|
Examination of the factor to affect during the use of antimicrobial agent situation in 0415 urinary tract infection and a light period Masaaki Ikemoto, Kosuke Mukoda, 佐々木雄啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011. |
|---|
|
|
1 case that we made de-escalation from carbapenem system to aminoglycoside system from a point of view of 0416 antimicrobial agent proper use Emiko Tanaka, Shiho Hirahara, Chizuru Shirokami, Tomoko before good luck, Tasuku Kawai levator, Norifumi Nakajima, Junko Terada, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011. |
|---|
|
|
Likelihood of the antimicrobial agent proper use to be able to see from 0417 AUD level and chemosensitive rate 篠原由憲 1, Yuichi Izumi 1, Long Yuji Mine 2, Satoshi Kamoshita 3, Seki Yukiko 4, Minako Tsukada 5, 樗木智聡 1, Masashi Shimomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011. |
|---|
|
|
Review of the vaccination program for 0418 staff risk of infection reduction High Suma Rina 1, 2, Manabu Yokota 1, 2, Makoto Hashimoto Kiyo 2, Hitoshi Murase 2, Komaki Hirose 2, Yuka Sugiura village 2, Forest good luck 2, Tsuyoshi Takeuchi 2, 松野匡克 2, Terumi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011. |
|---|
|
|
Ophthalmological infection rounds afferent utility in 0419 medical treatment wards Toshiaki Nakajima 1, 常友盛勝 1, Asako Ide 1, Ball Shiro Shima 1, Hidetoshi Kamimura 3, Eriko Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011. |
|---|
|
|
Investigation of the onset of infection situation in patients with 0420 methotrexate remedy articular rheumatism Morihiro Okada, Miki Segawa, Kimi Sakata, Masae Tsuji, Haba Hisae, Hiroaki Mizuno, Origin of Takeda, It is moisture in the west Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2011. |
|---|
|
|
The expansion of 0421 TDM enforcement drugs and effect by the drawing blood order induction for TDM Satoru Takeyama will 1, 2, Tadashi Tahara cord beauty 1, 八本聖秀 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011. |
|---|
|
|
The content change after the subdivision preparation of 0422 marketing sterilization finished benzalkonium chloride practical use concentrations liquid and study about the microbial contamination Kazuaki Takishima, Yukihiro Hamada, Yoshinobu Sasaki, Masaichi Kuroyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011. |
|---|
|
|
Action to an adoption product change of 0423 sodium hypochlorite preparation Oyama reason Takae 1, Yoshiyuki Tate 1, Masao Niiyama 2, Eishin Takahata 1, Yuko Muramoto 3, 又野禎也 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011. |
|---|
|
|
Antimicrobial agent consumption investigation (the second report) of the Tokyo-affiliated institution using 0424 ATC/DDD systems Mikako Nakano 1, Junichi Suwa 2, Mariko Kurosawa 3, Pine Yoshimitsu child 4, Miki Horiuchi Expo 5, Mariko Oe 6, Koichi Kawase 7, Small Saussurea Root Satoko 8, Takahashi sincerity 9, Yasuhiro Sasaki 10, Look at Shimazaki Kei; 11, Mariko Negishi 12, Mamoru Sato 13, Yumiko Umezaki 3, Funatsu Kumi 12 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011. |
|---|
|
|
The use trend of the antimicrobial agent using 0425 ATC/DDD systems and appropriate management by the ward pharmacist Aida sheath or 1, 久岡清子 1, 2, Kenji Sasaki 1, Yuki Nishitani 1, Naomi Akinaga 1, North residence Miki 1, Interval Chiharu 1, Kanuma Nao 1, Takashi Kameoka 1, Upper teacher Hisayuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011. |
|---|
|
|
Examination about consumption and the susceptibility of the antimicrobial agent in the acute phase elderly people special hospital using 0426 ATC/DDD systems Masanori Takigawa 1, Mikio Shirota 1, Mamoru Sato 1, 鈴木礼乃 4, Eriko Kano 2, 稲松考思 3, Miyoko Kato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2011. |
|---|
|
|
Change of the antimicrobial agent consumption before and after 0427 antimicrobial agent report system induction Akira Katayama rare 1, Jitsukawa Orient 1, Keiko Fukuda 1, Mitsunori Hino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011. |
|---|
|
|
Examination of the antibiotics proper use using 0428 AUD 大島良康 1, Maiko Kaji 1, 宮森勇昌 1, Yohei Mizuguchi 1, Kawabuchi Kumiko 2, Mari Sasaki 2, Mai Kawai 2, Keiko Kanda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011. |
|---|
|
|
Action of the antimicrobial agent consumption surveillance in 0429 Ehime 田中亮裕 1, Inami existence 2, Yuki Shinohara 3, Mayumi Nakahira 4, Masafumi Ono 5, Takashige Asakawa 6, Jin Machida 7, It is still person 8 Tagashira, Ryosuke Akizuki 9, Hisashi Otsuka 10, Shozo Senba 11, Hideki Mukai 12, Fukumoto piece beauty 13, Shinichi Watanabe 1, 末丸克矢 1, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011. |
|---|
|
|
The effect that 0430 anti bio grams and antibiotic regimen support using the Gram stain gave to antibiotic consumption and Pseudomonas aeruginosa susceptibility Yoshihiko Matsuki, Toshiaki Onuki, Yumi Matsumoto, Asami Yasuda, Akiko Shinoda, Tatsuya Suzuki, Hiroko Asai, Takahashi Yuka, Noriko Mishima, Arinobu Yumi, Noriko Iwasa, Kenichi Sugiura, Eriko Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011. |
|---|
|
|
The number of the antimicrobial agent in 0431 this hospital of use, the use days, the count of the dosage regimen and investigation of the chemosensitive rate Toshiaki Onuki, Yumi Matsumoto, Asami Yasuda, Akiko Shinoda, Tatsuya Suzuki, Yoshihiko Matsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011. |
|---|
|
|
Change of antimicrobial agent consumption and the susceptibility with 0432 generic drug changes Mariko Aota, Masashi Sakano, Hajime Sano group Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2011. |
|---|
|
|
Questionnaire findings - about activity report - ICT of 0433 2010 Ishikawa infection control special committees and TDM activities Miyuki Ishida 1, 2, Saeko Kondo 3, Ayumi Miyazaki 3, Hiroyuki Ikeda 1, 4, Satsuki Ito 1, 5, Yoshiyuki Goto 1, 6, Kiyoshi Sasayama 1, 7, Hiroaki Mizuno 1, 8, Kenji Miyazawa 1, 9, Yasuhiko Yamamoto 1, 10, It is moisture 1 in the west, 8, Aspect shrine Koji 1, 9, Kenichi Miyamoto 1, 5, Akihiro Tada 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011. |
|---|
|
|
The need of the use of antimicrobial agent intervention of the pharmacist judging from a use of 0434 antimicrobial agents report book presentation rate Matsushima greens, One river Etsuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011. |
|---|
|
|
Fact-finding about 0435 infection control and the action Ayako Sugiyama, Koichi Hirose, 斎藤孝啓, Look at the field seedling; Erika, Kazumi Kuribayashi, Ichiro Arakawa, Sakae, Adachi tree, 安西偕二郎, Yoko Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011. |
|---|
|
|
Fact-finding about activity and the action of the pharmacist in 0436 infection control Koichi Hirose, Ayako Sugiyama, Kazumi Kuribayashi, Ichiro Arakawa, Sakae, Adachi tree, 安西偕二郎, Yoko Kubota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011. |
|---|
|
|
Action ... to the antiMRSA medicine proper use for patients with activity - infection with MRSA of the infection control team in 0437 nosocomial infection measures Kenichi Kobayashi 1, Akemi Kawakami 2, Star Shuichiro 3, Takeaki Nishibori 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011. |
|---|
|
|
0438 ICT inauguration first anniversary : Ingenuity of cooperation with it, other occupations that have been working 原田七穂, 武本千恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2011. |
|---|
|
|
Examination of the risk factor about 0439 Clostridium difficile-related diarrhea Komura sum Keiko 1, 2, Long Akira Shima 3, Hiroyuki Uchida 4, Ryuichi Ogawa 2, Yoshiyuki Ishii 4, Toshiko Aramiya 1, Hirotoshi Echizen 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011. |
|---|
|
|
The present conditions of C.difficile associated diarrhea(CDAD) in 0440 this hospital and future measures Shuji Ono 1, Takeshi Kashiwabara 1, Tomoko Inoue 1, Kimiyoshi Yoshida 1, Motoi Fujii Expo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011. |
|---|
|
|
Investigation about the patients with 0441 Clostridium difficile-related diarrhea background 朴井三矢, Naoko Fujimura, Yu Kumi, Motoaki Nakao, Makoto Saito, Toshio Tanaka, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011. |
|---|
|
|
Examination of the factor about 0442 Clostridium difficile-related diarrhea Kishi, Matsuzaki, Yasuko Mizuno, Shinichiro Suzuki, 澤藤園子, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011. |
|---|
|
|
Present conditions investigation about the antibiotic exposure of 0443 children community-acquired pneumonia treatment Michiya Tanuma 1, Naoko Furuya 1, Toshiki Saito 1, Yukihiro Yuhara 2, Takahashi Hiro beauty 2, Yoshizo Watanabe 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011. |
|---|
|
|
Investigation about the use situation of 0444 tazobactam / piperacillin Middle storehouse Ichiro 1, 2, Daisuke Yamashita 1, 2, Akemi Horibe 1, 2, Kyoichi Wada 1, Oida chapter 1, Small Hara deferred chapter 1, Makoto Sada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2011. |
|---|
|
|
About the present conditions of the tetanic prophylactic treatment to patients with trauma in 0445 Nagoya memory hospitals Aino Yuri 1, Takeuchi 2, Aruki, Toshihiro Nakanishi 1, Kikuchi sentence 1, Satoshi Araki Eiko 1, Masaru Kawai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011. |
|---|
|
|
Bacteria pollution status of the shading bag for 0446 hyperalimentation Hosomi Kengo 1, Yumiko Hara 1, Hiroki Sugita 1, Sachiko Komaki 1, Norio Masumoto 1, Takako Yuko 1, Hiroaki Otsuki 1, Yoshihisa Takao 1, Offing former Kyoko 2, 名徳倫明 3, 廣谷芳彦 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011. |
|---|
|
|
About fact-finding and the fur Matthew tical care for a treatment outcome and the infection related to infliximab of 0447 articular rheumatism Kenichi Nomura 1, Ryoko Morii 2, Tomokazu Fujii 2, 澤柳直樹 2, Haruhiko Nakamura 2, 岩瀬定利 2, Hisashi Kamiya line 2, 牧野勇 1, Masao Maeda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011. |
|---|
|
|
One case that we intervened in through drug control instruction for infective endocarditis suspicion by 0448 E.coli Samura A, Naoki Hirose, Koibuchi Hiroyuki, Takenori Kurata, Naoko Matsuda, Toshiko Ogawa, 1, Kotobuki, Sekine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011. |
|---|
|
|
Study on risk factor of 0449 substrate specificity expansion type β - lactamase (ESBL)-producing bacteria infection 池田義明1, 5, 西山秀樹2, 5, 高坂久美子3, 5, 宮村耕一4, 5, 森一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011. |
|---|
|
|
Examination of the utility of professional calcitonin in 0450 bacterial infection treatment Hiroyuki Sakano, Maiko Tsukada, Takanori Akiba, Reiko Okazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2011. |
|---|
|
|
Pneumonia protective efficacy with the 23 values pneumococcus vaccine inoculation to the patients with 0451 chronic respiratory disease Yamashiro Sakae person 1, 4, Harumi Iwasaki 4, Taeko Eto 4, Mayu Okamoto 4, Minako Kawasaki 4, Jikumaru Aiko 4, Takeda Fumi 4, Naoko Todaka 4, Chiharu Matsuda 4, Jin Ayabe person 4, Jun Eto 4, Chiemi Kikuchi 4, Miho Yamamura 4, Shiho Tada beauty 4, Iwamoto Wakana 4, Tomohiro Yamamoto 4, Hirofumi Kajiwara 1, Tetsuji Sugata 2, Naoki Hagimoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011. |
|---|
|
|
Intervention effect to the initial treatment for blood cultures-positive patients by 0452 pharmacists Jin Tsukamoto 1, 2, Takashi Azuma 1, Toshiaki Igarashi 1, Toshiaki Nakamura 1, Masao Tobita 2, Yoko Muroi 2, Pond ヶ 谷諭史 3, Kazuki Takagi 3, Hiromichi Iwasaki 2, 3, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011. |
|---|
|
|
The carbapenem-based antimicrobial agent proper use using 0453 clinical paths and pyocyanic resistant trend 高野尊行 1, Kenichi Nakazono 1, Keiichiro Usui 2, Yasushi Kawatsu kernel 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011. |
|---|
|
|
Fact-finding of cleaning duties by the trust supplier worker whom we looked after from the viewpoint of 0454 environment infection management Michiyo Okada 1, Minako Yasuda 1, Okada sum intellect 2, 村井邦充 1, Takayuki Seko 1, 山田一聡 1, Hiroshi Hotta 1, Yoshihiro Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011. |
|---|
|
|
An action of this hospital in preventive measures against 0455 norovirus inside the hospital multiple infections and the evaluation Koike reason Expo 1, West Kyoko 1, Satoshi Sugai 1, Toshiyuki Koyanagi 2, Yagi Motohiro 2, Shigeru Yamashita 2, Igarashi civil virtues 3, Block Hidetoshi 3, Masao Okamura 3, 齊藤幹央 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011. |
|---|
|
|
Action to the safe use of medical supplies in 0456 this hospital Tomoko Kanemitsu 1, Emiko Kawano 1, Citizen of Hiroshi Yamashita 1, Spring wisteria incense 1, Yukari Ito 1, Mayumi Morikawa 1, Michiko Sekita 1, Yasuo Takayama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2011. |
|---|
|
|
Role of the pharmacist in incident report analysis in 0457 this hospital and the medical security Tomoaki Ikezaki, Koichi Tanabe, Machiko Nakamura, Tamura A enthusiast, Aya Handa, Jun Okubo, Kanako Shinohara, Satoko Takeuchi, Hidenori Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011. |
|---|
|
|
Preventive measures against 0458 different group blood transfusion (triggered by an incident report) Junichi Shimizu 1, Takeshi Minami husband 1, Satoshi Nakamura 2, Medical safety management Committee 3, Transfusion therapy executive committee 3, Computer Committee 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011. |
|---|
|
|
Applied - to the picking of improvement - first report compounding of medicines section of the medical security using 0459 handy terminals 伊藤護之, Masaru Arai, 眞壁秀樹, Osamu Sugimoto, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011. |
|---|
|
|
Contribution to the medical security by 0460 ward exclusive duty duties Bell mountain Naoto 1, Hiroshi Tsujimura 2, Kazuki Matsunaga 3, Tomoko Kano 3, Cedar light Hatsumi 3, Kazuhiko Kawakita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011. |
|---|
|
|
Analysis ... (the second report) of contribution ... pre-Abo id report to the medical security by 0461 drug control instruction duties Hiroshi Tsujimura 1, Bell mountain Naoto 2, Naomi Kuroki 1, Kazuhiko Kawakita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011. |
|---|
|
|
Role of the pharmacist to 0462 medical care security promotion activity 廣末毅 1, Yoko Imamura 1, Deer pot Hisako 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2011. |
|---|
|
|
For a problem for 0463 out of the hospital prescription entire surface publication and an offer of security, the reliable pharmacotherapy to action - inpatients - 廣實清司 1, Yutaka Uchida 1, Hiroyuki Furukawa 1, Naoki Kasai 2, Kenji Suizu 2, Miyuki Sugiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011. |
|---|
|
|
Risk management measures and practice in 0464 low-volume hospitals Great posterior Yukiko, Hiroshi Wagatsuma positive, Mieko Yoshimura, Saori Takahashi, Toshiaki Namiki, Kunio Kuwahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011. |
|---|
|
|
0465 Evaluation of the usefulness in patients trouble cases and risk management through the introduction of dispensing recorder "Choreco" 鈴木紀誉昭1, 桜井純蘭1, 沖畠里恵1, 水野善郎2, 土屋文人3, 原澤秀樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011. |
|---|
|
|
Utility of 0466 outpatient department prescription inspection Satoshi Sato boatman, Akiko Sandai, Okinoshima Yuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011. |
|---|
|
|
The compounding of medicines support of poison, the psychotropic drug (injection) using 0467 bar code and construction of the system of administration Toshi Ito Kazuko, Naoko Yoshinaga, 大山高廣, Tomoko Murayama, Takashi Uchida, 木永舞, Naomi Tanoe, Tsuyoshi Kojima, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011. |
|---|
|
|
Epicritic difference in medical supplies bar code by the difference in 0468 background colors 和田良浩, 藤金永美, 橋本茉耶子, Kazuyuki Ikeda, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2011. |
|---|
|
|
About a present conditions report and the preventive measures of the cold water re-hat affecting use of 0469 generic medicine promotion against risks Tadashi Hagiwara daylight 1, Hosokawa Kei period 1, Seiji Nakajima 1, Kazuya Yamauchi 1, 新井裕訓 1, Middle member of a village triad one 1, Atsuya Matsumoto 1, Mikio Sakakibara 2, Satoshi Okada 2, Shinya Sugiura 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011. |
|---|
|
|
0470 Efforts to hospital Medication errors due to multidisciplinary consultation : The role of the pharmacist in the medical safety management office 石渡渚1, 4, 佐藤はるか2, 宮地正和1, 井美縁1, 湯本哲郎1, 4, 川手佳子3, 二ツ神典子3, 加藤幸子3, 菅原るみ子3, 4, 工藤龍彦4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011. |
|---|
|
|
A construction and evaluation of the online incident report system which made much of 0471 breaking news characteristics Hiroshi Kanda kernel 1, 1, Sakae, Omori, Sumio Murase 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011. |
|---|
|
|
Preventive measures against dispensing errors using the envelope with the image of 0472 medical supplies Takashi Watanabe, 百合草憲勇, Tetsuji Maruno, Yoshinori Nakata, Akio Tanaka, Shigeki Nakane, Kentaro Moriwaki, Tomoko Sato, 渡久川敦子, 石本昌裕, Yoshikatsu Mizutani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011. |
|---|
|
|
Analysis about the incident occurrence of 0473 internal use prescriptions factor Yoko Kitano, 田中三広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011. |
|---|
|
|
It is ... for construction - simple and easy and precise prescription checking duties of the "prescription checking sheet" publication system which linked 0474 electronic charts 白川哲, 中尾圭裕, 岩尾恭寛, 植山寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2011. |
|---|
|
|
Examination - of output - utility of the eGFR level to 0475 out of the hospital prescriptions Kazuhiro Kondo, Kazuhiko Tamura, Kentaro Okita, Ayako Moriyama, Nakajima A Ichiro, Yoko Nagao, Mie Ogata, Shinseki green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011. |
|---|
|
|
For the proper use of 0476 medical supplies trial - of the testing information printing to - prescription Yukio Kamiya, Toshiaki Igarashi, Aya Konno, White waves shallows Masaki, Old Takaaki Tawara, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011. |
|---|
|
|
Effect on formulations inspection duties by the change of 0477 medicine bag indication contents 上條佳世, 小泉史子, 坂田穣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011. |
|---|
|
|
Making of the prescription for exclusive use of the ophthalmology that we applied 0478 medication histories list pattern prescription to 前原梨恵, Katsuaki Arai, Kaoru Nakamura, Noriko Shimizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011. |
|---|
|
|
Effect of all automatic tablet packaging machine compounding of medicines to give to the properties of matter of 0479 orally disintegrating tablets Shojiro Kyotani 1, 山下記承 1, Miki Iguchi 1, Takeo Nakamura 2, Seiichi Izumi 3, Seiji Zushi 4, Hisashi Hiramatsu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011. |
|---|
|
|
Incompatibility aspect of the forerunner, the late departure injection which you should recognize at 0480 checking prescriptions and stability Hiroshi Matsuya 1, Yutaka Uchida 2, Yu Nakahara 3, Fujiko Yamazaki 4, Asako Nakagawa 5, Hagiyama Hiroshi 6, Akira Ogata 7, Kazunori Yamamoto 8, 西村篤弘 9, Fukuo Kimura 10, Keizo Ishimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2011. |
|---|
|
|
Utilization - of laboratory study data, drug history in 0481 hospitalization, outpatient, approach of the prescription checking which added patients information and evaluation - prescription check seat 岩崎友美, 小原信一, 福士涼子, 内山和倫, 花田和大, 藤田祥子, 板垣史郎, 早狩誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011. |
|---|
|
|
Construction of the checking prescription system in the internal use anticancer drug requiring 0482 off-period Taniguchi male person, Ooi greens Yoshiko, Shintaro Koshida, Junichi Kubo, Takeshi Nishimaki, Eiji Funaki, Hiroyasu Sato, Yoshihiro Hashimoto, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011. |
|---|
|
|
Analysis and last year comparison of the doubt inquiry example in 0483 prescription order Hoshino Yugo, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011. |
|---|
|
|
Development of the application for smartphone of 0484 drug information search website "relief prescription infobox(R)" and the evaluation Aya Furukawa 1, Young Susumu Hayashi 2, Mari Takayama Michiko 1, Hiroe Shimane 1, Katsuhisa Goto 1, Country branch Masaki 1, Toshiki Hirai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011. |
|---|
|
|
The construction of 0485 new doubt inquiry databases and the evaluation 小形瑛, Masahide Onoe, Old Takaaki Tawara, Hiroki Sato, Hideki Yoshino, Yuka Kageyama, 深津祥央, Ikuko Yano, Toshiya Katsura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011. |
|---|
|
|
Effect of the electric charge to give it to a weight error at 0486 abstract folding 田山剛崇 1, 川本庸太 2, Hiromi Harada 2, Yasuyuki Saeki 3, Shizuko Maeda 1, Sugihara number beauty 1, Katsushi Miyake 1, Look at temple Shigetaka; 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2011. |
|---|
|
|
Investigation about consciousness and the attribute of the pharmacist for management instruction duties about 0487 high risk medicine Yusuke Nakayama 1, Mitsuko Onda 1, Seven Kaiyo child 2, Kato eugenic 1, Makoto Watanabe Yoriko 1, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hiroaki Mukai 1, Manabu Akazawa 3, Arakawa line straight 1, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011. |
|---|
|
|
An action of the pharmaceutical management instruction about the high-risk medicine in 0488 health insurance pharmacy and the related factor Kato eugenic 1, Mitsuko Onda 1, Seven Kaiyo child 2, Yusuke Nakayama 1, Makoto Watanabe Yoriko 1, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hiroaki Mukai 1, Manabu Akazawa 3, Arakawa line straight 1, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011. |
|---|
|
|
Association between calculation reason and enforcement situation of instruction contents becoming the addition grounds of 0489 specific drug management instruction addition Makoto Watanabe Yoriko 1, Mitsuko Onda 1, Seven Kaiyo child 2, Kato eugenic 1, Yusuke Nakayama 1, Rie Tanaka 1, Kenichi Tsubota 1, Shunya Matoba 1, Hiroaki Mukai 1, Manabu Akazawa 3, Arakawa line straight 1, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011. |
|---|
|
|
Association between calculation situation and management instruction contents of 0490 specific drug management instruction addition calculation Seven Kaiyo child 1, Mitsuko Onda 2, Kato eugenic 2, Yusuke Nakayama 2, Makoto Watanabe Yoriko 2, Rie Tanaka 2, Kenichi Tsubota 2, Shunya Matoba 2, Hiroaki Mukai 2, Manabu Akazawa 3, Arakawa line straight 2, Hirohisa Imai 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011. |
|---|
|
|
The analysis of 0491 cancer chemotherapy doubt inquiry contents and inspection of the prescription checking method 松岡加恵, 鈴木美由紀, 能登英子, 久田達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011. |
|---|
|
|
Action to the standardization for 0492 effective drug control instruction duties Hisako Yoshimoto, Kyoji Koda, Masanori Watanabe, 宮野早代, Yuko Nagasawa, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2011. |
|---|
|
|
It is ... for a proposal to consideration - fee-for-service about the sterile preparation in 0493 medical treatment sickbeds Yukio Kondo, 奥野靖隆, Yoshinori Shimura, Yoko Kikuchi, Wife deer Hiromi, Takashi Ando kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011. |
|---|
|
|
Effect by returning the present conditions and doubt content of the doubt inquiry of 0494 this hospital to a physician, a nurse New top Kanako, Morihiko Terashi, 野間口寛, Reiko Kirino, Tomohiro Kakimoto, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, West Kyoko Tsuji, Hiramatsu sheath Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011. |
|---|
|
|
Risk management effect by 0495 ward pharmacists Keiko Adachi, Kazuya Fujita, Masayasu Ito, Yukako Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011. |
|---|
|
|
The suggestion of the procedure to gather fixed quantity with 0496 injectors effectively and the inspection 神谷貞浩, It is still soil Koike, Mika Ozawa, 小嶋文良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011. |
|---|
|
|
Suggestion of the "dosage regimen" mention method of the injection attachment document based on the correct answer rate comparison of 0497 dose calculations Naoya Nishikawa, Takasago Miwako, Saeko Ueda, Miho Yamada, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011. |
|---|
|
|
0498 About usefulness contraindicated to combination between an injection drug, the medicine for internal use using Injection drug handling business support systems of a check 堂東和生1, 久保みさき1, 齊藤暢子1, 加藤雅美1, 矢野裕章1, 高橋幸市2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2011. |
|---|
|
|
To a compounding of medicines incident decrease in by the reexamination 0499 injection compounding of medicines procedures and compounding of medicines environment wrestle; for - human error zero - Yuka Arima, Junko Arima, House and estate Keiko, Upper Megumi Katahira, Takashi Furuta, 西八重乃, 下堂薗権洋, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011. |
|---|
|
|
Effect (the third report) that 0500 injection volumes of infusion give for practice Toshi Tanaka 1, A 1 in the hill, Gamo Makio 2, Masuo Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011. |
|---|
|
|
It is ... about use of relation ... administration set filter of the pharmacist about the proper use of 0501 medical care materials Yuko Hino, Hidekazu Fujita, 豊浜隆, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011. |
|---|
|
|
The effect that study (I) transfusion pump about the proper use of 0502 medical care devices and a transfusion tube give to intravenous feeding speed Masayuki Umemura 1, Hiroyuki Ono 1, 小野允也 1, 奥村慎悟 1, 加納章太 1, Takuya Yasuno 1, Hiroshi Mizuno group 1, Kazuto Hatakeyama 2, 矢野亨治 3, Tomoko Mori 3, Katsuo Shigeno 1, Side shop Yoshibumi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011. |
|---|
|
|
Examination ... in the institution in the action ... simple suspension method induction eighth year of the incompatibility evasion of 0503 simple suspension method 細川浩輝, Yuko Sasaki, Takahiro Akatsuka, Basket island Masahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011. |
|---|
|
|
Duties improvement about the simple suspension in 0504 Tsuyama center Hospital Yuri Yokoyama 1, Midori, Nakamura 1, Akiko Sakuma 1, Yu Haruki person 1, Tetsu Sugiyama University 1, Yukihiro Kawakami 2, Sachiyo Kondo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2011. |
|---|
